<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006715.pub2" GROUP_ID="ANAESTH" ID="593505021509502981" MERGED_FROM="" MODIFIED="2013-07-01 16:55:20 +0100" MODIFIED_BY="Jane Cracknell" REVIEW_NO="103" REVMAN_SUB_VERSION="5.2.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="5.0">
<COVER_SHEET MODIFIED="2013-07-01 16:55:20 +0100" MODIFIED_BY="Jane Cracknell">
<TITLE MODIFIED="2009-06-08 15:35:43 +0100" MODIFIED_BY="Jane Cracknell">Epidural analgesia for cardiac surgery</TITLE>
<CONTACT MODIFIED="2013-07-01 16:55:20 +0100" MODIFIED_BY="Jane Cracknell"><PERSON ID="18644" ROLE="AUTHOR"><PREFIX>Miss</PREFIX><FIRST_NAME>Vesna</FIRST_NAME><LAST_NAME>Svircevic</LAST_NAME><POSITION>Resident Anaesthesiology</POSITION><EMAIL_1>vesnasvircevic@hotmail.com</EMAIL_1><EMAIL_2>v.svircvic@umcutrecht.nl</EMAIL_2><ADDRESS><DEPARTMENT>Department of Perioperative Care and Emergency Medicine</DEPARTMENT><ORGANISATION>University Medical Center Utrecht</ORGANISATION><ADDRESS_1>PO Box 85500</ADDRESS_1><ADDRESS_2>Mailstop E 03.511</ADDRESS_2><CITY>Utrecht</CITY><ZIP>3508 GA</ZIP><COUNTRY CODE="NL">Netherlands</COUNTRY><PHONE_1>+31-30-2509677</PHONE_1><PHONE_2>+31-62-9035191</PHONE_2><FAX_1>+31-30-2541828</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2013-07-01 16:55:20 +0100" MODIFIED_BY="Jane Cracknell"><PERSON ID="18644" ROLE="AUTHOR"><PREFIX>Miss</PREFIX><FIRST_NAME>Vesna</FIRST_NAME><LAST_NAME>Svircevic</LAST_NAME><POSITION>Resident Anaesthesiology</POSITION><EMAIL_1>vesnasvircevic@hotmail.com</EMAIL_1><EMAIL_2>v.svircvic@umcutrecht.nl</EMAIL_2><ADDRESS><DEPARTMENT>Department of Perioperative Care and Emergency Medicine</DEPARTMENT><ORGANISATION>University Medical Center Utrecht</ORGANISATION><ADDRESS_1>PO Box 85500</ADDRESS_1><ADDRESS_2>Mailstop E 03.511</ADDRESS_2><CITY>Utrecht</CITY><ZIP>3508 GA</ZIP><COUNTRY CODE="NL">Netherlands</COUNTRY><PHONE_1>+31-30-2509677</PHONE_1><PHONE_2>+31-62-9035191</PHONE_2><FAX_1>+31-30-2541828</FAX_1></ADDRESS></PERSON><PERSON ID="041CC71E82E26AA200CD32E5FEFBBAC6" ROLE="AUTHOR"><PREFIX>Mr</PREFIX><FIRST_NAME>Martijn</FIRST_NAME><MIDDLE_INITIALS>M</MIDDLE_INITIALS><LAST_NAME>Passier</LAST_NAME><POSITION>Resident Anaesthesiology</POSITION><EMAIL_1>passier.m@bethesda.nl</EMAIL_1><ADDRESS><DEPARTMENT>Department of Perioperative Care and Emergency Medicine</DEPARTMENT><ORGANISATION>University Medical Center Utrecht</ORGANISATION><ADDRESS_1>PB Box 85500</ADDRESS_1><ADDRESS_2>Mailstop E 03.511</ADDRESS_2><CITY>Utrecht</CITY><ZIP>3508 GA</ZIP><COUNTRY CODE="NL">Netherlands</COUNTRY><PHONE_1>+31 302509677</PHONE_1><FAX_1>+31 302541828</FAX_1></ADDRESS></PERSON><PERSON ID="00939C4782E26AA200CD32E56D6B97AC" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Arno</FIRST_NAME><MIDDLE_INITIALS>P</MIDDLE_INITIALS><LAST_NAME>Nierich</LAST_NAME><POSITION>Anaesthesiologist/Intensivist</POSITION><EMAIL_1>a.p.nierich@isala.nl</EMAIL_1><ADDRESS><DEPARTMENT>Thoracic Anaesthesiology and Intensive care</DEPARTMENT><ORGANISATION>Isala Clinics</ORGANISATION><ADDRESS_1>PO Box 10500</ADDRESS_1><CITY>Zwolle</CITY><ZIP>8000 GM</ZIP><COUNTRY CODE="NL">Netherlands</COUNTRY><PHONE_1>+31384242199</PHONE_1></ADDRESS></PERSON><PERSON ID="17845" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Diederik</FIRST_NAME><LAST_NAME>van Dijk</LAST_NAME><EMAIL_1>ddijk@umcutrecht.nl</EMAIL_1><ADDRESS><DEPARTMENT>Division of Anesthesiology, Intensive Care and Emergency Medicine</DEPARTMENT><ORGANISATION>University Medical Center Utrecht</ORGANISATION><ADDRESS_1>PO Box 85500</ADDRESS_1><CITY>Utrecht</CITY><ZIP>3508 GA</ZIP><COUNTRY CODE="NL">Netherlands</COUNTRY><PHONE_1>+31-30-2509677</PHONE_1><FAX_1>+31-30-2541828</FAX_1></ADDRESS></PERSON><PERSON ID="050E1AC582E26AA2004A583D2C190A8F" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Cor</FIRST_NAME><MIDDLE_INITIALS>J</MIDDLE_INITIALS><LAST_NAME>Kalkman</LAST_NAME><POSITION>Professor Anaesthesiology</POSITION><EMAIL_1>c.j.kalkman@umcutrecht.nl</EMAIL_1><MOBILE_PHONE>+31 652014682</MOBILE_PHONE><ADDRESS><DEPARTMENT>Department of Perioperative Care and Emergency Medicine</DEPARTMENT><ORGANISATION>University Medical Center Utrecht</ORGANISATION><ADDRESS_1>PO Box 85500</ADDRESS_1><ADDRESS_2>Mailstop: E 03.511</ADDRESS_2><CITY>Utrecht</CITY><ZIP>3508 GA</ZIP><COUNTRY CODE="NL">Netherlands</COUNTRY><PHONE_1>+31302509677</PHONE_1><FAX_1>+31302541828</FAX_1></ADDRESS></PERSON><PERSON ID="6E9F1EEB82E26AA201AFF01290272DA6" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Geert</FIRST_NAME><MIDDLE_INITIALS>J</MIDDLE_INITIALS><LAST_NAME>van der Heijden</LAST_NAME><SUFFIX>PhD</SUFFIX><POSITION>Professor of Social Dentistry &amp; Head of Department</POSITION><EMAIL_1>Geert.vander.Heijden@acta.nl</EMAIL_1><URL>www.acta.nl</URL><MOBILE_PHONE>+31 6 83224640</MOBILE_PHONE><ADDRESS><DEPARTMENT>Department of Social Dentistry</DEPARTMENT><ORGANISATION>Academic Center for Dentistry Amsterdam (ACTA)</ORGANISATION><ADDRESS_1>5th Floor, Room 5N03</ADDRESS_1><ADDRESS_2>Gustav Mahlerlaan 3004</ADDRESS_2><CITY>Amsterdam</CITY><ZIP>1081LA</ZIP><COUNTRY CODE="NL">Netherlands</COUNTRY><PHONE_1>+31 205980247</PHONE_1><PHONE_2>+31 683224640</PHONE_2></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2013-06-14 15:11:21 +0100" MODIFIED_BY="Jane Cracknell">
<UP_TO_DATE>
<DATE DAY="1" MONTH="11" YEAR="2012"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="1" MONTH="11" YEAR="2012"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="8" MONTH="6" YEAR="2015"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="2007"/>
<REVIEW_PUBLISHED ISSUE="6" YEAR="2013"/>
<LAST_CITATION_ISSUE ISSUE="6" YEAR="2013"/>
</DATES>
<WHATS_NEW MODIFIED="2013-07-01 16:53:35 +0100" MODIFIED_BY="Jane Cracknell">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2013-07-01 16:53:35 +0100" MODIFIED_BY="Jane Cracknell">
<DATE DAY="1" MONTH="7" YEAR="2013"/>
<DESCRIPTION>
<P>Geert J van der Heijden's contact details amended.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2013-05-07 15:16:34 +0100" MODIFIED_BY="Jane Cracknell">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2010-01-19 12:32:16 +0000" MODIFIED_BY="Jane Cracknell">
<DATE DAY="21" MONTH="1" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>University Medical Center Utrecht, Julius Center for Health Sciences and Primary Care</NAME>
<COUNTRY CODE="NL">Netherlands</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2013-05-16 15:23:45 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2013-05-06 09:15:14 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2011-09-25 14:54:09 +0100" MODIFIED_BY="[Empty name]">Epidural analgesia for heart surgery</TITLE>
<SUMMARY_BODY MODIFIED="2013-05-06 09:15:14 +0100" MODIFIED_BY="[Empty name]">
<P>The use of thoracic epidural analgesia (TEA) in heart surgery is controversial. TEA produces a high level of pain relief and may reduce some of the adverse effects that are associated with heart surgery. Along with these potential benefits of TEA there is a widespread fear that TEA could cause bleeding into the epidural space (haematoma). We have conducted a review of medical trials to compare the effect of general anaesthesia (GA) alone with GA in combination with epidural analgesia on major complications in patients undergoing elective heart surgery. We identified 5035 titles of which 31 publications met all the inclusion criteria. These 31 publications reported on a total of 3047 patients, 1578 patients with GA and 1469 patients with TEA as well as GA. The risks of death, heart attack and stroke were not statistically significant, however our analysis showed statistically significant reductions in the risk of arrhythmias and pulmonary complications. Despite this, our findings must be viewed with caution. Epidural analgesia in heart surgery remains controversial in the absence of a sufficiently large and statistical significant effect on mortality, stroke, or myocardial infarction and while the risks are unclear.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2013-05-07 03:28:28 +0100" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2012-01-27 12:55:56 +0000" MODIFIED_BY="[Empty name]">
<P>A combination of general anaesthesia (GA) with thoracic epidural analgesia (TEA) may have a beneficial effect on clinical outcomes by reducing the risk of perioperative complications after cardiac surgery.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2013-05-06 09:32:43 +0100" MODIFIED_BY="[Empty name]">
<P>The objective of this review was to determine the impact of perioperative epidural analgesia in cardiac surgery on perioperative mortality and cardiac, pulmonary or neurological morbidity. We performed a meta-analysis to compare the<B> </B>risk of adverse events and mortality in patients undergoing cardiac surgery under general anaesthesia with and without epidural analgesia.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2013-05-07 03:28:28 +0100" MODIFIED_BY="Jane Cracknell">
<P>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (2012, Issue 12) in <I>The Cochrane Library</I>; MEDLINE (PubMed) (1966 to November 2012); EMBASE (1989 to November 2012); CINHAL (1982 to November 2012) and the Science Citation Index (1988 to November 2012).</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2013-05-06 08:58:35 +0100" MODIFIED_BY="[Empty name]">
<P>We included randomized controlled trials comparing outcomes in adult patients undergoing cardiac surgery with either GA alone or GA in combination with TEA.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2013-05-06 09:01:21 +0100" MODIFIED_BY="Jane Cracknell">
<P>All publications found during the search were manually and independently reviewed by the two authors. We identified 5035 titles, of which 4990 studies did not satisfy the selection criteria or were duplicate publications, that were retrieved from the five different databases. We performed a full review on 45 studies, of which 31 publications met all inclusion criteria. These 31 publications reported on a total of 3047 patients, 1578 patients with GA and 1469 patients with GA plus TEA.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2013-05-07 03:25:41 +0100" MODIFIED_BY="[Empty name]">
<P>Through our search (November 2012) we have identified 5035 titles, of which 31 publications met our inclusion criteria and reported on a total of 3047 patients. Compared with GA alone, the pooled risk ratio (RR) for patients receiving GA with TEA showed an odds ratio (OR) of 0.84 (95% CI 0.33 to 2.13, 31 studies) for mortality; 0.76 (95% CI 0.49 to 1.19, 17 studies) for myocardial infarction; and 0.50 (95% CI 0.21 to 1.18, 10 studies) for stroke. The relative risks (RR) for respiratory complications and supraventricular arrhythmias were 0.68 (95% CI 0.54 to 0.86, 14 studies) and 0.65 (95% CI 0.50 to 0.86, 15 studies) respectively.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2013-05-06 09:09:19 +0100" MODIFIED_BY="Jane Cracknell">
<P>This meta-analysis of studies, identified to 2010, showed that the use of TEA in patients undergoing coronary artery bypass graft surgery may reduce the risk of postoperative supraventricular arrhythmias and respiratory complications. There were no effects of TEA with GA on the risk of mortality, myocardial infarction or neurological complications compared with GA alone.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2013-05-16 15:23:45 +0100" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2013-05-16 15:23:45 +0100" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2013-05-06 09:20:02 +0100" MODIFIED_BY="[Empty name]">
<P>Advances in anaesthesiology, surgery, extracorporeal perfusion techniques, and perioperative care medicine have resulted in a reduced risk of perioperative complications and subsequently have improved postoperative outcomes after cardiac surgery<B> </B>(<LINK REF="REF-Coriat-2001" TYPE="REFERENCE">Coriat 2001</LINK>). The addition of thoracic epidural analgesia to general anaesthesia has been suggested to benefit patients after cardiac surgery in several trials<B> </B>(<LINK REF="STD-Royse-2003" TYPE="STUDY">Royse 2003</LINK>; <LINK REF="STD-Scott-2001" TYPE="STUDY">Scott 2001</LINK>).<B> </B>However, the technique is controversial because the insertion of an epidural catheter in patients requiring full heparinization for cardiopulmonary bypass may lead to an epidural haematoma.</P>
</CONDITION>
<INTERVENTION MODIFIED="2013-05-16 15:23:45 +0100" MODIFIED_BY="[Empty name]">
<P>A combination of general anaesthesia (GA) with thoracic epidural analgesia (TEA) may further improve outcomes after cardiac surgery (<LINK REF="REF-Djaiani-2000" TYPE="REFERENCE">Djaiani 2000</LINK>; <LINK REF="REF-Oxelbark-2001" TYPE="REFERENCE">Oxelbark 2001</LINK>; <LINK REF="REF-Zarate-2000" TYPE="REFERENCE">Zarate 2000</LINK>). TEA is a technique by which continuous infusion of local anaesthetic and opioid is given in the epidural space at high thoracic levels. TEA produces a high level of analgesia and may reduce the adverse effects that are associated with heart surgery.</P>
<P>A possible complication of TEA includes spinal cord compression, caused by a haematoma or abscess, which can result in paraplegia. Systemic anticoagulation is needed during cardiopulmonary bypass and may increase the incidence of epidural haematoma related to the use of an epidural catheter (<LINK REF="REF-Bang-2011" TYPE="REFERENCE">Bang 2011</LINK>; <LINK REF="REF-Ho-2000" TYPE="REFERENCE">Ho 2000</LINK>; <LINK REF="REF-Rosen-2004" TYPE="REFERENCE">Rosen 2004</LINK>).</P>
</INTERVENTION>
<THEORY MODIFIED="2013-05-06 09:26:09 +0100" MODIFIED_BY="[Empty name]">
<P>TEA may result in enhanced coronary perfusion, improved myocardial oxygen supply and a reduced incidence of dysrhythmias, via intense blockade of the sympathetic nervous system (<LINK REF="STD-Royse-2003" TYPE="STUDY">Royse 2003</LINK>; <LINK REF="STD-Scott-2001" TYPE="STUDY">Scott 2001</LINK>). Through the same mechanism, the size of perioperative myocardial infarction may be reduced<B> </B>(<LINK REF="REF-Beattie-2003" TYPE="REFERENCE">Beattie 2003</LINK>; <LINK REF="STD-Scott-2001" TYPE="STUDY">Scott 2001</LINK>; <LINK REF="REF-Turfrey-1997" TYPE="REFERENCE">Turfrey 1997</LINK>). TEA may also shorten the duration of tracheal intubation as well as the time spent in an intensive care unit and hospital, which could have major economic benefits (<LINK REF="REF-Bowler-2002" TYPE="REFERENCE">Bowler 2002</LINK>; <LINK REF="REF-Nicholson-2002" TYPE="REFERENCE">Nicholson 2002</LINK>; <LINK REF="STD-Priestley-2002" TYPE="STUDY">Priestley 2002</LINK>), and may prevent pulmonary complications<B> </B>(<LINK REF="REF-Ballentyne-1998" TYPE="REFERENCE">Ballentyne 1998</LINK>; <LINK REF="STD-Stenseth-1996" TYPE="STUDY">Stenseth 1996</LINK>).</P>
</THEORY>
<IMPORTANCE MODIFIED="2013-05-16 15:23:45 +0100" MODIFIED_BY="[Empty name]">
<P>A previous meta-analysis of 15 trials by Liu et al<B> </B>(<LINK REF="REF-Liu-2004" TYPE="REFERENCE">Liu 2004</LINK>) demonstrated fewer respiratory complications and dysrhythmias in patients assigned to TEA, but failed to show an effect of TEA on mortality or myocardial infarction. However, more trials comparing TEA and conventional anaesthesia for cardiac surgery are now available<B> </B>(<LINK REF="STD-Hansdottir-2006" TYPE="STUDY">Hansdottir 2006</LINK>; <LINK REF="STD-Lundstrom-2005" TYPE="STUDY">Lundstrom 2005</LINK>), and these were considered for inclusion in the present review.</P>
<P>The present meta-analysis could elucidate whether or not TEA has a benefit on relevant outcomes such as mortality and myocardial infarction. It does not clarify the clinical costs of TEA, which range from patient discomfort during epidural puncture to paraplegia. When the meta-analysis shows a significant benefit on mortality or other very relevant outcomes, whilst catastrophic complications are not observed in the patient samples that are included, one can argue that TEA should be used; although the safety of the technique has not been completely quantified. On the other hand, if no relevant benefits can be demonstrated, one could argue that TEA should not be applied in cardiac surgery as long as its safety remains unclear.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2012-01-27 13:11:12 +0000" MODIFIED_BY="[Empty name]">
<P>The objective of this review was to determine the impact of perioperative epidural analgesia in cardiac surgery on perioperative mortality and cardiac, pulmonary or neurological morbidity.</P>
</OBJECTIVES>
<METHODS MODIFIED="2013-05-16 15:23:45 +0100" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2013-05-07 15:17:34 +0100" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2013-05-07 15:17:34 +0100" MODIFIED_BY="[Empty name]">
<P>We included randomized controlled trials (RCT).</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2013-05-06 10:07:43 +0100" MODIFIED_BY="[Empty name]">
<P>We included adult patients undergoing general anaesthesia (GA) for cardiac surgery with and without thoracic epidural analgesia (TEA).</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2013-05-06 10:08:01 +0100" MODIFIED_BY="[Empty name]">
<P>We included trials that compared cardiac surgery with and without TEA. We excluded studies which compared cardiac surgery with and without spinal anaesthesia.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2013-05-06 09:37:10 +0100" MODIFIED_BY="[Empty name]">
<P>We did a separate meta-analysis for each of the outcomes listed below. We measured all outcomes at two weeks and six months after surgery.</P>
<CRIT_OUTCOMES_PRIMARY MODIFIED="2013-05-06 09:36:17 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Risk of mortality</LI>
<LI>Risk of myocardial infarction</LI>
</OL>
<P>We defined myocardial infarction as myocardial specific creatine kinase (CKMB) measurement greater than 50 U/l and peak CKMB/creatine kinase ratio of greater than 10%, or a new Q wave infarction.</P>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2013-05-06 09:37:10 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Risk of in-hospital pulmonary complications (respiratory insufficiency or pneumonia)</LI>
<LI>Risk of cardiac events (supraventricular or ventricular dysrhythmias or cardiac arrest)</LI>
<LI>Risk of neurological complications (epidural haematoma or abscess, transient ischaemic attack or cerebrovascular accident)</LI>
</OL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2013-05-07 03:31:38 +0100" MODIFIED_BY="Jane Cracknell">
<ELECTRONIC_SEARCHES MODIFIED="2013-05-07 03:31:38 +0100" MODIFIED_BY="Jane Cracknell">
<P>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (2012, Issue 12) in <I>The Cochrane Library</I>, MEDLINE (PubMed) (1966 to November 2012); EMBASE (1989 to November 2012); CINAHL (1982 to November 2012); and the Web of Science (SCI/SSCI) (1988 to November 2012) with relevant search terms relating to heart surgery procedures and neuraxial anaesthetic techniques.</P>
<P>We combined these search terms with a sensitive methodological filter (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>) for randomized trials, found in Chapter 6 of the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> Version 5.0.2 (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2013-05-06 09:41:27 +0100" MODIFIED_BY="Jane Cracknell">
<P>We screened reference lists from retrieved randomized trials, meta-analyses and systematic reviews to identify additional trials. We conducted a search by author for any individual who appeared as an author of two or more relevant articles.</P>
<P>We used PubMed's 'See related articles' function with relevant trial reports to search for additional references. In addition, we included the references of the following reviews on cardiac surgery and epidural analgesia (<LINK REF="REF-Ballentyne-1998" TYPE="REFERENCE">Ballentyne 1998</LINK>; <LINK REF="REF-Chaney-1997" TYPE="REFERENCE">Chaney 1997</LINK>; <LINK REF="REF-Liu-2004" TYPE="REFERENCE">Liu 2004</LINK>; <LINK REF="REF-Meissner-1997" TYPE="REFERENCE">Meissner 1997</LINK>; <LINK REF="REF-Rodgers-2000" TYPE="REFERENCE">Rodgers 2000</LINK>).</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2013-05-16 15:23:45 +0100" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2013-05-06 09:45:14 +0100" MODIFIED_BY="Jane Cracknell">
<P>Two authors (VS and MP) independently examined the titles and, where available, abstracts of studies identified using the search strategy, and handsearched reference lists. We retrieved any full studies that met our predefined inclusion criteria. If our judgements on inclusion or exclusion were split we discussed the article until we achieved consensus, with the help of a third review author (DD) where necessary.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2013-05-06 09:46:54 +0100" MODIFIED_BY="Jane Cracknell">
<P>For each title, abstract or full-text article, the two review authors (VS and MP) used a standardized selection form<B> </B>(<LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>) to extract data independently. The review authors were not blinded to the authors' or journals' names. All included trials were thoroughly studied by the two authors using the data collection form. The items that were scored were also listed in a standardized form.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2013-05-07 03:31:12 +0100" MODIFIED_BY="Jane Cracknell">
<P>Two review authors (VS and MP) independently assessed the quality of the studies according to the criteria described in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> Version 5.0.2<B> </B>(<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). We graded the risk of bias for each study in the categories of sequence generation, allocation concealment, blinding, incomplete outcome data and selective reporting. We graded each category as low risk (yes), high risk (no), or unclear risk of bias.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2013-04-30 11:50:50 +0100" MODIFIED_BY="Jane Cracknell">
<P>All outcomes were dichotomous. Both the sample sizes and the numbers of patients with events were summed across groups<B> </B>(<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2013-02-09 20:00:36 +0000" MODIFIED_BY="Jane Cracknell">
<P>The odds were calculated per treatment group for all outcomes. The Peto odds ratio was used as the pooled measure of effect.</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2013-04-30 11:53:46 +0100" MODIFIED_BY="Jane Cracknell">
<P>We contacted the first authors of included trials to obtain missing data that were necessary for the meta-analysis.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2013-05-06 09:50:41 +0100" MODIFIED_BY="Jane Cracknell">
<P>When significant heterogeneity was suspected from the I<SUP>2</SUP> statistic (I<SUP>2</SUP> = 25% or higher) for heterogeneity, or from visual inspection of the results, we used a random-effects model for pooling. In this model the RR for every trial is weighted by the reciprocal of its variance, whereby studies with a smaller standard error were given more weight than those with a larger standard error. We have explored sources of heterogeneity by looking at possible differences in clinical and methodological factors across the trials.</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2013-04-30 11:54:15 +0100" MODIFIED_BY="Jane Cracknell">
<P>We assessed publication bias for the two primary outcomes by both graphical inspection of the funnel plot and statistical testing of plot asymmetry, using a 95% confidence interval.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2013-05-16 15:23:45 +0100" MODIFIED_BY="Jane Cracknell">
<P>We used <LINK REF="REF-RevMan-5.1" TYPE="REFERENCE">RevMan 5.1</LINK> for quantitative analysis. As all our outcomes were binary data, we related the numbers reporting an outcome in each group to the numbers at risk to derive a relative risk (RR) and 95% confidence interval, or as an odds ratio (OR) through the Peto method where appropriate. We applied the Peto method to obtain the OR for mortality as there were 15 trials with zero events, and for the myocardial infarction analysis as numbers of events were very small. As a general rule, we used a fixed-effect model for calculations of summary estimates and their 95% confidence intervals (CI).</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2013-05-06 10:09:16 +0100" MODIFIED_BY="Jane Cracknell">
<P>We planned an exploratory subgroup analysis that included trials with two different methods of GA, the fast-track protocol (short-acting opioids) versus regular GA. We also performed a subgroup analysis on the results for mortality at the two-week period, for high and low risk of bias studies. A low risk of bias study was defined as a study where no categories or only the detection bias category (blinding of patient and medical personnel) were inadequate. A high risk of bias study was defined as a study where any of the other bias categories (sequence generation, allocation concealment, incomplete outcome data and selective reporting) were inadequate.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2013-05-06 10:02:34 +0100" MODIFIED_BY="Jane Cracknell">
<P>We conducted a sensitivity analysis in low risk of bias trials to estimate the robustness of the results for mortality at the two-week period.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2013-05-16 15:23:45 +0100" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2013-05-16 15:23:45 +0100" MODIFIED_BY="[Empty name]">
<P>See <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> and <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>.</P>
<SEARCH_RESULTS MODIFIED="2013-05-16 15:23:45 +0100" MODIFIED_BY="[Empty name]">
<P>We identified 5035 titles, of which 4990 studies did not satisfy the selection criteria or were duplicate publications, from the five different databases (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>).</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2013-05-06 10:10:28 +0100" MODIFIED_BY="[Empty name]">
<P>We performed a full review of 45 studies, of which 31 publications met our inclusion criteria (see <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>). These 31 publications reported on a total of 3047 patients, 1578 patients with GA and 1469 patients with GA plus TEA. There were no trials in languages other than English identified.</P>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2013-05-06 10:04:48 +0100" MODIFIED_BY="Jane Cracknell">
<P>We excluded 14 of the 45 assessed studies for the reasons shown in the table <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2013-05-16 15:20:46 +0100" MODIFIED_BY="[Empty name]">
<P>Incomplete data were rare and when present this was reported, making attrition bias minimal. Blinding of outcome assessors was rarely mentioned and was treated as a possible risk of detection bias.</P>
<ALLOCATION MODIFIED="2013-05-16 15:20:46 +0100" MODIFIED_BY="[Empty name]">
<P>The risk of selection bias was unclear. We have included only randomized controlled trials in this meta-analysis, however the method of randomization and allocation concealment were not always clearly stated (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>; <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>).</P>
</ALLOCATION>
<BLINDING MODIFIED="2013-05-16 15:20:46 +0100" MODIFIED_BY="[Empty name]">
<P>Performance bias was high in this meta-analysis as the patients and personnel were not blinded in 85% of the trials<B> </B>(<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>; <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>).</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2013-05-16 15:20:46 +0100" MODIFIED_BY="[Empty name]">
<P>There was a minimal possibility of attrition bias as the outcome data were not complete in six trials (see <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>; <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>).</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2013-05-16 15:20:46 +0100" MODIFIED_BY="[Empty name]">
<P>There was a low risk of reporting bias (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>; <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>).</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2012-05-22 11:17:44 +0100" MODIFIED_BY="[Empty name]">
<P>Other potential sources of bias were not identified.</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2013-05-15 20:29:36 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="5">
<I>Mortality</I>
</HEADING>
<P>All 31 studies reported mortality (see <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>). Of those studies, 29 (<LINK REF="STD-Bach-2002" TYPE="STUDY">Bach 2002</LINK>; <LINK REF="STD-Bakhtiary-2007" TYPE="STUDY">Bakhtiary 2007</LINK>; <LINK REF="STD-Barrington-2005" TYPE="STUDY">Barrington 2005</LINK>; <LINK REF="STD-Berendes-2003" TYPE="STUDY">Berendes 2003</LINK>; <LINK REF="STD-Brix_x002d_Christensen-1998" TYPE="STUDY">Brix-Christensen 1998</LINK>; <LINK REF="STD-Caputo-2009" TYPE="STUDY">Caputo 2009</LINK>;<LINK REF="STD-Caputo-2011" TYPE="STUDY">Caputo 2011</LINK>; <LINK REF="STD-de-Vries-2002" TYPE="STUDY">de Vries 2002</LINK>; <LINK REF="STD-El_x002d_Baz-1987" TYPE="STUDY">El-Baz 1987</LINK>; <LINK REF="STD-Fillinger-2002" TYPE="STUDY">Fillinger 2002</LINK>; <LINK REF="STD-Hansdottir-2006" TYPE="STUDY">Hansdottir 2006</LINK>; <LINK REF="STD-Heijmans-2007" TYPE="STUDY">Heijmans 2007</LINK>; <LINK REF="STD-Kendall-2004" TYPE="STUDY">Kendall 2004</LINK>; <LINK REF="STD-Kilickan-2006" TYPE="STUDY">Kilickan 2006</LINK>; <LINK REF="STD-Kirno-1994" TYPE="STUDY">Kirno 1994</LINK>; <LINK REF="STD-Lagunilla-2006" TYPE="STUDY">Lagunilla 2006</LINK>; <LINK REF="STD-Liem-1992" TYPE="STUDY">Liem 1992</LINK>; <LINK REF="STD-Lundstrom-2005" TYPE="STUDY">Lundstrom 2005</LINK>; <LINK REF="STD-Moore-1995" TYPE="STUDY">Moore 1995</LINK>; <LINK REF="STD-Nygard-2004" TYPE="STUDY">Nygard 2004</LINK>; <LINK REF="STD-Onan-2011" TYPE="STUDY">Onan 2011</LINK>; <LINK REF="STD-Rein-1989" TYPE="STUDY">Rein 1989</LINK>; <LINK REF="STD-Royse-2003" TYPE="STUDY">Royse 2003</LINK>; <LINK REF="STD-Scott-2001" TYPE="STUDY">Scott 2001</LINK>; <LINK REF="STD-Sharma-2010" TYPE="STUDY">Sharma 2010</LINK>; <LINK REF="STD-Stenseth-1994" TYPE="STUDY">Stenseth 1994</LINK>; <LINK REF="STD-Stenseth-1996" TYPE="STUDY">Stenseth 1996</LINK>; <LINK REF="STD-Svircevic-2011" TYPE="STUDY">Svircevic 2011</LINK>; <LINK REF="STD-Tenling-1999" TYPE="STUDY">Tenling 1999</LINK>) reported on mortality within two  weeks after surgery (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>), and two studies (<LINK REF="STD-Loick-1999" TYPE="STUDY">Loick 1999</LINK>; <LINK REF="STD-Priestley-2002" TYPE="STUDY">Priestley 2002</LINK>) reported mortality after six-months follow-up (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>). Combining data from 29 studies showed no difference in the rate of mortality two weeks after surgery for patients receiving TEA with GA versus GA (OR 0.84; 95% CI 0.33 to 2.13) (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>). Of the 29 included studies, 17 did not provide an estimate resulting in the overall OR being based on 12 studies. The meta-analysis of studies that evaluated mortality six months after surgery included two studies with 170 patients (I<SUP>2 </SUP>= 0%) and yielded an RR of 1.35 (95% CI 0.08 to 22.83) (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>).</P>
<P>Subgroup analysis showed that the risk of mortality at the two-week period in both low (<LINK REF="STD-Barrington-2005" TYPE="STUDY">Barrington 2005</LINK>; <LINK REF="STD-Berendes-2003" TYPE="STUDY">Berendes 2003</LINK>; <LINK REF="STD-Caputo-2009" TYPE="STUDY">Caputo 2009</LINK>; <LINK REF="STD-Caputo-2011" TYPE="STUDY">Caputo 2011</LINK>; <LINK REF="STD-Hansdottir-2006" TYPE="STUDY">Hansdottir 2006</LINK>; <LINK REF="STD-Kilickan-2006" TYPE="STUDY">Kilickan 2006</LINK>; <LINK REF="STD-Moore-1995" TYPE="STUDY">Moore 1995</LINK>; <LINK REF="STD-Scott-2001" TYPE="STUDY">Scott 2001</LINK>; <LINK REF="STD-Svircevic-2011" TYPE="STUDY">Svircevic 2011</LINK>; <LINK REF="STD-Tenling-1999" TYPE="STUDY">Tenling 1999</LINK>) and high<B> </B>(<LINK REF="STD-Bach-2002" TYPE="STUDY">Bach 2002</LINK>; <LINK REF="STD-Bakhtiary-2007" TYPE="STUDY">Bakhtiary 2007</LINK>; <LINK REF="STD-Brix_x002d_Christensen-1998" TYPE="STUDY">Brix-Christensen 1998</LINK>; <LINK REF="STD-de-Vries-2002" TYPE="STUDY">de Vries 2002</LINK>; <LINK REF="STD-El_x002d_Baz-1987" TYPE="STUDY">El-Baz 1987</LINK>; <LINK REF="STD-Fillinger-2002" TYPE="STUDY">Fillinger 2002</LINK>; <LINK REF="STD-Kendall-2004" TYPE="STUDY">Kendall 2004</LINK>; <LINK REF="STD-Kirno-1994" TYPE="STUDY">Kirno 1994</LINK>; <LINK REF="STD-Liem-1992" TYPE="STUDY">Liem 1992</LINK>; <LINK REF="STD-Lundstrom-2005" TYPE="STUDY">Lundstrom 2005</LINK>; <LINK REF="STD-Nygard-2004" TYPE="STUDY">Nygard 2004</LINK>; <LINK REF="STD-Onan-2011" TYPE="STUDY">Onan 2011</LINK>; <LINK REF="STD-Rein-1989" TYPE="STUDY">Rein 1989</LINK>; <LINK REF="STD-Royse-2003" TYPE="STUDY">Royse 2003</LINK>; <LINK REF="STD-Sharma-2010" TYPE="STUDY">Sharma 2010</LINK>; <LINK REF="STD-Stenseth-1994" TYPE="STUDY">Stenseth 1994</LINK>; <LINK REF="STD-Stenseth-1996" TYPE="STUDY">Stenseth 1996</LINK>) risk of bias groups was not significantly different between the patients receiving TEA compared with patients receiving GA alone (OR 0.83; 95% CI 0.25 to 2.70 and OR 0.85; 95% CI 0.19 to 3.79, respectively). The explanatory subgroup analysis, which included trials with two different methods of general anaesthesia, the fast-track protocol (short-acting opioids) versus regular GA, was not feasible due to lack of data.</P>
<P>Sensitivity analysis (<LINK REF="CMP-006.01" TYPE="ANALYSIS">Analysis 6.1</LINK>) showed that the risk of mortality within two weeks after surgery in low risk of bias studies was not different between the groups (OR 0.83; 95% CI 0.25 to 2.70).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">
<I>Myocardial infarction</I>
</HEADING>
<P>Seventeen studies reported on acute myocardial infarction (AMI). Fifteen studies (<LINK REF="STD-Bakhtiary-2007" TYPE="STUDY">Bakhtiary 2007</LINK>; <LINK REF="STD-Barrington-2005" TYPE="STUDY">Barrington 2005</LINK>; <LINK REF="STD-Caputo-2009" TYPE="STUDY">Caputo 2009</LINK>; <LINK REF="STD-Caputo-2011" TYPE="STUDY">Caputo 2011</LINK>; <LINK REF="STD-de-Vries-2002" TYPE="STUDY">de Vries 2002</LINK>; <LINK REF="STD-Fillinger-2002" TYPE="STUDY">Fillinger 2002</LINK>; <LINK REF="STD-Hansdottir-2006" TYPE="STUDY">Hansdottir 2006</LINK>; <LINK REF="STD-Heijmans-2007" TYPE="STUDY">Heijmans 2007</LINK>; <LINK REF="STD-Kendall-2004" TYPE="STUDY">Kendall 2004</LINK>; <LINK REF="STD-Liem-1992" TYPE="STUDY">Liem 1992</LINK>; <LINK REF="STD-Onan-2011" TYPE="STUDY">Onan 2011</LINK>; <LINK REF="STD-Scott-2001" TYPE="STUDY">Scott 2001</LINK>; <LINK REF="STD-Stenseth-1994" TYPE="STUDY">Stenseth 1994</LINK>; <LINK REF="STD-Stenseth-1996" TYPE="STUDY">Stenseth 1996</LINK>; <LINK REF="STD-Svircevic-2011" TYPE="STUDY">Svircevic 2011</LINK>), which included 2127 patients, reported AMI after two weeks of follow-up (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>). There was no difference in the rate of AMI between groups of patients receiving TEA compared with patients receiving GA alone (OR 0.76; 95% CI 0.49 to1.19; I<SUP>2 </SUP>=<SUP> </SUP>0% ). Three out of the 15 included studies did not provide an estimate, resulting in the overall OR being based on 12 studies.<B> </B>The meta-analysis of studies that evaluated AMI six months after surgery included two studies (<LINK REF="STD-Loick-1999" TYPE="STUDY">Loick 1999</LINK>; <LINK REF="STD-Priestley-2002" TYPE="STUDY">Priestley 2002</LINK>) with 170 patients (I<SUP>2 </SUP>= 0%) and yielded an RR of 0.41 (95% CI 0.06 to 3.03) (<LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">
<I>Respiratory events</I>
</HEADING>
<P>A total of 14 studies presented data on the number of patients who had respiratory complication within two weeks of surgery. Pooled analysis of data from 2011 patients (<LINK REF="STD-Barrington-2005" TYPE="STUDY">Barrington 2005</LINK>; <LINK REF="STD-Berendes-2003" TYPE="STUDY">Berendes 2003</LINK>; <LINK REF="STD-Caputo-2011" TYPE="STUDY">Caputo 2011</LINK>; <LINK REF="STD-de-Vries-2002" TYPE="STUDY">de Vries 2002</LINK>; <LINK REF="STD-El_x002d_Baz-1987" TYPE="STUDY">El-Baz 1987</LINK>; <LINK REF="STD-Fillinger-2002" TYPE="STUDY">Fillinger 2002</LINK>; <LINK REF="STD-Hansdottir-2006" TYPE="STUDY">Hansdottir 2006</LINK>; <LINK REF="STD-Liem-1992" TYPE="STUDY">Liem 1992</LINK>; <LINK REF="STD-Lundstrom-2005" TYPE="STUDY">Lundstrom 2005</LINK>; <LINK REF="STD-Royse-2003" TYPE="STUDY">Royse 2003</LINK>; <LINK REF="STD-Scott-2001" TYPE="STUDY">Scott 2001</LINK>; <LINK REF="STD-Svircevic-2011" TYPE="STUDY">Svircevic 2011</LINK>; <LINK REF="STD-Tenling-1999" TYPE="STUDY">Tenling 1999</LINK>) showed a lower risk of respiratory events for patient receiving TEA during surgery compared with those receiving GA alone (RR 0.68; 95% CI 0.54 to 0.86). The heterogeneity of these data was high (I<SUP>2 </SUP>= 42%) (<LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>). With the use of a random-effects model the RR for respiratory events within two weeks was RR 0.66 (95% CI 0.45 to 0.98). One study (<LINK REF="STD-Priestley-2002" TYPE="STUDY">Priestley 2002</LINK>) had a six-month follow-up of respiratory events (RR 3.00; 95% CI 0.13 to 71.92); this study was not included in the meta-analysis.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">
<I>Supraventricular tachyarrhythmias</I>
</HEADING>
<P>Thirteen studies (<LINK REF="STD-Bakhtiary-2007" TYPE="STUDY">Bakhtiary 2007</LINK>; <LINK REF="STD-Barrington-2005" TYPE="STUDY">Barrington 2005</LINK>; <LINK REF="STD-Caputo-2009" TYPE="STUDY">Caputo 2009</LINK>; <LINK REF="STD-Caputo-2011" TYPE="STUDY">Caputo 2011</LINK>; <LINK REF="STD-de-Vries-2002" TYPE="STUDY">de Vries 2002</LINK>; <LINK REF="STD-Fillinger-2002" TYPE="STUDY">Fillinger 2002</LINK>; <LINK REF="STD-Hansdottir-2006" TYPE="STUDY">Hansdottir 2006</LINK>; <LINK REF="STD-Liem-1992" TYPE="STUDY">Liem 1992</LINK>; <LINK REF="STD-Kilickan-2006" TYPE="STUDY">Kilickan 2006</LINK>; <LINK REF="STD-Nygard-2004" TYPE="STUDY">Nygard 2004</LINK>; <LINK REF="STD-Royse-2003" TYPE="STUDY">Royse 2003</LINK>; <LINK REF="STD-Scott-2001" TYPE="STUDY">Scott 2001</LINK>; <LINK REF="STD-Svircevic-2011" TYPE="STUDY">Svircevic 2011</LINK>) that included 2250 patients reported on supraventricular tachyarrhythmias (SVT) within the two weeks after surgery. The use of TEA was associated with a lower risk of SVT compared with GA alone (RR 0.65 95% CI 0.50 to 0.86) (<LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>). However, heterogeneity between the studies was high (I<SUP>2 </SUP>= 69%). With the use of a random-effects model the RR for SVT within two weeks was RR 0.65 (95% CI 0.50 to 0.86). After six-months follow-up, the beneficial effect of TEA on SVT was not statistically significant, but was only reported by two trials (<LINK REF="STD-Loick-1999" TYPE="STUDY">Loick 1999</LINK>; <LINK REF="STD-Priestley-2002" TYPE="STUDY">Priestley 2002</LINK>) (RR 0.76; 95% CI 0.39 to 1.51) (<LINK REF="CMP-004.02" TYPE="ANALYSIS">Analysis 4.2</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">
<I>Neurologic complications</I>
</HEADING>
<P>Ten trials reported on stroke. One study (<LINK REF="STD-Priestley-2002" TYPE="STUDY">Priestley 2002</LINK>) had a six-month follow-up (RR of 3.00, 95% CI: 0.13 to 71.92) and nine (<LINK REF="STD-Barrington-2005" TYPE="STUDY">Barrington 2005</LINK>; <LINK REF="STD-Caputo-2009" TYPE="STUDY">Caputo 2009</LINK>; <LINK REF="STD-Caputo-2011" TYPE="STUDY">Caputo 2011</LINK>; <LINK REF="STD-Fillinger-2002" TYPE="STUDY">Fillinger 2002</LINK>; <LINK REF="STD-Hansdottir-2006" TYPE="STUDY">Hansdottir 2006</LINK>; <LINK REF="STD-Heijmans-2007" TYPE="STUDY">Heijmans 2007</LINK>; <LINK REF="STD-Royse-2003" TYPE="STUDY">Royse 2003</LINK>; <LINK REF="STD-Scott-2001" TYPE="STUDY">Scott 2001</LINK>; <LINK REF="STD-Svircevic-2011" TYPE="STUDY">Svircevic 2011</LINK>) had a two-week follow-up. The frequency of  neurological complications was lower in patients receiving TEA compared with those receiving GA alone. Pooled analysis of these 1791 patients, showed that there was not significant difference in the risk of neurological complications (OR 0.50; 95% CI 0.21 to 1.18; I<SUP>2 </SUP>= 0%) (<LINK REF="CMP-005.01" TYPE="ANALYSIS">Analysis 5.1</LINK>). Two of the nine included studies did not provide an estimate, resulting in the overall OR being based on seven studies.</P>
<P>There were no reported episodes of epidural haematoma in any of the included studies.</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2013-05-16 15:20:46 +0100" MODIFIED_BY="[Empty name]">
<P>We conducted a meta-analysis of clinical trials comparing the effects of cardiac surgery with or without TEA on mortality and cardiac, respiratory and neurological complications. Our meta-analysis showed statistically significant reductions in the risk of supraventricular tachyarrhythmias and respiratory complications. The differences for risk of mortality, myocardial infarction and stroke after TEA were not statistically significant. In order to overcome lack of statistical power due to the small sample sizes of individual clinical studies, we were able to pool a large number of available clinical studies. These studies were performed over a 30-year time span, however, possibly reducing control of variability in the protocols for patient selection, treatment and outcome measurement.</P>
<P>The potential of TEA for decreasing tachyarrhythmias has been reported before (<LINK REF="STD-Royse-2003" TYPE="STUDY">Royse 2003</LINK>; <LINK REF="STD-Scott-2001" TYPE="STUDY">Scott 2001</LINK>) and was confirmed in this meta-analysis. However, the included studies were heterogeneous and the confidence intervals were wide. The large study by Scott et al (<LINK REF="STD-Scott-2001" TYPE="STUDY">Scott 2001</LINK>) contributes the most to this result. In this study, B-blockers were discontinued five days perioperatively, which may explain the large benefit of TEA on supraventricular arrhythmias. Repeating the meta-analysis without the data from the study by Scott results in similar findings. While the Scott study was encouraging, most studies published since then have been unable to repeat its results. A recent, well designed study by Hansdottir (<LINK REF="STD-Hansdottir-2006" TYPE="STUDY">Hansdottir 2006</LINK>) revealed no reduction in the incidence of adverse events. Recent studies have shown that postoperative supraventricular tachyarrhythmias can also be reduced with clearly less invasive treatments such as B-blockers and amiodarone (<LINK REF="REF-Burgess-2006" TYPE="REFERENCE">Burgess 2006</LINK>; <LINK REF="REF-Kerstein-2004" TYPE="REFERENCE">Kerstein 2004</LINK>; <LINK REF="STD-Nygard-2004" TYPE="STUDY">Nygard 2004</LINK>). The majority of the studies included in this meta-analysis did not report on whether the patients also used drugs to prevent postoperative arrhythmias. It is, therefore, unclear whether TEA has an additional preventive effect in patients who are also administered prophylactic antiarrhythmic drugs after their operation.</P>
<P>Our meta-analysis showed that TEA results in a statistically significant reduction in postoperative respiratory complications, which is consistent with previous meta-analyses (<LINK REF="REF-Ballentyne-1998" TYPE="REFERENCE">Ballentyne 1998</LINK>; <LINK REF="REF-Chaney-2006" TYPE="REFERENCE">Chaney 2006</LINK>). This may be explained by the superior analgesia after TEA, which facilitates earlier spontaneous respiration in the intensive care unit and faster tracheal extubation. It has been shown that other strategies to allow earlier tracheal extubation can also reduce respiratory complications (<LINK REF="REF-Silbert-1998" TYPE="REFERENCE">Silbert 1998</LINK>).</P>
<P>There are several limitations in the quality of the included randomized studies that warrant caution in the interpretation of the results of this meta-analysis. First, the time period in which these studies were undertaken spanned over 30 years. The quality of anaesthesiological and intensive care has clearly improved over these years. It is possible that some beneficial effects of TEA, such as earlier extubation, are currently also achieved with modern general anaesthetics. Secondly, the allocation concealment was unclear and blinding information absent in the majority of the trials (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>; <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>),<B> </B>and most of the included studies were designed to evaluate the effect of TEA on intermediate or surrogate outcome measures instead of clinical endpoints. The non-standardized coverage of clinical outcomes in most studies carried a high risk of observer bias, in particular when the endpoint adjudication was not blinded. Finally, as in any meta-analysis, our results may be subject to publication bias.</P>
<P>As sympathicolysis and enhanced coronary perfusion can be achieved with TEA, which could result in an improved myocardial oxygen balance (<LINK REF="STD-Priestley-2002" TYPE="STUDY">Priestley 2002</LINK>; <LINK REF="STD-Scott-2001" TYPE="STUDY">Scott 2001</LINK>), we were interested in a possible difference in risk of myocardial infarction. Our findings are largely comparable to those of the previous two meta-analyses (<LINK REF="REF-Ballentyne-1998" TYPE="REFERENCE">Ballentyne 1998</LINK>; <LINK REF="REF-Liu-2004" TYPE="REFERENCE">Liu 2004</LINK>). However, it should be noted that the risk of overall bias in this and previous meta-analyses is probably high as the allocation and blinding were unclear in most of the trials. Since we were able to include 27 studies involving 2077 patients, which is substantially more patients than the earlier two previous meta-analyses, the confidence intervals are narrower resulting in more precise effect estimates. Still, for our meta-analysis the statistical power remains too low to reach statistical significance for the beneficial effect estimates for TEA on the risk of mortality, myocardial infarction and stroke. It should be noted that in order to demonstrate statistical significance for a difference in the risk of myocardial infarction from 3.8% after GA to 2.8% after TEA (as found in this meta-analysis), it would require a sample size of at least 10,000 patients.</P>
<P>This meta-analysis shows that the use of TEA in patients undergoing cardiac surgery reduces the risk of postoperative supraventricular arrhythmias and respiratory complications (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>).<B> </B>The scarcity of events precludes conclusions about mortality, myocardial infarction and stroke, but the estimates suggest a reduced risk after TEA. The risk of side effects of TEA, including epidural haematoma<B> </B>(<LINK REF="REF-Bang-2011" TYPE="REFERENCE">Bang 2011</LINK>; <LINK REF="REF-Ho-2000" TYPE="REFERENCE">Ho 2000</LINK>; <LINK REF="REF-Ho-2006" TYPE="REFERENCE">Ho 2006</LINK>; <LINK REF="REF-Rosen-2004" TYPE="REFERENCE">Rosen 2004</LINK>), could not be assessed with the current meta-analysis.</P>
<SUMMARY_OF_RESULTS MODIFIED="2013-05-07 03:47:09 +0100" MODIFIED_BY="[Empty name]">
<P>This meta-analysis shows that the use of TEA in patients undergoing cardiac surgery reduces the risk of postoperative supraventricular arrhythmias and respiratory complications (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>).</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2013-05-07 03:48:14 +0100" MODIFIED_BY="[Empty name]">
<P>The scarcity of events precludes statistically significant conclusions about mortality, myocardial infarction and stroke. The risk of side effects of TEA was not reported in any of the included studies and therefore could not be assessed with the current meta-analysis. In order to find the true risk of side effects, such as neurological complications, an updated review should consider including non-randomized controlled trials in the review.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2013-05-07 03:49:18 +0100" MODIFIED_BY="[Empty name]">
<P>We identified 11 low risk of bias studies (<LINK REF="STD-Barrington-2005" TYPE="STUDY">Barrington 2005</LINK>; <LINK REF="STD-Berendes-2003" TYPE="STUDY">Berendes 2003</LINK>; <LINK REF="STD-Caputo-2009" TYPE="STUDY">Caputo 2009</LINK>; <LINK REF="STD-Caputo-2011" TYPE="STUDY">Caputo 2011</LINK>; <LINK REF="STD-Hansdottir-2006" TYPE="STUDY">Hansdottir 2006</LINK>; <LINK REF="STD-Kilickan-2006" TYPE="STUDY">Kilickan 2006</LINK>; <LINK REF="STD-Moore-1995" TYPE="STUDY">Moore 1995</LINK>; <LINK REF="STD-Priestley-2002" TYPE="STUDY">Priestley 2002</LINK>; <LINK REF="STD-Scott-2001" TYPE="STUDY">Scott 2001</LINK>; <LINK REF="STD-Svircevic-2011" TYPE="STUDY">Svircevic 2011</LINK>; <LINK REF="STD-Tenling-1999" TYPE="STUDY">Tenling 1999</LINK>),<B> </B>18 high risk of bias studies (<LINK REF="STD-Bach-2002" TYPE="STUDY">Bach 2002</LINK>; <LINK REF="STD-Bakhtiary-2007" TYPE="STUDY">Bakhtiary 2007</LINK>; <LINK REF="STD-Brix_x002d_Christensen-1998" TYPE="STUDY">Brix-Christensen 1998</LINK>; <LINK REF="STD-de-Vries-2002" TYPE="STUDY">de Vries 2002</LINK>; <LINK REF="STD-El_x002d_Baz-1987" TYPE="STUDY">El-Baz 1987</LINK>; <LINK REF="STD-Fillinger-2002" TYPE="STUDY">Fillinger 2002</LINK>; <LINK REF="STD-Kendall-2004" TYPE="STUDY">Kendall 2004</LINK>; <LINK REF="STD-Kirno-1994" TYPE="STUDY">Kirno 1994</LINK>; <LINK REF="STD-Liem-1992" TYPE="STUDY">Liem 1992</LINK>; <LINK REF="STD-Loick-1999" TYPE="STUDY">Loick 1999</LINK>; <LINK REF="STD-Lundstrom-2005" TYPE="STUDY">Lundstrom 2005</LINK>; <LINK REF="STD-Nygard-2004" TYPE="STUDY">Nygard 2004</LINK>; <LINK REF="STD-Onan-2011" TYPE="STUDY">Onan 2011</LINK>, <LINK REF="STD-Rein-1989" TYPE="STUDY">Rein 1989</LINK>; <LINK REF="STD-Royse-2003" TYPE="STUDY">Royse 2003</LINK>; <LINK REF="STD-Sharma-2010" TYPE="STUDY">Sharma 2010</LINK>; <LINK REF="STD-Stenseth-1994" TYPE="STUDY">Stenseth 1994</LINK>; <LINK REF="STD-Stenseth-1996" TYPE="STUDY">Stenseth 1996</LINK>) and two studies with unclear risk of bias<B> </B>(<LINK REF="STD-Heijmans-2007" TYPE="STUDY">Heijmans 2007</LINK>; <LINK REF="STD-Lagunilla-2006" TYPE="STUDY">Lagunilla 2006</LINK>).</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2012-01-27 14:04:20 +0000" MODIFIED_BY="[Empty name]">
<P>The risk of overall bias in this and previous meta-analyses is probably high as the allocation and blinding were unclear in most of the trials.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2013-05-07 03:49:35 +0100" MODIFIED_BY="[Empty name]">
<P>Our findings are largely comparable to those of the previous two meta-analyses (<LINK REF="REF-Ballentyne-1998" TYPE="REFERENCE">Ballentyne 1998</LINK>; <LINK REF="REF-Liu-2004" TYPE="REFERENCE">Liu 2004</LINK>).</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2013-05-07 03:50:37 +0100" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2013-05-07 03:50:03 +0100" MODIFIED_BY="[Empty name]">
<P>This meta-analysis showed that the use of TEA in cardiac surgery may reduce the risk of postoperative supraventricular arrhythmias, respiratory complications and neurological complications, but has no effect on the risk of mortality and myocardial infarction.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2013-05-07 03:50:37 +0100" MODIFIED_BY="[Empty name]">
<P>In view of inconsistent results for different outcomes and the long time period over which the included studies were undertaken, it would be interesting to focus future research on potential benefits of TEA compared to contemporary anaesthesia methods.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2013-05-07 03:51:13 +0100" MODIFIED_BY="Jane Cracknell">
<P>We would like to thank Mathew Zacharias (content editor), Marialena Trivella (statistical editor), Joanne Guay, Shafi Mussa, R Peter Alston (peer reviewers) and Janet Wale (CARG consumer editor) for their help and editorial advice during the preparation of this review.</P>
<P>We would also like to thank Dr Jane Ballantyne, Dr R Peter Alston, Dr W Scott Beattie Dr Shafi Mussa, Janet Wale, Maryann Napoli and Nete Villebro for their help and editorial advice during the preparation of the protocol for the systematic review.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2013-05-07 03:53:20 +0100" MODIFIED_BY="[Empty name]">
<P>None known</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2013-05-07 03:52:19 +0100" MODIFIED_BY="[Empty name]">
<P>Conceiving the review: Vesna Svircevic (VS), Diedrik van Dijk (DD), Cor Kalkman (CK), Arno Nierich (AN), Jan Dieleman (JD)<BR/>Co-ordinating the review: VS<BR/>Undertaking manual searches: VS, Martijn Passier (MP)<BR/>Screening search results: VS, MP<BR/>Organizing retrieval of papers: VS, MP<BR/>Screening retrieved papers against inclusion criteria: VS, MP<BR/>Appraising quality of papers: VS, MP<BR/>Abstracting data from papers: VS, MP<BR/>Writing to authors of papers for additional information: VS, MP, Geert van der Heijden (GH)<BR/>Providing additional data about papers: VS, MP<BR/>Obtaining and screening data on unpublished studies: VS, MP, GH<BR/>Data management for the review: GH<BR/>Entering data into Review Manager (<LINK REF="REF-RevMan-5.1" TYPE="REFERENCE">RevMan 5.1</LINK>): VS<BR/>RevMan statistical data: VS, GH<BR/>Other statistical analysis not using RevMan: VS, GH<BR/>Double entry of data: data entered by person one: VS, MP; data entered by person two: GH, DD<BR/>Interpretation of data: VS, MP, GH<BR/>Statistical inferences: VS, MP, GH<BR/>Writing the review: VS, MP<BR/>Performing previous work that was the foundation of the present study: VS, JD, AN, CK, DD<BR/>Guarantor for the review (one author): VS<BR/>Person responsible for reading and checking review before submission: VS, MP, DD</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2013-05-07 05:25:16 +0100" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2013-05-07 05:19:31 +0100" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2013-05-07 05:15:01 +0100" MODIFIED_BY="Jane Cracknell">
<STUDY DATA_SOURCE="PUB" ID="STD-Bach-2002" MODIFIED="2010-02-04 09:50:08 +0000" MODIFIED_BY="[Empty name]" NAME="Bach 2002" YEAR="2002">
<REFERENCE MODIFIED="2010-02-04 09:50:08 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Bach F, Grundmann U, Bauer M, Buchinger H, Soltész S, Graeter T, et al</AU>
<TI>Modulation of the inflammatory response to cardiopulmonary bypass by dopexamine and epidural anesthesia</TI>
<SO>Acta Anaesthesiologica Scandinavica</SO>
<YR>2002</YR>
<VL>46</VL>
<PG>1227-35</PG>
<IDENTIFIERS MODIFIED="2009-12-18 11:59:41 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-12-18 11:59:41 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="12421195"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2010-02-03 10:34:24 +0000" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bakhtiary-2007" MODIFIED="2013-05-07 05:11:10 +0100" MODIFIED_BY="[Empty name]" NAME="Bakhtiary 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-05-07 05:11:10 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Bakhtiary F, Therapidis P, Dzemali O, Ak K, Ackermann H, Meininger D, et al</AU>
<TI>Impact of high thoracic epidural anesthesia on incidence of perioperative atrial fibrillation in off-pump coronary bypass grafting: a prospective randomized study</TI>
<SO>Journal of Thoracic and Cardiovascular Surgery</SO>
<YR>2007</YR>
<VL>134</VL>
<PG>460-4</PG>
<IDENTIFIERS MODIFIED="2009-12-18 12:00:42 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-12-18 12:00:42 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="17662790"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Barrington-2005" MODIFIED="2010-02-04 09:50:17 +0000" MODIFIED_BY="[Empty name]" NAME="Barrington 2005" YEAR="2005">
<REFERENCE MODIFIED="2010-02-04 09:50:17 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Barrington MJ, Kluger R, Watson R, Scott DA, Harris KJ</AU>
<TI>Epidural anesthesia for coronary artery bypass surgery compared with general anesthesia alone does not reduce biochemical markers of myocardial damage</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>2005</YR>
<VL>100</VL>
<PG>921-8</PG>
<IDENTIFIERS MODIFIED="2009-12-18 12:03:58 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-12-18 12:03:58 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="15781499"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Berendes-2003" MODIFIED="2010-02-04 09:50:22 +0000" MODIFIED_BY="[Empty name]" NAME="Berendes 2003" YEAR="2003">
<REFERENCE MODIFIED="2010-02-04 09:50:22 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Berendes E, Schmidt C, Van Aken H, Hartlage MG, Wirtz S, Reinecke H, et al</AU>
<TI>Reversible cardiac sympathectomy by high thoracic epidural anesthesia improves regional left ventricular function in patients undergoing coronary artery bypass grafting: a randomized trial</TI>
<SO>Archives of Surgery</SO>
<YR>2003</YR>
<VL>138</VL>
<PG>1283-90</PG>
<IDENTIFIERS MODIFIED="2009-12-18 12:05:58 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-12-18 12:04:43 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="14662525"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brix_x002d_Christensen-1998" MODIFIED="2010-02-04 09:50:25 +0000" MODIFIED_BY="[Empty name]" NAME="Brix-Christensen 1998" YEAR="1998">
<REFERENCE MODIFIED="2010-02-04 09:50:25 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Brix-Christensen V, Tonnesen E, Sorensen IJ, Bilfinger TV, Sanchez RG, Stefano GB</AU>
<TI>Effects of anaesthesia based on high versus low doses of opioids on the cytokine and acute-phase protein responses in patients undergoing cardiac surgery</TI>
<SO>Acta Anaesthesiologica Scandinavica</SO>
<YR>1998</YR>
<VL>42</VL>
<PG>63&#8211;70</PG>
<IDENTIFIERS MODIFIED="2009-12-18 12:05:30 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-12-18 12:05:30 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="9527747"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Caputo-2009" MODIFIED="2013-05-07 05:12:59 +0100" MODIFIED_BY="[Empty name]" NAME="Caputo 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-05-07 05:12:59 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Caputo M, Alwair H, Rogers CA, Ginty M, Monk C, Tomkins S, et al</AU>
<TI>Myocardial, inflammatory, and stress responses in off-pump coronary artery bypass graft surgery with thoracic epidural anesthesia</TI>
<SO>The Annals of Thoracic Surgery</SO>
<YR>2009</YR>
<VL>87</VL>
<PG>1119-26</PG>
<IDENTIFIERS MODIFIED="2010-01-19 14:04:10 +0000" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2010-01-19 14:04:10 +0000" MODIFIED_BY="Jane Cracknell" TYPE="MEDLINE" VALUE="19324137"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-12-18 12:34:09 +0000" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Caputo-2011" MODIFIED="2013-05-07 05:13:17 +0100" MODIFIED_BY="[Empty name]" NAME="Caputo 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-05-07 05:13:17 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Caputo M, Alwair H, Rogers CA, Pike K, Cohen A, Monk C, et al</AU>
<TI>Thoracic epidural anesthesia improves early outcomes in patients undergoing off-pump coronary artery bypass surgery: a prospective, randomized, controlled trial</TI>
<SO>Anesthesiology</SO>
<YR>2011</YR>
<VL>114(2)</VL>
<PG>380-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2013-02-08 10:51:01 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-02-08 10:51:01 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="21245735"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-de-Vries-2002" MODIFIED="2013-05-07 05:14:47 +0100" MODIFIED_BY="[Empty name]" NAME="de Vries 2002" YEAR="2002">
<REFERENCE MODIFIED="2013-05-07 05:14:47 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>de Vries AJ, Mariani MA, van der Maaten JM, Loef BG, Lip H</AU>
<TI>To ventilate or not after minimally invasive direct coronary artery bypass surgery: the role of epidural anesthesia</TI>
<SO>Journal of Cardiothoracic and Vascular Anesthesia</SO>
<YR>2002</YR>
<VL>16</VL>
<PG>21-6</PG>
<IDENTIFIERS MODIFIED="2009-12-18 12:30:44 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-12-18 12:30:44 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="11854873"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-El_x002d_Baz-1987" MODIFIED="2010-02-04 09:50:59 +0000" MODIFIED_BY="[Empty name]" NAME="El-Baz 1987" YEAR="1987">
<REFERENCE MODIFIED="2010-02-04 09:50:59 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>El-Baz N, Goldin M</AU>
<TI>Continuous epidural infusion of morphine for pain relief after cardiac operations</TI>
<SO>Journal of Cardiovascular Surgery</SO>
<YR>1987</YR>
<VL>93</VL>
<PG>878&#8211;83</PG>
<IDENTIFIERS MODIFIED="2009-12-18 12:06:50 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-12-18 12:06:50 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="2952842"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fillinger-2002" MODIFIED="2013-05-07 05:15:01 +0100" MODIFIED_BY="Jane Cracknell" NAME="Fillinger 2002" YEAR="2002">
<REFERENCE MODIFIED="2013-05-07 05:15:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Fillinger MP, Yeager MP, Dodds TM, Fillinger MF, Whalen PK, Glass DD</AU>
<TI>Epidural anesthesia and analgesia: effects on recovery from cardiac surgery</TI>
<SO>Journal of Cardiothoracic and Vascular Anesthesia</SO>
<YR>2002</YR>
<VL>16</VL>
<PG>15-20</PG>
<IDENTIFIERS MODIFIED="2009-12-18 12:08:27 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-12-18 12:08:27 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="11854872"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hansdottir-2006" MODIFIED="2013-05-07 05:14:14 +0100" MODIFIED_BY="Jane Cracknell" NAME="Hansdottir 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-05-07 05:14:14 +0100" MODIFIED_BY="Jane Cracknell" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Hansdottir V, Philip J, Olsen MF, Eduard C, Houltz E, Ricksten SE</AU>
<TI>Thoracic epidural versus intravenous patient-controlled analgesia after cardiac surgery: a randomized controlled trial on length of hospital stay and patient-perceived quality of recovery</TI>
<SO>Anesthesiology</SO>
<YR>2006</YR>
<VL>104</VL>
<PG>142-51</PG>
<IDENTIFIERS MODIFIED="2010-01-19 14:53:58 +0000" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2010-01-19 14:53:58 +0000" MODIFIED_BY="Jane Cracknell" TYPE="MEDLINE" VALUE=" 16394700 "/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Heijmans-2007" MODIFIED="2010-02-04 09:51:11 +0000" MODIFIED_BY="[Empty name]" NAME="Heijmans 2007" YEAR="2007">
<REFERENCE MODIFIED="2010-02-04 09:51:11 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Heijmans J, Fransen E, Buurman W, Maessen J, Roekaerts P</AU>
<TI>Comparison of the modulatory effects of four different fast-track anesthetic techniques on the inflammatory response to cardiac surgery with cardiopulmonary bypass</TI>
<SO>Journal of Cardiothoracic and Vascular Anesthesia</SO>
<YR>2007</YR>
<VL>21</VL>
<PG>512-8</PG>
<IDENTIFIERS MODIFIED="2009-12-18 12:09:58 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-12-18 12:09:58 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="17678776"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kendall-2004" MODIFIED="2010-02-04 09:51:19 +0000" MODIFIED_BY="[Empty name]" NAME="Kendall 2004" YEAR="2004">
<REFERENCE MODIFIED="2010-02-04 09:51:19 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kendall JB, Russell GN, Scawn ND, Akrofi M, Cowan CM, Fox MA</AU>
<TI>A prospective, randomised, single-blind pilot study to determine the effect of anaesthetic technique on troponin T release after off-pump coronary artery surgery</TI>
<SO>Anaesthesia</SO>
<YR>2004</YR>
<VL>59</VL>
<PG>545-9</PG>
<IDENTIFIERS MODIFIED="2009-12-18 12:11:12 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-12-18 12:11:12 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="15144293"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kilickan-2006" MODIFIED="2010-02-04 09:51:24 +0000" MODIFIED_BY="[Empty name]" NAME="Kilickan 2006" YEAR="2006">
<REFERENCE MODIFIED="2010-02-04 09:51:24 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kiliçkan L, Gonca S, Dalçik C, Dalçik H, Solak M, Bayindir O, et al</AU>
<TI>General anesthesia with thoracic epidural anesthesia in the cardiopulmonary bypass surgery reduces apoptosis by upregulating antiapoptotic protein Bcl-2</TI>
<SO>Journal of cardiovascular surgery</SO>
<YR>2006</YR>
<VL>47</VL>
<PG>315-22</PG>
<IDENTIFIERS MODIFIED="2009-12-18 12:12:05 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-12-18 12:12:05 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="16760868"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kirno-1994" MODIFIED="2010-02-04 09:51:27 +0000" MODIFIED_BY="[Empty name]" NAME="Kirno 1994" YEAR="1994">
<REFERENCE MODIFIED="2010-02-04 09:51:27 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kirnö K, Friberg P, Grzegorczyk A, Milocco I, Ricksten SE, Lundin S</AU>
<TI>Thoracic epidural anesthesia during coronary artery bypass surgery: effects on cardiac sympathetic activity, myocardial blood flow and metabolism, and central hemodynamics</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>1994</YR>
<VL>79</VL>
<PG>1075-81</PG>
<IDENTIFIERS MODIFIED="2009-12-18 12:12:53 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-12-18 12:12:53 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="7978429"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lagunilla-2006" MODIFIED="2010-02-04 09:51:30 +0000" MODIFIED_BY="[Empty name]" NAME="Lagunilla 2006" YEAR="2006">
<REFERENCE MODIFIED="2010-02-04 09:51:30 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Lagunilla J, Garcia-Bengochea JB, Fernandez AL, Alvarez J, Rubio J, Rodriguez J, et al</AU>
<TI>High thoracic epidural blockade increases myocardial oxygen availability in coronary surgery patients</TI>
<SO>Acta Anaesthesiologica Scandinavica</SO>
<YR>2006</YR>
<VL>50</VL>
<PG>780-6</PG>
<IDENTIFIERS MODIFIED="2009-12-18 12:13:43 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-12-18 12:13:43 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="16879458"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liem-1992" MODIFIED="2010-02-04 09:47:54 +0000" MODIFIED_BY="[Empty name]" NAME="Liem 1992" YEAR="1992">
<REFERENCE MODIFIED="2010-02-04 09:47:54 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liem TH, Hasenbos MA, Booij LH, Gielen MJ</AU>
<TI>Coronary artery bypass grafting using two different anesthetic techniques: Part 2: Postoperative outcome</TI>
<SO>Journal of Cardiothoracic and Vascular Anesthesia</SO>
<YR>1992</YR>
<VL>6</VL>
<PG>152-6</PG>
<IDENTIFIERS MODIFIED="2009-12-18 12:16:29 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-12-18 12:16:29 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="1533166"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Loick-1999" MODIFIED="2010-02-04 09:51:47 +0000" MODIFIED_BY="[Empty name]" NAME="Loick 1999" YEAR="1999">
<REFERENCE MODIFIED="2010-02-04 09:51:47 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Loick HM, Schmidt C, Van Aken H, Junker R, Erren M, Berendes E, et al</AU>
<TI>High thoracic epidural anesthesia, but not clonidine, attenuates the perioperative stress response via sympatholysis and reduces the release of troponin T in patients undergoing coronary artery bypass grafting</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>1999</YR>
<VL>88</VL>
<PG>701-9</PG>
<IDENTIFIERS MODIFIED="2009-12-18 12:20:05 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-12-18 12:20:05 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="10195508"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lundstrom-2005" MODIFIED="2013-03-13 10:49:09 +0000" MODIFIED_BY="[Empty name]" NAME="Lundstrom 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-03-13 10:49:09 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Lundstrom LH, Nygard E, Hviid LB, Pedersen FM, Ravn J, Aldershvile J, et al</AU>
<TI>The effects of thoracic epidural analgesia on the occurence of late postoperative hypoxemia in patients undergoing elective coronary bypass surgery: a randomized controlled trial</TI>
<SO>Chest</SO>
<YR>2005</YR>
<VL>128</VL>
<PG>1564-70</PG>
<IDENTIFIERS MODIFIED="2009-12-18 12:21:43 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-12-18 12:21:43 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="16162759"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Moore-1995" MODIFIED="2010-02-04 09:51:54 +0000" MODIFIED_BY="[Empty name]" NAME="Moore 1995" YEAR="1995">
<REFERENCE MODIFIED="2010-02-04 09:51:54 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Moore CM, Cross MH, Desborough JP, Burrin JM, Macdonald IA, Hall GM</AU>
<TI>Hormonal effects of thoracic extradural analgesia for cardiac surgery</TI>
<SO>British Journal of Anesthesia</SO>
<YR>1995</YR>
<VL>75</VL>
<PG>387-93</PG>
<IDENTIFIERS MODIFIED="2009-12-18 12:23:28 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-12-18 12:23:28 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="7488474"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nygard-2004" MODIFIED="2010-02-04 09:51:57 +0000" MODIFIED_BY="[Empty name]" NAME="Nygard 2004" YEAR="2004">
<REFERENCE MODIFIED="2010-02-04 09:51:57 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Nygård E, Sørensen LH, Hviid LB, Pedersen FM, Ravn J, Thomassen L, et al</AU>
<TI>Effects of amiodarone and thoracic epidural analgesia on atrial fibrillation after coronary artery bypass grafting</TI>
<SO>Journal of Cardiothoracic Vascular Anesthesia</SO>
<YR>2004</YR>
<VL>18</VL>
<PG>709-14</PG>
<IDENTIFIERS MODIFIED="2010-01-19 14:42:06 +0000" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2010-01-19 14:42:06 +0000" MODIFIED_BY="Jane Cracknell" TYPE="MEDLINE" VALUE="15650978"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Onan-2011" MODIFIED="2013-02-09 18:47:24 +0000" MODIFIED_BY="[Empty name]" NAME="Onan 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-02-09 18:47:24 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Onan IS, Onan B, Korkmaz AA, Oklu L, Kilickan L, Gonca S, Dalcik H, Sanisoglu I</AU>
<TI>Effects of thoracic epidural anesthesia on flow and endothelium of internal thoracic artery in coronary artery bypass graft surgery</TI>
<SO>Journal of Cardiothoracic and Vascular Anesthesia</SO>
<YR>2011</YR>
<VL>25(6)</VL>
<PG>1063-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2013-02-09 22:31:44 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-02-09 22:31:39 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="21835638"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Priestley-2002" MODIFIED="2010-02-04 09:51:59 +0000" MODIFIED_BY="[Empty name]" NAME="Priestley 2002" YEAR="2002">
<REFERENCE MODIFIED="2010-02-04 09:51:59 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Priestley MC, Cope L, Halliwell R, Gibson P, Chard RB, Skinner M, et al</AU>
<TI>Thoracic epidural anesthesia for cardiac surgery: The effects on tracheal intubation time and length of hospital stay</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>2002</YR>
<VL>94</VL>
<PG>275&#8211;82</PG>
<IDENTIFIERS MODIFIED="2009-12-18 12:24:21 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-12-18 12:24:21 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="11812684"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rein-1989" MODIFIED="2010-02-04 09:52:02 +0000" MODIFIED_BY="[Empty name]" NAME="Rein 1989" YEAR="1989">
<REFERENCE MODIFIED="2010-02-04 09:52:02 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Rein KA, Stenseth R, Myhre HO, Levang OW, Krogstad A</AU>
<TI>The influence of thoracic epidural analgesia on transcapillary fluid balance in subcutaneous tissue. A study in patients undergoing aortocoronary bypass surgery</TI>
<SO>Acta Anaesthesiologica Scandinavica</SO>
<YR>1989</YR>
<VL>33</VL>
<PG>79-83</PG>
<IDENTIFIERS MODIFIED="2009-12-18 12:25:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-12-18 12:25:34 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="2644753"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Royse-2003" MODIFIED="2010-02-04 09:52:07 +0000" MODIFIED_BY="[Empty name]" NAME="Royse 2003" YEAR="2003">
<REFERENCE MODIFIED="2010-02-04 09:52:07 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Royse C, Royse A, Soeding P, Blake D, Pang J</AU>
<TI>Prospective randomized trial of high thoracic epidural analgesia for coronary artery bypass surgery</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>2003</YR>
<VL>75</VL>
<PG>93-100</PG>
<IDENTIFIERS MODIFIED="2009-12-18 12:25:57 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-12-18 12:25:57 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="12537199"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Scott-2001" MODIFIED="2010-02-04 09:52:09 +0000" MODIFIED_BY="[Empty name]" NAME="Scott 2001" YEAR="2001">
<REFERENCE MODIFIED="2010-02-04 09:52:09 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Scott NB, Turfrey DJ, Ray DAA, Nzewi O, Sutcliffe NP, Lal AB, et al</AU>
<TI>A Prospective Randomized Study of the Potential Benefits of Thoracic Epidural Anesthesia and Analgesia in Patients Undergoing Coronary Artery Bypass Grafting</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>2001</YR>
<VL>93</VL>
<PG>528-35</PG>
<IDENTIFIERS MODIFIED="2009-12-18 12:26:19 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-12-18 12:26:19 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="11524314"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sharma-2010" MODIFIED="2013-02-08 19:04:07 +0000" MODIFIED_BY="[Empty name]" NAME="Sharma 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-02-08 19:04:07 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sharma M, Mehta Y, Sawhney R, Vats M, Trehan N</AU>
<TI>Thoracic epidural analgesia in obese patients with body mass index of more than 30 kg/m2 for off pump coronary artery bypass surgery</TI>
<SO>Annals Cardiac Anaesthesia</SO>
<YR>2010</YR>
<VL>13(1)</VL>
<PG>28-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2013-02-09 22:30:56 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-02-09 22:30:56 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="20075532"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stenseth-1994" MODIFIED="2010-02-04 09:52:16 +0000" MODIFIED_BY="[Empty name]" NAME="Stenseth 1994" YEAR="1994">
<REFERENCE MODIFIED="2010-02-04 09:52:16 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Stenseth R, Bjella L, Berg EM, Christensen O, Levang OW, Gisvold SE</AU>
<TI>Thoracic epidural analgesia in aortocoronary bypass surgery. I: Haemodynamic effects</TI>
<SO>Acta Anaesthesiologica Scandinavica</SO>
<YR>1994</YR>
<VL>38</VL>
<PG>826-33</PG>
<IDENTIFIERS MODIFIED="2009-12-18 12:28:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-12-18 12:28:34 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="7887106"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stenseth-1996" MODIFIED="2010-02-04 09:45:23 +0000" MODIFIED_BY="[Empty name]" NAME="Stenseth 1996" YEAR="1996">
<REFERENCE MODIFIED="2010-02-04 09:45:23 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stenseth R, Bjella L, Berg EM, Christensen O, Levang OW, Gisvold SE</AU>
<TI>Effects of thoracic epidural analgesia on pulmonary function after coronary artery bypass surgery</TI>
<SO>European Journal of Cardiothoracic Surgery</SO>
<YR>1996</YR>
<VL>10</VL>
<PG>859-65</PG>
<IDENTIFIERS MODIFIED="2009-12-18 12:26:53 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-12-18 12:26:53 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="8911839"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Svircevic-2011" MODIFIED="2013-02-08 11:15:55 +0000" MODIFIED_BY="[Empty name]" NAME="Svircevic 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-02-08 11:15:55 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Svircevic V, Nierich AP, Moons KG, Diephuis JC, Ennema JJ, Brandon Bravo Bruinsma GJ, Kalkman CJ, van Dijk D</AU>
<TI>Thoracic epidural anesthesia for cardiac surgery: a randomized trial</TI>
<SO>Anesthesiology</SO>
<YR>2011</YR>
<VL>114(2)</VL>
<PG>262-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2013-02-08 13:42:00 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-02-08 13:42:00 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="21239976"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tenling-1999" MODIFIED="2010-02-04 09:52:23 +0000" MODIFIED_BY="[Empty name]" NAME="Tenling 1999" YEAR="1999">
<REFERENCE MODIFIED="2010-02-04 09:52:23 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Tenling A, Joachimsson PO, Tydén H, Wegenius G, Hedenstierna G</AU>
<TI>Thoracic epidural anesthesia as an adjunct to general anesthesia for cardiac surgery: effects on ventilation-perfusion relationships</TI>
<SO>Journal of Cardiothoracic and Vascular Anesthesia</SO>
<YR>1999</YR>
<VL>13</VL>
<PG>258-64</PG>
<IDENTIFIERS MODIFIED="2009-12-18 12:29:28 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-12-18 12:29:28 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="10392674"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2013-05-07 05:19:31 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Chae-1998" MODIFIED="2010-02-04 10:30:13 +0000" MODIFIED_BY="[Empty name]" NAME="Chae 1998" YEAR="1998">
<REFERENCE MODIFIED="2010-02-04 10:30:13 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chae BK, Lee HW, Sun K, Choi YH, Kim HM</AU>
<TI>The effect of combinedepidural and light general anesthesia on stress hormones in open heart surgery patients</TI>
<SO>Surgery today</SO>
<YR>1998</YR>
<VL>28</VL>
<PG>727-731</PG>
<IDENTIFIERS MODIFIED="2010-02-04 10:30:11 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-02-04 10:30:11 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="9697266"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dohle-2001" MODIFIED="2010-02-04 10:31:27 +0000" MODIFIED_BY="[Empty name]" NAME="Dohle 2001" YEAR="2001">
<REFERENCE MODIFIED="2010-02-04 10:31:27 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dhole S, Mehta Y, Saxena H, Juneja R, Trehan N</AU>
<TI>Comparison of continousthoracic epidural and paravertebral blocks for postoperative analgesia after minimally invasive direct coronary artery bypass surgery</TI>
<SO>Journal of Cardiothoracic and Vascular Anesthesia</SO>
<YR>2001</YR>
<VL>15</VL>
<PG>288-292</PG>
<IDENTIFIERS MODIFIED="2010-02-04 09:58:17 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-02-04 09:58:17 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="11426357"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fawcett-1997" MODIFIED="2010-02-04 10:34:50 +0000" MODIFIED_BY="[Empty name]" NAME="Fawcett 1997" YEAR="1997">
<REFERENCE MODIFIED="2010-02-04 10:34:50 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fawcett WJ, Edwards RE, Quinn AC, MacDonald IA, Hall GM</AU>
<TI>Thoracic epidural analgesia started after cardiopulmonary bypass. Adrenergic, cardiovascular and respiratory sequelae</TI>
<SO>Anaesthesia</SO>
<YR>1997</YR>
<VL>52</VL>
<PG>294-199</PG>
<IDENTIFIERS MODIFIED="2010-02-04 10:34:50 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-02-04 10:34:50 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="9135178"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Greisen-2012" MODIFIED="2013-02-08 13:39:59 +0000" MODIFIED_BY="[Empty name]" NAME="Greisen 2012" YEAR="2012">
<REFERENCE MODIFIED="2013-02-08 13:39:59 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Greisen J, Nielsen DV, Sloth E, Jakobsen CJ</AU>
<TI>High thoracic epidural analgesia decreases stress hyperglycemia and insulin need in cardiac surgery patients</TI>
<SO>Acta Anaesthesiologica Scandinavica</SO>
<YR>2013</YR>
<VL>57(2)</VL>
<PG>171-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2013-02-08 13:49:58 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-02-08 13:49:58 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="22762307"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jakobsen-2012" MODIFIED="2013-02-08 18:31:15 +0000" MODIFIED_BY="[Empty name]" NAME="Jakobsen 2012" YEAR="2012">
<REFERENCE MODIFIED="2013-02-08 18:31:15 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jakobsen CJ, Bhavsar R, Nielsen DV, Ryhammer PK, Sloth E, Greisen J</AU>
<TI>High thoracic epidural analgesia in cardiac surgery: part 1-high thoracic epidural analgesia improves cardiac performance in cardiac surgery patients</TI>
<SO>Journal of Cardiothoracic and Vascular Anesthesia</SO>
<YR>2012</YR>
<VL>26(6)</VL>
<PG>1039-47</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="22770758"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jideus-2001" MODIFIED="2011-09-25 14:59:35 +0100" MODIFIED_BY="[Empty name]" NAME="Jideus 2001" YEAR="2001">
<REFERENCE MODIFIED="2011-09-25 14:59:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jideus L, Joachimsson PE, Stridsberg M, et al</AU>
<TI>Thoracic epidural anesthesia does not influence the occurrence of postoperative sustainedatrial fibrillation</TI>
<SO>Annuals of Thoracic Surgery</SO>
<YR>2001</YR>
<VL>72</VL>
<PG>65-71</PG>
<IDENTIFIERS MODIFIED="2010-02-04 09:42:24 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-02-04 09:42:24 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="11465233"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kessler-2005" MODIFIED="2010-02-04 10:40:22 +0000" MODIFIED_BY="[Empty name]" NAME="Kessler 2005" YEAR="2005">
<REFERENCE MODIFIED="2010-02-04 10:40:22 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kessler P, Aybek T, Neidhart G, et al</AU>
<TI>Comparison of three anesthetic techniques for off-pump coronary artery bypass grafting: General anesthesia, combined general and high thoracic epidural anesthesia, or high thoracic epidural anesthesia alone</TI>
<SO>Journal of Cardiothoracic and Vascular Anesthesia</SO>
<YR>2005</YR>
<VL>19</VL>
<PG>32-9</PG>
<IDENTIFIERS MODIFIED="2010-02-04 10:39:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-02-04 10:39:34 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="15747266"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liang-2012" MODIFIED="2013-02-08 13:56:31 +0000" MODIFIED_BY="[Empty name]" NAME="Liang 2012" YEAR="2012">
<REFERENCE MODIFIED="2013-02-08 13:56:31 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liang Y, Chu H, Zhen H, Wang S, Gu M</AU>
<TI>A prospective randomized study of intraoperative thoracic epidural analgesia in off-pump coronary artery bypass surgery</TI>
<SO>Journal of Anesthesia</SO>
<YR>2012</YR>
<VL>26(3)</VL>
<PG>393-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2013-02-08 13:57:05 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-02-08 13:57:05 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="22274169"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liem-1992a" MODIFIED="2013-05-07 05:16:21 +0100" MODIFIED_BY="[Empty name]" NAME="Liem 1992a" YEAR="">
<REFERENCE MODIFIED="2013-05-07 05:16:21 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liem TH, Booij LH, Hasenbos MA, Gielen MJ</AU>
<TI>Coronary artery bypass grafting using two different anesthetic techniques: Part I: Hemodynamic results</TI>
<SO>Journal of Cardiothoraocic and Vascular Anesthesia</SO>
<YR>1992</YR>
<VL>6</VL>
<PG>148-55</PG>
<IDENTIFIERS MODIFIED="2010-02-04 10:53:14 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-02-04 10:53:14 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="1533165"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liem-1992b" MODIFIED="2013-05-07 05:16:58 +0100" MODIFIED_BY="[Empty name]" NAME="Liem 1992b" YEAR="">
<REFERENCE MODIFIED="2013-05-07 05:16:58 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liem TH, Booij LH, Gielen MJ, Hasenbos MA, van Egmond J</AU>
<TI>Coronary artery bypass grafting using two different anesthetic techniques: Part 3: Adrenergic responses</TI>
<SO>Journal of Cardiothoracic and Vascular Anesthesia</SO>
<YR>1992</YR>
<VL>6</VL>
<PG>162-7</PG>
<IDENTIFIERS MODIFIED="2010-02-04 10:54:15 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-02-04 10:54:15 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="1533167"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mehta-1998" MODIFIED="2013-05-07 05:17:20 +0100" MODIFIED_BY="[Empty name]" NAME="Mehta 1998" YEAR="1998">
<REFERENCE MODIFIED="2013-05-07 05:17:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mehta Y, Swaminathan M, Mishra Y, Trehan N</AU>
<TI>A comparative evaluation of intrapleural pain relief after minimally invasive direct coronary artery bypass surgery</TI>
<SO>Journal of Cardiothoracic and Vascular Anesthesia</SO>
<YR>1998</YR>
<VL>12</VL>
<PG>162-5</PG>
<IDENTIFIERS MODIFIED="2010-02-04 10:59:45 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-02-04 10:59:45 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="9583546"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Olivier-2005" MODIFIED="2010-02-04 10:45:47 +0000" MODIFIED_BY="[Empty name]" NAME="Olivier 2005" YEAR="2005">
<REFERENCE MODIFIED="2010-02-04 10:45:47 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Olivier JF, Le N, Choinière JL, Prieto I, Basile F, Hemmerling T</AU>
<TI>Comparison of three different epidural solutions in off-pump cardiac surgery: pilot study</TI>
<SO>British Journal of Anaesthesia</SO>
<YR>2005</YR>
<VL>95</VL>
<PG>685-91</PG>
<IDENTIFIERS MODIFIED="2010-02-04 10:45:47 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-02-04 10:45:47 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="16183682"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stenseth-1995" MODIFIED="2013-05-07 05:18:45 +0100" MODIFIED_BY="[Empty name]" NAME="Stenseth 1995" YEAR="1995">
<REFERENCE MODIFIED="2013-05-07 05:18:45 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stenseth R, Berg EM, Bjella L, Christensen O, Levang OW, Gisvold SE</AU>
<TI>Effects of thoracic epidural analgesia on coronary hemodynamics and myocardial metabolism in coronary artery bypass surgery</TI>
<SO>Journal of Cardiothoracic and Vascular Anesthesia</SO>
<YR>1995</YR>
<VL>9</VL>
<PG>503-9</PG>
<IDENTIFIERS MODIFIED="2010-02-04 10:56:49 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-02-04 10:56:49 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="8547549"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Thorelius-1996" MODIFIED="2013-05-07 05:19:31 +0100" MODIFIED_BY="[Empty name]" NAME="Thorelius 1996" YEAR="1996">
<REFERENCE MODIFIED="2013-05-07 05:19:31 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Thorelius J, Ekroth R, Hallhagen S, et al</AU>
<TI>Thoracolumbar epidural blockade as adjunct to high dose fentanyl/midazolam anesthesia in coronary surgery: Effects of sternotomy</TI>
<SO>European Journal of Cardiothoracic Surgery</SO>
<YR>1996</YR>
<VL>10</VL>
<PG>754-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2013-02-08 18:46:18 +0000" MODIFIED_BY="[Empty name]"/>
<ONGOING_STUDIES MODIFIED="2010-02-04 09:31:13 +0000" MODIFIED_BY="[Empty name]"/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2013-05-07 05:25:16 +0100" MODIFIED_BY="Jane Cracknell">
<ADDITIONAL_REFERENCES MODIFIED="2013-05-07 05:25:16 +0100" MODIFIED_BY="Jane Cracknell">
<REFERENCE ID="REF-Ballentyne-1998" MODIFIED="2010-02-04 09:36:03 +0000" MODIFIED_BY="[Empty name]" NAME="Ballentyne 1998" TYPE="JOURNAL_ARTICLE">
<AU>Ballantyne JC, Carr DB, deFerranti S, Suarez T, Lau J, Chalmers TC, et al</AU>
<TI>The comparative effects of postoperative analgesic therapies on pulmonary outcome: cumulative meta-analyses of randomized, controlled trials</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>1998</YR>
<VL>86</VL>
<PG>598-612</PG>
<IDENTIFIERS MODIFIED="2010-01-19 14:34:08 +0000" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2010-01-19 14:34:08 +0000" MODIFIED_BY="Jane Cracknell" TYPE="MEDLINE" VALUE="9495424"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Bang-2011" MODIFIED="2013-05-07 05:20:31 +0100" MODIFIED_BY="[Empty name]" NAME="Bang 2011" TYPE="JOURNAL_ARTICLE">
<AU>Bang J, Kim JU, Lee YM, Joh J, An EH, Lee JY, et al</AU>
<TI>Spinal epidural hematoma related to an epidural catheter in a cardiac surgery patient - A case report</TI>
<SO>Korean Journal of Anesthesiology</SO>
<YR>2011</YR>
<VL>61(6)</VL>
<PG>524-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Beattie-2003" MODIFIED="2009-12-18 10:23:47 +0000" MODIFIED_BY="[Empty name]" NAME="Beattie 2003" TYPE="JOURNAL_ARTICLE">
<AU>Beattie WS, Badner NH, Choi PT</AU>
<TI>Meta-analysis demonstrates statistically significant reduction in postoperative myocardial infarction with the use of thoracic epidural analgesia</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>2003</YR>
<VL>97</VL>
<PG>919-20</PG>
<IDENTIFIERS MODIFIED="2009-12-18 10:23:47 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-12-18 10:23:47 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="12933434"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Bowler-2002" MODIFIED="2010-02-04 09:36:31 +0000" MODIFIED_BY="[Empty name]" NAME="Bowler 2002" TYPE="JOURNAL_ARTICLE">
<AU>Bowler I, Djaiani G, Abel R, Pugh S, Dunne J, Hall J</AU>
<TI>A combination of intrathecal morphine and remifentanil anesthesia for fast-track cardiac anesthesia and surgery</TI>
<SO>Journal of Cardiothoracic and Vascular Anesthesia</SO>
<YR>2002</YR>
<VL>16</VL>
<PG>709-14</PG>
<IDENTIFIERS MODIFIED="2010-01-19 14:35:23 +0000" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2010-01-19 14:35:23 +0000" MODIFIED_BY="Jane Cracknell" TYPE="MEDLINE" VALUE="12486651"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Burgess-2006" MODIFIED="2011-01-06 13:42:33 +0000" MODIFIED_BY="Jane Cracknell" NAME="Burgess 2006" TYPE="JOURNAL_ARTICLE">
<AU>Burgess DC, Kilborn MJ, Keech AC</AU>
<TI>Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis</TI>
<SO>European Heart Journal</SO>
<YR>2006</YR>
<VL>27</VL>
<PG>2846-57</PG>
<IDENTIFIERS MODIFIED="2009-12-18 10:32:20 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-12-18 10:32:20 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="17015402"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Chaney-1997" MODIFIED="2010-02-04 09:37:07 +0000" MODIFIED_BY="[Empty name]" NAME="Chaney 1997" TYPE="JOURNAL_ARTICLE">
<AU>Chaney MA</AU>
<TI>Intrathecal and epidural anesthesia and analgesia for cardiac surgery</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>1997</YR>
<VL>84</VL>
<PG>1211-21</PG>
<IDENTIFIERS MODIFIED="2010-01-19 14:36:29 +0000" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2010-01-19 14:36:29 +0000" MODIFIED_BY="Jane Cracknell" TYPE="MEDLINE" VALUE="9174295"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Chaney-2006" MODIFIED="2010-02-04 09:37:38 +0000" MODIFIED_BY="[Empty name]" NAME="Chaney 2006" TYPE="JOURNAL_ARTICLE">
<AU>Chaney MA</AU>
<TI>Intrathecal and epidural anesthesia and analgesia for cardiac surgery</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>2006</YR>
<VL>102</VL>
<PG>45-64</PG>
<IDENTIFIERS MODIFIED="2010-01-19 14:36:49 +0000" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2010-01-19 14:36:49 +0000" MODIFIED_BY="Jane Cracknell" TYPE="MEDLINE" VALUE="16368803"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Coriat-2001" MODIFIED="2010-02-04 09:38:12 +0000" MODIFIED_BY="[Empty name]" NAME="Coriat 2001" TYPE="JOURNAL_ARTICLE">
<AU>Coriat P, Beaussier M</AU>
<TI>Fast-tracking after coronary artery bypass graft surgery</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>2001</YR>
<VL>92</VL>
<PG>1081-3</PG>
<IDENTIFIERS MODIFIED="2009-12-18 10:35:05 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-12-18 10:35:05 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="11323325"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Djaiani-2000" MODIFIED="2010-02-04 09:42:49 +0000" MODIFIED_BY="[Empty name]" NAME="Djaiani 2000" TYPE="JOURNAL_ARTICLE">
<AU>Djaiani G</AU>
<TI>Thoracic epidural anesthesia as an adjunct to general anesthesia for cardiac surgery: effects on ventilation-perfusion relationships</TI>
<SO>Journal of Cardiothoracic and Vascular Anesthesia</SO>
<YR>2000</YR>
<VL>14</VL>
<PG>359-60</PG>
<IDENTIFIERS MODIFIED="2009-12-18 10:36:28 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-12-18 10:36:28 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="10890498"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2013-04-30 11:50:53 +0100" MODIFIED_BY="Jane Cracknell" NAME="Higgins 2011" TYPE="OTHER">
<TI>Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]</TI>
<SO>The Cochrane Collaboration</SO>
<YR>2011</YR>
<VL>www.cochrane-handbook.org</VL>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ho-2000" MODIFIED="2009-12-18 10:38:17 +0000" MODIFIED_BY="[Empty name]" NAME="Ho 2000" TYPE="JOURNAL_ARTICLE">
<AU>Ho AM, Chung DC, Joynt GM</AU>
<TI>Neuraxial blockade and hematoma in cardiac surgery: estimating the risk of a rare adverse event that has not (yet) occurred</TI>
<SO>Chest</SO>
<YR>2000</YR>
<VL>117</VL>
<PG>551-5</PG>
<IDENTIFIERS MODIFIED="2009-12-18 10:38:14 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-12-18 10:38:14 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="10669702"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Ho-2006" MODIFIED="2010-02-04 09:43:07 +0000" MODIFIED_BY="[Empty name]" NAME="Ho 2006" TYPE="JOURNAL_ARTICLE">
<AU>Ho AM, Li PT, Karmakar MK</AU>
<TI>Risk of hematoma after epidural anesthesia and analgesia for cardiac surgery</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>2006</YR>
<VL>103</VL>
<PG>1327</PG>
<IDENTIFIERS MODIFIED="2009-12-18 10:39:32 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-12-18 10:39:32 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="17056978 "/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kerstein-2004" MODIFIED="2010-02-04 09:43:16 +0000" MODIFIED_BY="[Empty name]" NAME="Kerstein 2004" TYPE="JOURNAL_ARTICLE">
<AU>Kerstein J, Soodan A, Qamar M, Majid M, Lichstein E, Hollander G, et al</AU>
<TI>Giving IV and oral amiodarone perioperatively for the prevention of postoperative atrial fibrillation in patients undergoing coronary artery bypass surgery: the GAP study</TI>
<SO>Chest</SO>
<YR>2004</YR>
<VL>126</VL>
<PG>716-24</PG>
<IDENTIFIERS MODIFIED="2009-12-18 10:40:39 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-12-18 10:40:39 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="15364747 "/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Liu-2004" MODIFIED="2009-12-18 10:41:11 +0000" MODIFIED_BY="[Empty name]" NAME="Liu 2004" TYPE="JOURNAL_ARTICLE">
<AU>Liu SS, Block BM, Wu CL</AU>
<TI>Effects of perioperative central neuraxial analgesia on outcome after coronary artery bypass surgery: a meta-analysis</TI>
<SO>Anesthesiology</SO>
<YR>2004</YR>
<VL>101</VL>
<PG>153-61</PG>
<IDENTIFIERS MODIFIED="2009-12-18 10:41:11 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-12-18 10:41:11 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="15220785"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Meissner-1997" MODIFIED="2013-05-07 05:23:56 +0100" MODIFIED_BY="[Empty name]" NAME="Meissner 1997" TYPE="JOURNAL_ARTICLE">
<AU>Meissner A, Rolf N, Van Aken H</AU>
<TI>Thoracic epidural anesthesia and the patient with heart disease: benefits, risks, and controversies</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>1997</YR>
<VL>85</VL>
<PG>517-28</PG>
<IDENTIFIERS MODIFIED="2009-12-18 10:41:52 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-12-18 10:41:52 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="9296403"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Nicholson-2002" MODIFIED="2013-05-07 05:24:21 +0100" MODIFIED_BY="[Empty name]" NAME="Nicholson 2002" TYPE="JOURNAL_ARTICLE">
<AU>Nicholson DJ, Kowalski SE, Hamilton GA, Meyers MP, Serrette C, Duke PC</AU>
<TI>Postoperative pulmonary function in coronary artery bypass graft surgery patients undergoing early tracheal extubation: a comparison between short-term mechanical ventilation and early extubation</TI>
<SO>Journal of Cardiothoracic and Vascular Anesthesia</SO>
<YR>2002</YR>
<VL>16</VL>
<PG>27-31</PG>
<IDENTIFIERS MODIFIED="2010-01-19 14:39:19 +0000" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2010-01-19 14:39:19 +0000" MODIFIED_BY="Jane Cracknell" TYPE="MEDLINE" VALUE="11854874 "/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Oxelbark-2001" MODIFIED="2013-05-07 05:24:44 +0100" MODIFIED_BY="[Empty name]" NAME="Oxelbark 2001" TYPE="JOURNAL_ARTICLE">
<AU>Oxelbark S, Bengtsson L, Eggersen M, Kopp J, Pedersen J, Sanchez R</AU>
<TI>Fast track as a routine for open heart surgery</TI>
<SO>European Journal of Cardiothoracic Surgery</SO>
<YR>2001</YR>
<VL>19</VL>
<PG>460-3</PG>
<IDENTIFIERS MODIFIED="2010-01-19 14:43:40 +0000" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2010-01-19 14:43:40 +0000" MODIFIED_BY="Jane Cracknell" TYPE="MEDLINE" VALUE="11306313"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-RevMan-5.1" MODIFIED="2013-05-07 05:24:59 +0100" MODIFIED_BY="Jane Cracknell" NAME="RevMan 5.1" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2011</YR>
<EN>5.1</EN>
<PB>The Nordic Cochrane Centre</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rodgers-2000" MODIFIED="2013-05-07 05:25:16 +0100" MODIFIED_BY="[Empty name]" NAME="Rodgers 2000" TYPE="JOURNAL_ARTICLE">
<AU>Rodgers A, Walker N, Schug S, McKee A, Kehlet H, van Zundert A, et al</AU>
<TI>Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials</TI>
<SO>BMJ</SO>
<YR>2000</YR>
<VL>321</VL>
<PG>1493</PG>
<IDENTIFIERS MODIFIED="2010-01-19 14:45:48 +0000" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2010-01-19 14:45:48 +0000" MODIFIED_BY="Jane Cracknell" TYPE="MEDLINE" VALUE="11118174"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Rosen-2004" MODIFIED="2010-02-04 09:44:38 +0000" MODIFIED_BY="[Empty name]" NAME="Rosen 2004" TYPE="JOURNAL_ARTICLE">
<AU>Rosen DA, Hawkinberry II, DW Rosen KR, Gustafson RA, Hogg JP, Broadman LM</AU>
<TI>An epidural hematoma in an adolescent patient after cardiac surgery</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>2004</YR>
<VL>98</VL>
<PG>966-9</PG>
<IDENTIFIERS MODIFIED="2009-12-18 10:47:36 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-12-18 10:47:36 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="15041581"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Silbert-1998" MODIFIED="2009-12-18 10:52:50 +0000" MODIFIED_BY="[Empty name]" NAME="Silbert 1998" TYPE="JOURNAL_ARTICLE">
<AU>Silbert BS, Santamaria JD, O'Brien JL, Blyth CM, Kelly WJ, Molnar RR</AU>
<TI>Early extubation following coronary artery bypass surgery: a prospective randomized controlled trial</TI>
<SO>Chest</SO>
<YR>1998</YR>
<VL>113</VL>
<PG>1481-8</PG>
<IDENTIFIERS MODIFIED="2009-12-18 10:52:50 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-12-18 10:52:50 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="9631781 "/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Turfrey-1997" MODIFIED="2010-02-04 09:44:46 +0000" MODIFIED_BY="[Empty name]" NAME="Turfrey 1997" TYPE="JOURNAL_ARTICLE">
<AU>Turfrey DJ, Ray DA, Sutcliffe NP, Ramayya P, Kenny GN, Scott NB</AU>
<TI>Thoracic epidural anaesthesia for coronary artery bypass graft surgery. Effects on postoperative complications</TI>
<SO>Anaesthesia</SO>
<YR>1997</YR>
<VL>52</VL>
<PG>1090-5</PG>
<IDENTIFIERS MODIFIED="2010-01-19 14:48:19 +0000" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2010-01-19 14:48:19 +0000" MODIFIED_BY="Jane Cracknell" TYPE="MEDLINE" VALUE="9404174"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Zarate-2000" MODIFIED="2010-02-04 09:44:55 +0000" MODIFIED_BY="[Empty name]" NAME="Zarate 2000" TYPE="JOURNAL_ARTICLE">
<AU>Zarate E, Latham P, White PF, Bossard R, Morse L, Douning LK, et al</AU>
<TI>Fast-track cardiac anesthesia: use of remifentanil combined with intrathecal morphine as an alternative to sufentanil during desflurane anesthesia</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>2000</YR>
<VL>91</VL>
<PG>283-7</PG>
<IDENTIFIERS MODIFIED="2010-01-19 14:48:57 +0000" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2010-01-19 14:48:57 +0000" MODIFIED_BY="Jane Cracknell" TYPE="MEDLINE" VALUE="10910832"/>
</IDENTIFIERS>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2013-05-15 20:31:19 +0100" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2013-05-15 20:31:19 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2012-05-22 11:22:05 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bach-2002">
<CHAR_METHODS>
<P>Randomized controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-22 11:22:01 +0100" MODIFIED_BY="[Empty name]">
<P>40 patients scheduled for elective coronary artery bypass grafting surgery. Exclusion criteria were impaired coagulation, allergies to local anaesthetics, corticoid medication, preoperative signs of infection, renal or liver failure, diabetes mellitus and an impaired left ventricular function (ejection fraction 50%)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-22 11:22:05 +0100" MODIFIED_BY="[Empty name]">
<P>Continuous epidural infusion of bupivacaine 0.25% versus general anaesthesia group</P>
<P>The 13 patients received an epidural bolus of 10ml of bupivacaine 0.25% through the catheter followed by a continuous epidural infusion of bupivacaine 0.25% (Bupivacain 0.25%, Curasan Pharma AG, Kleinostheim, Germany) adjusted to body height for the whole observation period until 18h after surgery. The control group consists of 13 patients who received an intravenous dopexamine infusion beside general anaesthesia and 14 patients with general anaesthesia alone who received equal volumes of NaCl 0.9% intravenously as placebo in a time-matched fashion.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-02-01 15:39:07 +0000" MODIFIED_BY="[Empty name]">
<P>Inflammatory response</P>
<P>Mortality</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-15 20:20:51 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bakhtiary-2007">
<CHAR_METHODS>
<P>Randomized controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-22 11:22:10 +0100" MODIFIED_BY="Jane Cracknell">
<P>132 patients with symptomatic coronary artery disease were prospective enrolled in this study. All patients underwent elective OPCAB surgery and were randomized to receive either GA or combined GATEA. Patients with a history of atrial arrhythmias, those undergoing emergency operations, and patients requiring intraoperative inotropic support were excluded from this study.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-05-15 20:20:51 +0100" MODIFIED_BY="[Empty name]">
<P>General anaesthesia only or combined general anaesthesia with high thoracic epidural analgesia (66 patients in each group)</P>
<P>TEA: a continuous epidural infusion with ropivacaine 0.16% and sufentanil 1 g/mL at an hourly rate of 2 to 5 mL was started after a bolus dose of 6 mL to provide intraoperative analgesia. GA: propofol (1.5 mg/kg) and remifentanil (1 ug/kg) administered over 120 seconds. After loss of eyelash reflex, 0.1 mg/kg of cisatracurium was administered to facilitate tracheal intubation. Anaesthesia was maintained with continuous infusion of propofol (50-100 ug/kg/min) and remifentanil (0.1-0.3 ug/kg/min). Patients undergoing GA without TEA received intravenous metamizole (Novalgin; Aventis Pharma, Bad Soden, Germany), a peripheral analgesic derived from pyrazolone acid, 15 mg/kg, before skin incision. Intravenous piritramide, a-receptor agonist with a potency of 0.7 compared with morphine, 0.1 mg/kg, was administered after completion of coronary anastomosis and repeated during wound closure.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-09-26 14:38:31 +0100" MODIFIED_BY="[Empty name]">
<P>Mortality<BR/>Myocardial infarction<BR/>Supraventricular tachyarrhythmias</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-07 04:05:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Barrington-2005">
<CHAR_METHODS>
<P>Randomized controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-05-07 04:03:36 +0100" MODIFIED_BY="[Empty name]">
<P>120 patients scheduled for elective coronary artery bypass grafting surgery</P>
<P>All patients scheduled for elective CABG surgery (using cardiopulmonary bypass (CPB)) were eligible. Exclusion criteria were emergency or repeat CABG surgery, combined valve and CABG surgery, aspirin ingestion within 6 days of surgery, a platelet count 150x10<SUP>9</SUP>/L, an international normalized ratio 1.1, active neurological disease, and cutaneous disorders at the epidural insertion site.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-05-07 04:05:19 +0100" MODIFIED_BY="[Empty name]">
<P>General anaesthesia only or combined general anaesthesia with high thoracic epidural analgesia (ropivacaine 1%; 60 patients in each group)</P>
<P>epidural block was established with 5 mL of ropivacaine 1% and fentanyl 50 ug. If required, the block was extended with 2 mL of ropivacaine 1%.</P>
<P>GA was induced with midazolam (0.05 - 0.1 mg/kg), fentanyl (7-15 ug/kg for the GA group and 5-7 ug/kg for the HTEA group), propofol (20 mg increments as required), and rocuronium (0.6 mg/kg). GA was maintained with propofol 3-6 mg/kg/hr. Further doses of rocuronium 10 mg were given only for overt patient movement, with no additional rocuronium given after CPB.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-05-07 04:05:10 +0100" MODIFIED_BY="[Empty name]">
<P>Mortality<BR/>Myocardial infarction<BR/>Supraventricular tachyarrhythmias<BR/>Stroke</P>
<P>Respiratory complications<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-07 04:06:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Berendes-2003">
<CHAR_METHODS>
<P>Randomized controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-05-07 04:04:33 +0100" MODIFIED_BY="[Empty name]">
<P>73 patients scheduled for coronary artery bypass who had left ventricular ejection fraction of 50% or more</P>
<P>Eligible patients had coronary artery disease with a left ventricular function of 50% or more and were scheduled for elective CABG. Exclusion criteria were any pre-existing endocrinological diseases, renal insufficiency, coagulation disorders or right and/or left ventricular dysfunction, concomitant disorders of heart valves, having undergone cardiac surgical procedures, acute myocardial infarction and heart failure.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-05-07 04:06:04 +0100" MODIFIED_BY="[Empty name]">
<P>General anaesthesia only (37 patients) or combined general anaesthesia with high thoracic epidural analgesia (36 patients) (bupivacaine and sufentanil)</P>
<P>correct position of the epidural was tested by 2 ml of bupivacaine 0.5% with epinephrine. Before induction high TEA was initiated by 6-12 mL of bupivacaine 0.5% and 15-25 ug sufentanil. General anaesthesia was induced in all patients with midazolam 0.1 mg/kg IV and pancuronium 0.1 mg/kg. The GA group received propofol 1.5-3 mg/kg/hr and sufentanil 1-2 ug/kg/hr. In the TEA group they received propofol 1.5-3 mg/kg/hr supported by repetitive injections of sufentanil 0.2-1 ug/kg.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-05-07 04:06:15 +0100" MODIFIED_BY="[Empty name]">
<P>Mortality<BR/>Respiratory complications</P>
<P>Left ventricular function</P>
<P>Postoperative complications</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-07 04:07:39 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Brix_x002d_Christensen-1998">
<CHAR_METHODS>
<P>Randomized controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-05-07 04:06:54 +0100" MODIFIED_BY="[Empty name]">
<P>16 patients scheduled for elective coronary artery bypass grafting surgery</P>
<P>Patients with diabetes mellitus or cancer were excluded</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-05-07 04:07:39 +0100" MODIFIED_BY="[Empty name]">
<P>Low dose opioid anaesthesia (epidural: bupivacaine 2 mg/mL and fentanyl 5 ug/mL at 5 ml/hr)) and general inhalational anaesthesia with fentanyl (8 patients in each group)</P>
<P>In the TEA group 8 mL of bupivacaine 0.5 % was injected 30 mins before surgery. Peroperative a continuous epidural infusion was given with bupivacaine 2 mg/ ml and fentanyl 5ug/mL at 5 mL/hr. General anaesthesia was induced with midazolam 0.15 mg/kg and fentanyl 5ug/kg. Muscle relaxation was achieved with pancuronium 0.1mg/kg. Anaesthesia was maintained with enflurane 0.4-0.8%. In the high dose fentanyl group anaesthesia was induced with midazolam 0.15 mg/kg and fentanyl 50 ug/kg. Anaesthesia was maintained with enflurane, midazolam and sufentanil.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-01-27 16:01:51 +0000" MODIFIED_BY="[Empty name]">
<P>Mortality</P>
<P>Cytokine response</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-07 04:09:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Caputo-2009">
<CHAR_METHODS MODIFIED="2009-12-18 12:38:36 +0000" MODIFIED_BY="[Empty name]">
<P>Randomized controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-12-18 12:39:25 +0000" MODIFIED_BY="[Empty name]">
<P>74 patients undergoing off-pump coronary artery bypass surgery</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-05-07 04:09:04 +0100" MODIFIED_BY="[Empty name]">
<P>The anaesthetic technique consisted of premedication with benzodiazepines, and induction with intravenous infusion of propofol at 3 mg/kg/hr combined with fentanyl (10 to 20 g/kg). Neuromuscular blockade was achieved with 0.1 to 0.15 mg/kg pancuronium bromide or vecuronium.</P>
<P>Intervention (36 patients): bilateral neuraxial block was established from T1 to T10 with an initial bolus of 5 mL bupivacaine 0.5% followed by another 5-mL bolus after 10 minutes. After induction of GA and when central haemodynamic status was stable, a continuous infusion of 0.125% bupivacaine and 0.0003% clonidine (150 g in 500 mL) was commenced at an initial rate of 10 mL/h</P>
<P>Control (38 patients): In the GA group, a patient-controlled analgesia intravenous morphine pump was started in the intensive care unit for 48 hours by using a 1 mg bolus dosing with a 5-minute lockout period</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-05-07 04:09:17 +0100" MODIFIED_BY="[Empty name]">
<P>Mortality</P>
<P>Stroke</P>
<P>Myocardial infarction</P>
<P>Supraventricular arrhythmias</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-07 04:11:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Caputo-2011">
<CHAR_METHODS MODIFIED="2013-05-07 04:09:57 +0100" MODIFIED_BY="[Empty name]">
<P>Two-centre, open, parallel-group, randomized controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-02-08 10:59:25 +0000" MODIFIED_BY="[Empty name]">
<P>226 adults undergoing primary OPCAB surgery without the use of CPB and cardioplegic arrest</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-05-07 04:11:14 +0100" MODIFIED_BY="[Empty name]">
<P>In both groups the induction with propofol at 0.5&#8211;1 mg/kg combined with fentanyl (10 &#8211;20g/kg). Neuromuscular blockade was achieved with 0.1&#8211;0.15 mg/kg pancuronium bromide or vecuronium. Anesthesia was maintained with either isoflurane at 0.8 &#8211;1.0 minimal anaesthetic concentration or intravenous propofol 3&#8211; 4 mg/kg/hr, at the discretion of the consultant anaesthetist. Patients in the GAE group had a thoracic epidural catheter sited in the operating theatre immediately before surgery at the T2&#8211;3 or T3&#8211;4 intervertebral space. Bilateral neuraxial block was established from T1 to T10 with an initial bolus of 5 mL bupivacaine, 0.5%, followed by another 5 mL bolus after 10 min. Determination of the spread of block was performed with ethyl chloride spray. After induction of GA and when central hemodynamic status was stable, a continuous infusion of 0.125% bupivacaine and 0.0003% clonidine (150 g in 500 mL) was commenced at an initial rate of 10 ml/hr.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-02-08 11:00:34 +0000" MODIFIED_BY="[Empty name]">
<P>Mortality<BR/>Myocardial infarction</P>
<P>Chest infections</P>
<P>Pain scores</P>
<P>Length of hospital stay</P>
<P>Arrhythmias</P>
<P>Stroke</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-02-08 10:45:52 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-07 04:14:20 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-de-Vries-2002">
<CHAR_METHODS>
<P>Randomized controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-22 11:23:19 +0100" MODIFIED_BY="[Empty name]">
<P>90 patients scheduled for elective minimally invasive direct coronary artery bypass surgery</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-05-07 04:14:10 +0100" MODIFIED_BY="[Empty name]">
<P>30 patients had general anaesthesia and were extubated immediately after surgery (extubated group), 30 patients had a thoracic epidural (bupivacaine and sufentanil) and general anaesthesia and were extubated immediately after surgery (epidural group), and 30 patients had general anaesthesia and were ventilated after surgery (intubated group)</P>
<P>In the extubated group, at induction the patients received midazolam, 0.1 mg/kg, and sufentanil, 0.5 to 1 ug/kg. Anaesthesia was maintained with either isoflurane (0.5% to 0.8%) or propofol (3 to 5 mg/kg/hr) with incremental supplements of sufentanil (25 to 50 g) when the mean arterial pressure (MAP) exceeded baseline values by 20%.</P>
<P>In the epidural group, a thoracic epidural catheter was inserted at the T3-4 level before induction of anaesthesia. Anaesthesia was induced with midazolam, 0.1 mg/kg, and sufentanil, 0.5 to 1 g/kg. Through the epidural catheter, 8 to 10 mL of bupivacaine 0.25% with sufentanil, 25 ug/10 mL, were given 10 minutes before the start of surgery. Anaesthesia was maintained as in the extubated group. In the intubated group, induction of anaesthesia was performed with midazolam and sufentanil as previously reported.15 Briefly, midazolam, 0.1 mg/kg, and sufentanil, 1.5 ug/kg, were slowly infused over 5 minutes. Anaesthesia was maintained with continuous infusions of midazolam and sufentanil at a rate of 2 ug/kg/min for midazolam and 1 ug/kg/hr for sufentanil. In all groups, pancuronium, 0.1 mg/kg, was administered to facilitate endotracheal intubation.</P>
<P>In the extubated group and in the intubated group, postoperative analgesia was given on patient request with piritramide, 0.2 mg/kg intramuscularly. In the epidural group, a continuous infusion of bupivacaine 0.125% and sufentanil, 25 ug/50 mL, was given at 8 to 10 mL/hr. All groups received additional paracetamol suppositories, 1g 4 times daily.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-05-07 04:14:20 +0100" MODIFIED_BY="[Empty name]">
<P>Mortality<BR/>Myocardial infarction or ischaemia (ST segment analysis)<BR/>Haemodynamics: MAP and heart rate</P>
<P>Pain scores</P>
<P>Length of hospital stay</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-02-18 19:29:00 +0000" MODIFIED_BY="[Empty name]">
<P>MIDCAB surgery</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-07 04:15:39 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-El_x002d_Baz-1987">
<CHAR_METHODS>
<P>Randomized controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-03-16 11:11:24 +0000" MODIFIED_BY="[Empty name]">
<P>60 patients, aged 34 to 76 years, after coronary artery bypass surgery (one to four grafts)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-05-07 04:15:31 +0100" MODIFIED_BY="[Empty name]">
<P>IV opioids or low dose continuous opioid epidural analgesia (morphine 0.1 mg/mL at 1 mL/hr) with 30 patients in each group.</P>
<P>General anaesthesia was induced with pentothal 3-4 mg/kg followed by succinylcholine 1-2 mg/kg. Anaesthesia was maintained with a nitrous-oxide-oxygen-halothane gas mixture. Pancuronium 0.1-0.2 mg/kg was used for muscle relaxation to facilitate control of ventilation.</P>
<P>The control group received morphine 2 mg/2 hr and as needed. The epidural group received a continuous epidural infusion of 0.1 mg morphine/hr, this was supplemented by 2 mg IV as needed.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-05-07 04:15:39 +0100" MODIFIED_BY="[Empty name]">
<P>Mortality<BR/>Respiratory function</P>
<P>Cardiovascular parameters</P>
<P>Pain relief</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-07 04:18:00 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fillinger-2002">
<CHAR_METHODS>
<P>Randomized controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-05-07 04:16:32 +0100" MODIFIED_BY="[Empty name]">
<P>60 patients scheduled for elective coronary artery bypass</P>
<P>Patients scheduled for elective CABG surgery were considered eligible for inclusion in the study in the absence of any specific contraindication to the use of EAA (heparin or warfarin (Coumadin (Endo Laboratories Inc, Wilmington, DE)) anticoagulation, pre-existing coagulopathy, infection at insertion site, or septicaemia).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-05-07 04:18:00 +0100" MODIFIED_BY="[Empty name]">
<P>General anaesthesia with IV morphine or combined general anaesthesia with high thoracic epidural analgesia (bupivacaine 0.5% at 4-10 mL/hr) with 30 patients in each group.</P>
<P>On arrival in the operating room, intravenous sedation was initiated with incremental doses of fentanyl &#8804;2 ug/kg, and midazolam, 0&#8804;.05 mg/kg. GA was induced in all patients with intravenous fentanyl (5 to 20 g/kg total), midazolam (0.1 mg/kg), thiopental (1 to 2 mg/kg), and pancuronium or vecuronium for muscle relaxation and tracheal intubation. Inhaled isoflurane was used for anaesthesia maintenance. Muscle relaxation was reversed at the end of the operation with neostigmine and glycopyrrolate.</P>
<P>For participants randomized to receive TEAA, a thoracic epidural catheter was inserted after vascular catheter placements and before induction of GA. After a negative epidural test dose of 3 mL of 1.5% lidocaine with 1:200,000 epinephrine, the epidural catheter was injected with preservative-free morphine, 20 ug/kg, and 0.5% bupivacaine, in 5 mg increments, to a total loading dose of 25 to 35 mg of bupivacaine. Then the epidural catheters were continuously infused with 0.5% bupivacaine with morphine, 25 ug/mL, at 4 to 10 mL/hr beginning after the induction of GA. Clinical signs of inadequate epidural analgesia (haemodynamic response to surgical stimulation) during surgery were managed with a 3 mL bolus of the infusion solution followed by an increase in the infusion rate of 1 mL/hr (to a maximum of 10 mL/hr).</P>
<P>After surgery: patients in the GA group received intravenous morphine for postoperative analgesia according to a standard CTICU protocol, whereas patients in the TEAA group received an epidural infusion of 0.125% bupivacaine with morphine, 25 ug/mL, at 4 to 10 mL/h.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-09-26 14:38:44 +0100" MODIFIED_BY="[Empty name]">
<P>Mortality<BR/>Myocardial infarction<BR/>Supraventricular tachyarrhythmias<BR/>Stroke<BR/>Respiratory (time to tracheal extubation)</P>
<P>Pain control</P>
<P>Duration of hospital stay</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-07 04:21:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hansdottir-2006">
<CHAR_METHODS>
<P>Randomized controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-05-07 04:19:15 +0100" MODIFIED_BY="[Empty name]">
<P>113 patients undergoing elective cardiac surgery (CABG, cardiac valve procedures, combined CABG and valve procedures or the Maze procedure, with or without CABG), absence of contraindications to epidural anaesthesia, abnormal coagulation tests (i.e., partial thromboplastin time 45 sec or prothrombin time (international normalized ratio) 1.5 or a platelet count 80,000), or recent (1 week) treatment with thrombolytic or potent antiplatelet drugs (streptokinase, alteplase, clopidogrel, abciximab, tirofiban, integrelin). Aspirin treatment was not considered a contraindication to the placement of a thoracic epidural catheter.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-05-07 04:21:23 +0100" MODIFIED_BY="[Empty name]">
<P>General anaesthesia with postsurgical PCA with morphine or combined general anaesthesia with high thoracic epidural analgesia (bupivacaine 5 mg/mL at 0.05 mL/kg/hr)</P>
<P>All patients (58 patients in epidural group and 55 in the control group) received infusions of propofol and remifentanil to a target anaesthetic depth of 15-25 AAI using an auditory evoked response monitor. Tracheal intubation was facilitated with 0.5 mg/kg atracurium. After induction of anaesthesia and insertion of monitoring devices, patients in the PCTEA group received an epidural 0.1 mL/kg bolus dose followed by a continuous 0.05 mL/kg/hr infusion with bupivacaine (5 mg/mL). In the PCTEA group, postoperative pain treatment was achieved by epidural bolus doses of 2 mL of the mixture 1 mg/mL bupivacaine plus 2 g/mL fentanyl plus 2 g/mL adrenaline, a lockout interval of 20 min, and a background epidural infusion of 0.1 mL/kg/hr. An epidural 0.1 ml/kg loading dose of this mixture was given at the end of surgery. In the PCA group, postoperative pain treatment was achieved by intravenous PCA morphine with bolus doses of 0.01 mg/kg and a lockout interval of 6 min with no background infusion. A loading dose of 0.1 mg/kg morphine was given in the operating room when remifentanil infusion was stopped.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-09-26 14:38:44 +0100" MODIFIED_BY="[Empty name]">
<P>Myocardial infarction<BR/>Supraventricular tachyarrhythmias<BR/>Stroke<BR/>Respiratory (lung volumes)</P>
<P>Pain and sedation scores</P>
<P>Length of hospital stay</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-15 20:21:06 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Heijmans-2007">
<CHAR_METHODS>
<P>Randomized controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-05-15 20:21:02 +0100" MODIFIED_BY="[Empty name]">
<P>60 patients undergoing elective cardiac surgery</P>
<P>Exclusion criteria included left ventricular ejection fraction of less than 25%, hypothermic circulatory arrest, recent myocardial infarction, preoperative inotropic or intra-aortic balloon pump metabolic, or neurologic diseases. All patients were receiving chronic B-adrenoceptor blocking drugs</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-05-15 20:21:06 +0100" MODIFIED_BY="[Empty name]">
<P>Alfentanil or low dose remifentanil or high dose remifentanil or epidural (15 patients in the epidural and 45 patients in the control group)</P>
<P>A test dose of 2 mL of lidocaine 2% was given to test for the correct position of the catheter. A loading dose of 10 mL of bupivacaine 0.25% with 2.5 mg of morphine was infused over 1 hour.</P>
<P>In the present study, 4 groups of patients were compared as follows: group 1 (AG): a loading dose of alfentanil, 50 ug/kg, was infused over 4 minutes, and, thereafter, alfentanil was infused at a maintenance rate of 1 ug/kg/min throughout surgery; group 2 (HDRG): a loading dose of remifentanil, 2.5 ug/kg, was infused over 4 minutes, and, thereafter, remifentanil was infused at a maintenance rate of 0.5 ug/kg/min throughout surgery; group 3 (LDRG): a loading dose of remifentanil, 2.5 ug/kg, was infused over 4 minutes, and, thereafter, remifentanil was infused at a maintenance rate of 0.25 ug/kg/min; and group 4 (TEG): a loading dose of remifentanil, 2.5 ug/kg, was infused over 4 minutes, and, thereafter, remifentanil was infused at a maintenance rate of 0.125 ug/kg/min and via thoracic epidural infusion bupivacaine 0.375% plus morphine 0.2 mg/mL were administered at a rate of 1.5 mL/hr throughout surgery. The initial infusion setting for propofol on the Diprifusor was a plasma concentration of 2 ug/mL to be reached in 4 minutes.</P>
<P>At arrival in the ICU, a sedative-analgesic infusion of propofol, 0.5 mg/kg/hr, together with alfentanil, 0.1 ug/kg/min, in group 1 and remifentanil, 0.025 g/kg/ min, in groups 2, 3, and 4, were started for 4 hours. If necessary, propofol was increased to achieve the desired level of sedation (Ramsay sedation score 3, 4, or 5). Additionally, acetaminophen, 1 g, 4 times daily, was started as a basic analgesic. In the TEG group, the catheter was left in position 48 hours postoperatively and bupivacaine 0.125% and morphine, 0.2 mg/mL, were infused at a rate of 1.5 mL/hr. Fifteen minutes before cessation of the sedative analgesic infusion, pirinitramide, a synthetic morphine derivative (analgesic potency in comparison with morphine [1] is 0.7) 0.15 mg/kg, intravenously, was administered in the remifentanil groups 2 and 3, and placebo was administered to the AG in a blinded fashion.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-05-07 04:25:59 +0100" MODIFIED_BY="[Empty name]">
<P>Infectious parameters (CRP, IL-6)</P>
<P>Mortality<BR/>Supraventricular tachyarrhythmias<BR/>Stroke</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-15 20:21:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kendall-2004">
<CHAR_METHODS>
<P>Randomized controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-05-15 20:21:15 +0100" MODIFIED_BY="[Empty name]">
<P>26 patients undergoing off pump coronary artery bypass grafting</P>
<P>Patients undergoing emergency surgery and those with unstable angina were excluded from the study. Patients with plasma creatinine values greater than 160 mmol/L were also excluded from the study. Patients taking anticoagulant therapy and those with any other contraindication to the insertion of a thoracic epidural were also excluded.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-05-07 04:29:33 +0100" MODIFIED_BY="[Empty name]">
<P>General anaesthesia: propofol or isoflurane or epidural: isoflurane with bupivacaine</P>
<P>In the propofol group (9 patients), anaesthesia was induced with fentanyl 10-15 ug/kg and propofol delivered by a DiprifusorTM pump (AstraZeneca, London, England), aiming for a target blood concentration in the range 4-8 ug/mL</P>
<P>In the isoflurane group (9 patients), anaesthesia was induced with etomidate 0.2 mg/kg and fentanyl 10-15 ug/kg. Anaesthesia was maintained with isoflurane in oxygen and air at an end-tidal concentration of 1%. This was discontinued at the end of the procedure, and a propofol infusion was started to provide sedation if required until the criteria for tracheal extubation were met</P>
<P>In the epidural group (8 patients), anaesthesia was as for the isoflurane group, with the exception that fentanyl was given in a dose of 1.5 ug/kg epidural: bupivacaine 0.1% with fentanyl<BR/>5 ug/ml was given, followed by an infusion of 0.1 ml/kg/hr, adjusted according to haemodynamic values</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-05-07 04:30:56 +0100" MODIFIED_BY="[Empty name]">
<P>Mortality<BR/>Myocardial infarction (troponin levels, new Q waves, loss of R progression) </P>
<P>Prolonged intensive care stay (GT; 24 hr)</P>
<P>Duration of tracheal intubation</P>
<P>Return to operating room</P>
<P>Intraoperative haemodynamic parameters</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-02-18 16:05:38 +0000" MODIFIED_BY="[Empty name]">
<P>Surgery with the octopus</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-07 04:32:29 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kilickan-2006">
<CHAR_METHODS>
<P>Randomized controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-05-07 04:31:34 +0100" MODIFIED_BY="[Empty name]">
<P>80 patients scheduled for elective coronary artery bypass grafting</P>
<P>Exclusion criteria: contraindications for the epidural technique, contraindications to any of the intended drugs in the treatment protocol, alcohol abuse, cognitive impairment</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-05-07 04:31:51 +0100" MODIFIED_BY="[Empty name]">
<P>General anaesthesia alone or general anaesthesia in combination with high thoracic epidural analgesia (40 patients in each group).</P>
<P>Anaesthesia was induced in all groups by 0.2 mg/kg midazolam, 10-15 ug/kg fentanyl and 0.1 mg/kg vecuronium. Anaesthesia was maintained with propofol 2-6 mg/kg/hr and 2 ug/kg fentanyl intermittently. In the TEA group, 1 hr before surgery a bolus of 20 mg of bupivacaine was administered and a continuous infusion was started (bupivacaine 0.25 % at 8 ml/hr).</P>
<P>Postoperatively, in the TEA group received an epidural infusion of bupivacaine 0.125%, 4-10 ml/hr. The control group received a standard analgesia protocol (morphine PCA)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-05-07 04:32:29 +0100" MODIFIED_BY="[Empty name]">
<P>Mortality<BR/>Bcl-2 immunoreactivity (rate of apoptosis)</P>
<P>Haemodynamic parameters (CI)</P>
<P>Reperfusion ventricular fibrillation</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-07 04:33:33 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kirno-1994">
<CHAR_METHODS>
<P>Randomized controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-05-07 04:32:59 +0100" MODIFIED_BY="[Empty name]">
<P>20 patients undergoing coronary artery bypass grafting</P>
<P>All patients had a history of stable ischaemic heart disease with 2 or 3 vessel coronary artery disease and an ejection fraction of &gt; 50%. Patients with co-existing valvular anomaly, arrhythmias or diabetes mellitus were not included.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-05-07 04:33:22 +0100" MODIFIED_BY="[Empty name]">
<P>General anaesthesia (fentanyl nitrous oxide) and general anaesthesia and epidural analgesia with 10 patients in each group.</P>
<P>Anaesthesia was induced with thiopental 3-5 mg/kg, followed by pancuronium 0.1 mg/kg IV. Fentanyl was given in incremental doses up to a total amount of 10-15 ug/kg before sternotomy. The patients were ventilated with 70% nitrous oxide in oxygen. In the TEA group 3-3.5 mL mepivacaine was given epidurally after induction.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-05-07 04:33:33 +0100" MODIFIED_BY="[Empty name]">
<P>Mortality</P>
<P>MAP</P>
<P>Regional myocardial oxygen consumption</P>
<P>Myocardial ischaemia</P>
<P>Haemodynamic parameters</P>
<P>Noradrenaline spillover (sympathetic nervous system activation)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-07 04:34:46 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lagunilla-2006">
<CHAR_METHODS>
<P>Randomized controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-05-07 04:34:02 +0100" MODIFIED_BY="[Empty name]">
<P>50 patients submitted for scheduled coronary revascularization of, at least, the left anterior descending (LAD) coronary artery were enrolled in the study.</P>
<P>The exclusion criteria were as follows: patient refusal, urgent or emergency procedure, unstable haemodynamic status (myocardial infarction less than 2 weeks prior to surgery, requirement for inotropic drugs or for intra-aortic balloon contrapulsation), absence of normal sinus rhythm, neurologic or neuromuscular disorders, previous thoracic or cervical spine surgery or trauma, significant left main coronary artery stenosis, anticoagulation, haematologic disorders and infection at the puncture site.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-05-07 04:34:36 +0100" MODIFIED_BY="[Empty name]">
<P>General anaesthesia with a thoracic epidural with either ropivacaine or a saline solution with 25 patients in each group.</P>
<P>Thereafter, general anaesthesia was induced with midazolam 1 mg, remifentanil at 0.7 mg/kg/min, cisatracurium in a single bolus of 0.2 mg/kg and 2-3% inhaled sevoflurane in oxygen. All patients received the corresponding volume of plain saline or 0.3% ropivacaine, in a blind manner, accordingly to the group to which they had been randomized. Then, an epidural infusion of 0.3% ropivacaine at 5-7 ml/hr (reduced to 2-3 mL/h during grafting) was started in all patients. In the postoperative period, 0.2% ropivacaine with 5 mg/mL fentanyl was used for analgesia in all patients, employing a patient controlled system.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-05-07 04:34:46 +0100" MODIFIED_BY="[Empty name]">
<P>Mortality</P>
<P>Haemodynamic parameters</P>
<P>Intramyocardial oxygen partial pressure</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-15 20:30:16 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liem-1992">
<CHAR_METHODS>
<P>Randomized controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-05-15 20:30:16 +0100" MODIFIED_BY="[Empty name]">
<P>54 patients scheduled for elective coronary artery bypass surgery</P>
<P>To be admitted to the study they were required to have normal or only moderately impaired left ventricular (LV) function (ejection fraction greater than 40%) as assessed by preoperative LV cineangiography and a LV end-diastolic pressure of less than 18 mmHg. Patients who had a myocardial infarction in the 7 days preceding surgery. Pre-existing haemorrhagic diathesis, or valvular heart disease were excluded from the study.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-05-07 04:37:08 +0100" MODIFIED_BY="[Empty name]">
<P>High thoracic epidural with bupivacaine 0.375% plus sufentanil 5 ug/mL in combination with general anaesthesia midazolam/N<SUB>2</SUB>O and general anaesthesia with midazolam/fentanyl (27 patients in each group).</P>
<P>IV anaesthesia in the GA group was induced over a period of 10 minutes with midazolam, 0.1 mg/kg, sufentanil, 5 ug/kg, and pancuronium, 0.1 mg/kg. Anaesthesia was maintained with an infusion of midazolam, 0.1 mg/kg/hr, and sufentanil, 2.5 ug/kg/hr. Pancuronium, 0.025 mg/kg, was administered every hour.</P>
<P>Epidural analgesia in the TEA group was induced, over a period of 10 minutes, with a mixture of 0.375% bupivacaine plus sufentanil, 1:200,000 (i.e., 5 ug/mL) in a dose of 0.05 mL/cm body length. Continuous epidural analgesia was then started with 0.125% bupivacaine plus sufentanil, 1:1,000,000 (i.e., 1 ug/mL) at an infusion rate of 0.05 mL/cm body length/hour. Just before induction of GA, measurements were taken (point 2). IV anaesthesia was induced with etomidate, 0.2 mg/kg, midazolam, 0.1 mg/kg, and pancuronium, 0.1 mg/kg. IV anaesthesia was maintained with an infusion of midazolam, 0.1 mg/kg/hr, and after the establishment of cardiopulmonary bypass (CPB), a bolus of midazolam, 0.05 mg/kg, was administered IV; pancuronium, 0.025 mg/kg, was administered every hour.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-05-07 04:37:43 +0100" MODIFIED_BY="[Empty name]">
<P>Mortality<BR/>Myocardial infarction<BR/>Haemodynamic parameters<BR/>Respiratory complications</P>
<P>VAS scores</P>
<P>Time to awakening</P>
<P>Arrythmias (tachycardia)</P>
<P>Adrenergic responses</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-05-07 04:37:49 +0100" MODIFIED_BY="[Empty name]">
<P>All three articles</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-15 20:21:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Loick-1999">
<CHAR_METHODS>
<P>Randomized controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-22 11:24:27 +0100" MODIFIED_BY="[Empty name]">
<P>70 patients scheduled for elective coronary artery bypass grafting</P>
<P>Seventy-two patients scheduled for elective CABG fulfilled the study criteria and were selected for the investigation. Disorders of the intestine and liver, gastritis, ulcera ventriculi and duodeni, autonomic neuropathy, and diabetes mellitus (patients receiving insulin or oral hypoglycaemic drugs) were exclusion criteria</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-05-15 20:21:19 +0100" MODIFIED_BY="[Empty name]">
<P>General anaesthesia with clonidine IV or general anaesthesia with thoracic epidural analgesia with 25 patients in epidural group and 45 in the control group (with and without clonidine).</P>
<P>Anaesthesia was induced with sufentanil (1-2 mg/kg) and propofol (1-2 mg/kg). Pancuronium (0.1 mg/kg) was used to facilitate tracheal intubation. Anaesthesia was maintained by a continuous infusion of sufentanil (1-2 ug/kg/hr) and propofol (1-3 mg/kg/hr) throughout the surgical procedure. On the day of surgery, after insertion of the invasive catheters, the patients received 8-12 mL of bupivacaine 0.375% and 16-24 ug of sufentanil into the epidural space. In the clonidine group, patients received a standardized opioid-based general anaesthesia supplemented with IV clonidine. In the control group, patients received a standardized opioid-based general anaesthesia without any supplement. Postoperative pain management consisted of an IV application of 1 g of paracetamol four times daily. Additionally, patients in the clonidine and control groups were allowed to administer a bolus of 2 mg of piritramide IV on demand by a patient-controlled analgesia device with a lockout time of 20 min. Patients in the TEA group received a continuous infusion of 2-3 mL of bupivacaine 0.75% via the epidural catheter. If the patient was &lt; 65 yr of age, the bupivacaine solution contained 1 ug/mL sufentanil, but this drug was not given to older patients. If pain relief was not sufficient, patients administered an additional 2 mL of bupivacaine with a lockout interval of 20 min. IV piritramide was supplemented for additional pain relief.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-05-07 04:39:34 +0100" MODIFIED_BY="[Empty name]">
<P>Mortality<BR/>Myocardial infarction and ischaemia</P>
<P>Haemodynamics, lactate, cortisol plasma levels, and cardiac enzymes<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-15 20:21:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lundstrom-2005">
<CHAR_METHODS>
<P>Randomized controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-05-15 20:21:23 +0100" MODIFIED_BY="[Empty name]">
<P>A total of 50 patients undergoing elective coronary artery bypass grafting</P>
<P>The criteria for inclusion in the study were age greater than 18 years, sinus rhythm on the ECG preoperatively, and written and oral informed consent. The criteria for exclusion from the study were oral anticoagulation and coagulopathy</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-22 11:24:37 +0100" MODIFIED_BY="[Empty name]">
<P>Conventional IV anaesthesia (24 patients) or general anaesthesia combined with thoracic epidural anaesthesia followed by postoperative epidural analgesia (26 patients) with bupivacaine</P>
<P>Epidural analgesia was induced with 8 to 10 mL of bupivacaine, 5 mg/mL. Anaesthesia was induced with IV midazolam, 3 to 5 mg, fentanyl, 0.3 mg, and a dose of pancuronium, 0.1 mg/kg. Anaesthesia was maintained with isoflurane and a continuous epidural infusion of bupivacaine, 1.25 mg/mL, with morphine, 25 ug/mL and 5 mL/h. Top-up bolus doses of 4 mL of bupivacaine, 5 mg/mL, were administered hourly during the operation. The administration of fentanyl was restricted to the dose given at the induction of general anaesthesia. Postoperatively, the epidural infusion continued, and bolus doses of 4 mL of 0.25% bupivacaine were administered as needed Anaesthesia was induced with midazolam, 3 to 5 mg, fentanyl, 15 to 30 ug/kg, and pancuronium, 0.1 mg/kg, which were administered at induction only and not repeated. Anaesthesia was maintained with isoflurane. Analgesia in the CON group was provided with intermittent IV morphine boluses (2.5 to 5 mg) until the morning of the first postoperative day when morphine, 5 to 10 mg, orally were given as needed. Postoperatively, all patients received oral paracetamol, 1 g every 6 h.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-09-26 14:38:47 +0100" MODIFIED_BY="[Empty name]">
<P>Mortality<BR/>Respiratory complications: episodic hypoxaemia</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-07 04:45:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Moore-1995">
<CHAR_METHODS>
<P>Randomized controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-05-07 04:44:39 +0100" MODIFIED_BY="Jane Cracknell">
<P>18 patients undergoing elective coronary artery bypass grafting</P>
<P>They had no history of metabolic or endocrine disease and had a normal bleeding time</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-05-07 04:45:14 +0100" MODIFIED_BY="[Empty name]">
<P>General anaesthesia alone or combined with thoracic epidural analgesia with 9 patients in each group</P>
<P>Bupivacaine 0.5% was given in 2 mL increments to achieve a adequate block, followed by an infusion of 0.375% bupivacaine at 5-8 mL/hr. General anaesthesia was induced by all patients with sufentanil 10 ug/kg, followed by a sleep-dose of thiopentone. Pancuronium 0.1 mg/kg was given and ventilation was with nitrous oxide in 50% oxygen. Post-OK analgesia was with 0.25 % bupivacaine at 5-8 mL/hr, increments of 2.5 mg papaveretum IV was given in the control group.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-09-29 12:57:08 +0100" MODIFIED_BY="Jane Cracknell">
<P>Mortality</P>
<P>Plasma catacholamines</P>
<P>Plasma cortisol</P>
<P>Serum insulin and growth hormone</P>
<P>Haemodynamic parameters</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-07 04:46:27 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Nygard-2004">
<CHAR_METHODS>
<P>Randomized controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-05-07 04:45:44 +0100" MODIFIED_BY="[Empty name]">
<P>163 patients scheduled for elective coronary artery bypass grafting</P>
<P>Patients scheduled for elective CABG were screened for participation in the study. Inclusion criterion was sinus rhythm. Exclusion criteria were off-pump surgery; implanted pacemaker; use of amiodarone within 4 months of enrolment; a history of amiodarone toxicity; known thyroid disease, liver disease, or uncontrolled heart failure; a resting heart rate of less than 50 beats/min in the absence of medical therapy known to slow the heart rate; anticoagulant medication with warfarin; coagulopathy; pregnancy; and use of antiarrhythmic drugs other than alfa1-receptor antagonists, calcium channel antagonists, and digoxin.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-05-07 04:46:27 +0100" MODIFIED_BY="[Empty name]">
<P>Group E (44 patients) had perioperative TEA, group E and A had TEA and amiodarone (35 patients), group A had amiodarone (36 patients), and group C served as control (48 patients).</P>
<P>On arrival in the operating room, epidural analgesia was induced with 8 to 10 mL of bupivacaine, 5 mg/mL. Anaesthesia was induced with intravenous (IV) midazolam, 3 to 5 mg, fentanyl, 0.3 mg, and pancuronium, 0.1 mg/kg. Anaesthesia was maintained with isoflurane in oxygen and a continuous epidural infusion of bupivacaine, 1.25 mg/mL, with morphine, 25 ug/mL, 5 mL/h. Additional bolus doses of 4 mL of bupivacaine, 5 mg/mL, were given hourly during the operation. Fentanyl was restricted to the dose given at induction of anaesthesia. Postoperatively, the epidural infusion was continued for 4 days. In groups A and C, anaesthesia was induced with midazolam, 3 to 5 mg, fentanyl, 15 to 30 ug/kg, and pancuronium, 0.1 mg/kg. Anaesthesia was maintained with isoflurane in oxygen. Postoperative analgesia in the non-TEA groups was provided with intermittent IV morphine boluses (2.5 to 5 mg) until the morning of the first postoperative day when 5 to 10 mg of oral morphine was given as needed.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-09-26 14:38:47 +0100" MODIFIED_BY="[Empty name]">
<P>Mortality</P>
<P>Supraventricular tachyarrhythmias</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-15 20:30:58 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Onan-2011">
<CHAR_METHODS MODIFIED="2013-02-08 18:42:10 +0000" MODIFIED_BY="[Empty name]">
<P>A prospective randomized study</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-02-08 18:38:17 +0000" MODIFIED_BY="[Empty name]">
<P>30 patients with documented 3-vessel coronary artery disease who were scheduled for elective coronary artery bypass graft surgery</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-05-15 20:30:58 +0100" MODIFIED_BY="[Empty name]">
<P>In both groups, anesthesia was induced with midazolam (0.1-0.2 mg/kg), fentanyl (7-10 g/kg), and rocuronium (0.6 mg/kg). The patients in the GA TEA group received a 20-mg bolus of 0.25% bupivacaine through the epidural catheters 1 hour before surgery. During the intraoperative period, 0.25% bupivacaine was infused at a rate of 20 mg/hr. The patients received a continuous epidural infusion of 0.125% bupivacaine, 4 to 10 mL/h, after surgery to attain sensory blockade.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-02-08 18:53:41 +0000" MODIFIED_BY="[Empty name]">
<P>Immunoreactivity</P>
<P>(Mortality)<BR/>(Myocardial infarction)</P>
<P>Graft blood flow</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-02-08 18:37:41 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-07 04:50:25 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Priestley-2002">
<CHAR_METHODS>
<P>Randomized controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-05-07 04:48:36 +0100" MODIFIED_BY="Jane Cracknell">
<P>100 patients scheduled for elective coronary artery bypass grafting</P>
<P>All patients presenting for elective CABG were eligible for inclusion unless they had one or more of the following exclusion criteria: contraindications to the epidural technique (e.g., pre-existing coagulopathy, anticoagulation (i.e., full therapeutic doses of standard or low-molecular-weight heparin, warfarin, thrombolytic drugs, or potent antiplatelet drugs), or systemic or local infection); arthritis of the thoracic or cervical spine with a history of associated neurologic deficit; coexisting surgery (e.g., valvular, carotid, or aortic surgery); contraindications to any of the intended drugs in the treatment protocol; significant alcohol or other substance abuse; cognitive impairment; or other reason for inability to comply with treatment as assessed by the investigators.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-05-07 04:50:18 +0100" MODIFIED_BY="[Empty name]">
<P>High (T1 to T4) thoracic epidural anaesthesia (TEA) with ropivacaine 1% (4 mL bolus, 3-5 mL/h infusion), with fentanyl (100 ug bolus, 15-25 ug/hr infusion) and a propofol infusion (6 mg/kg/hr) in 50 patients. Another 50 patients (the general anaesthesia group) received fentanyl 15 ug/kg and propofol (5 mg/kg/hr), followed by IV morphine patient-controlled analgesia.</P>
<P>On the day of surgery, after monitoring devices were inserted, an epidural bolus of 4 mL ropivacaine 1% and fentanyl 100 ug was administered, with supplemental ropivacaine 1% given as necessary to obtain blockade. After the bolus, an epidural infusion was commenced with ropivacaine 1% and fentanyl 5 ug/mL, and this continued for 48 h at 3-5 mL/hr. General anaesthesia (GA) in the TEA group consisted of IV fentanyl 2 ug/kg plus propofol 15 mg/kg/hr until consciousness was lost, followed by a propofol infusion at 6 mg/kg/hr, which continued until wiring of the sternum was completed. The GA group received fentanyl 15 ug/kg in divided doses from the induction of anaesthesia to sternotomy, in addition to propofol 15 mg/kg/hr until loss of consciousness, followed by a propofol infusion of 5 mg/kg/h (the larger fentanyl dose allowed a slightly smaller propofol dose than in the TEA group) until sternal closure. During cardiopulmonary bypass (CPB), a morphine infusion was commenced at 40 ug/kg/hr.</P>
<P>All patients received pancuronium 0.1 mg/kg for muscle relaxation</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-05-07 04:50:25 +0100" MODIFIED_BY="[Empty name]">
<P>Mortality<BR/>VAS pain score<BR/>Stroke<BR/>Respiratory parameters: spirometry results</P>
<P>Time to extubation</P>
<P>Length of hospital stay</P>
<P>Mobilization goals</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-07 04:51:28 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rein-1989">
<CHAR_METHODS>
<P>Randomized controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-22 11:25:02 +0100" MODIFIED_BY="[Empty name]">
<P>16 male patients requiring aorta-coronary bypass with extra-corporal circulation</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-05-07 04:51:28 +0100" MODIFIED_BY="[Empty name]">
<P>General anaesthesia alone or general anaesthesia combined with thoracic epidural analgesia (8 patients in each group)</P>
<P>All patients received morphine-scopolamine as premedication. General anaesthesia was obtained by the administration of thiopentone, pancuronium, nitrous oxide, diazepam and oxygen. The control group received fentanyl 54 ug/kg , the study group received fentanyl 14 ug/kg. TEA at T4-T5, initial dose of 50 mg bupivacaine, followed by 20 mg/hr during surgery. Postoperatively the control patients received morphine, the TEA patients were treated with epidural bupivacaine at 20 mg/hr.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-02-01 15:46:02 +0000" MODIFIED_BY="[Empty name]">
<P>Transcapillary fluid balance</P>
<P>Postoperative haemodynamics</P>
<P>(Mortality)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-07 04:52:30 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Royse-2003">
<CHAR_METHODS>
<P>Randomized controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-22 11:25:10 +0100" MODIFIED_BY="[Empty name]">
<P>76 patients receiving elective coronary artery bypass grafting with cardiopulmonary bypass</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-05-07 04:51:56 +0100" MODIFIED_BY="[Empty name]">
<P>High thoracic epidural analgesia with ropivacaine and fentanyl (37 patients) or IV morphine analgesia (39 patients)</P>
<P>Acetaminophen, indomethacin, and tramadol were allowed as supplemental analgesia in both groups</P>
<P>Epidural at T1-2 or T2-3. Eight mL of 0.5% ropivacaine with 20 ug of fentanyl was administered prior to induction of anaesthesia. Thereafter, ropivacaine 0.2% with fentanyl 2 ug/mL was infused at a rate of 5 to 14 mL per hour, adjusted to attain a sensory blockade of T1 to T10, and was ceased at 6:00 am on postoperative day 3. Anaesthesia consisted of midazolam (3 to 5 mg), fentanyl (200 ug), and a target-controlled infusion of propofol. For the control group anaesthesia consisted of midazolam (3 to 5 mg), propofol (2 to 4 g/mL), and a 2-stage target controlled alfentanil infusion (2 ug/mL, reduced to 0.05 ug/mL after cardiopulmonary bypass, and ceased after sternal wiring. Nurses were permitted to administer boluses of morphine in the intensive care unit until the patient was awake. This was followed by demand patient controlled intravenous morphine (1 mg bolus with 5 minute lockout period), which was continued until 6:00 am on postoperative day 3.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-05-07 04:52:30 +0100" MODIFIED_BY="[Empty name]">
<P>Pain</P>
<P>Physiotherapy cooperation</P>
<P>Depression and post-traumatic stress</P>
<P>Somatosensory sensitization</P>
<P>Lung function</P>
<P>Intraoperative haemodynamics</P>
<P>(Mortality)<BR/>(Myocardial infarction)<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-07 15:22:05 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Scott-2001">
<CHAR_METHODS>
<P>Randomized controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-22 11:25:33 +0100" MODIFIED_BY="[Empty name]">
<P>408 patients undergoing elective coronary artery bypass grafting with a normal coagulation screen and an ejection fraction of &gt; 35%</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-05-07 04:53:48 +0100" MODIFIED_BY="[Empty name]">
<P>General anaesthesia alone (202 patients) or general anaesthesia combined with thoracic epidural analgesia (bupivacaine and clonidine) in 206 patients</P>
<P>All patients received target-controlled infusions (TCIs) of propofol and alfentanil for anaesthesia and analgesia, respectively. In Group GA, TCI of alfentanil continued for 24 hr and was then converted to a patient-controlled analgesia (PCA) IV morphine pump for another 48 h by using 1 mg bolus dosing with a 3 min lockout period. Patients in Group TEA had a thoracic epidural catheter sited in the operating theatre immediately before surgery at the T2-3 or T3-4 interspace with an initial bolus of 5 mL bupivacaine 0.5% followed by another 5 mL bolus after 10 min. After induction of GA and when central haemodynamic status was stable, a continuous infusion of 0.125% bupivacaine and 0.0006% clonidine (300 ug in 500 mL) commenced at an initial rate of 10 mL/hr. In Group TEA, the epidural infusion continued for 96 hr. &#8220;Top-up&#8221; bolus doses up to a maximum of 4 mL of 0.25% bupivacaine were administered either when the patient complained of pain.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-05-07 15:22:05 +0100" MODIFIED_BY="[Empty name]">
<P>(Mortality)<BR/>Myocardial infarction<BR/>Supraventricular arrhythmias<BR/>Stroke or cerebrovascular accident<BR/>Pulmonary complications</P>
<P>Acute confusion</P>
<P>Significant bleeding</P>
<P>Renal failure</P>
<P>Incidence of major organ complications</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-08-25 14:44:59 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-15 20:21:31 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sharma-2010">
<CHAR_METHODS MODIFIED="2013-02-08 18:52:42 +0000" MODIFIED_BY="[Empty name]">
<P>Randomized controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-02-08 18:52:03 +0000" MODIFIED_BY="[Empty name]">
<P>Sixty patients scheduled for elective OPCAB</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-05-15 20:21:28 +0100" MODIFIED_BY="[Empty name]">
<P>Patients in both the groups received general anaesthesia as per hospital protocol. Intravenous propofol (1-1.5 mg/kg) for induction of anesthesia along with fentanyl citrate (2-3 µgm/kg), midazolam (0.04 mg/kg) and vecuronium bromide (0.1 mg/kg) while isoflurane (1- 2 MAC) in air and oxygen mixture was used for maintenance of anesthesia. An epidural catheter was placed at C7-T1 /T1 -T2<SUB> </SUB>level. Intrathecal placement was ruled out by using 3 mL of 2% lignocaine as a test dose. Once on the operation table, the patient was administered a bolus dose of 8-10 mL of bupivacaine (0.25%), inducing sensory block till at least T4. After confirming the block by loss of sensation to cold and pin prick, general anesthesia was administered. Bupivacaine infusion (0.125%) with 1µg/mL fentanyl citrate) at the rate of 5 mL/hr was commenced and continued till 3rd postoperative day for providing intra- and postoperative analgesia.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-05-15 20:21:31 +0100" MODIFIED_BY="[Empty name]">
<P>Postoperative spirometric values</P>
<P>Postoperative PaO<SUB>2</SUB>/FiO<SUB> 2 </SUB>ratio and PaCO<SUB>2</SUB> values</P>
<P>Painscores</P>
<P>(Mortality)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-05-07 04:57:43 +0100" MODIFIED_BY="[Empty name]">
<P>Only obese patients (BMI &gt; 30 kg/m<SUP>2</SUP>) were included</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-15 20:21:34 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Stenseth-1994">
<CHAR_METHODS>
<P>Randomized controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-05-07 05:01:36 +0100" MODIFIED_BY="[Empty name]">
<P>28 male patients &lt; 65 years and with an ejection fraction of &gt; 50% undergoing cardiac surgery. They were all ASA III with double or triple vessel disease</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-05-15 20:21:34 +0100" MODIFIED_BY="[Empty name]">
<P>General anaesthesia with high dose fentanyl (10 patients), general anaesthesia with low dose fentanyl and thoracic epidural analgesia (18 patients).</P>
<P>Epidural at T4-5 or T5-6. 10 mL 0.5% bupivacaine, top up doses of 4 mL 0.5% bupivacaine during surgery. GA with thiopentone, pancuronium. High dose fentanyl was 20-30 ug/kg, low dose fentanyl was 5 ug/kg. HF received morphine IV on demand, both epidural groups received a continuous epidural infusion of bupivacaine 0.5 % at 3 mL/hr with additional top ups of 4 mL every hour.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-02-01 15:46:03 +0000" MODIFIED_BY="[Empty name]">
<P>(Mortality)<BR/>(Myocardial infarction)</P>
<P>Hypertension</P>
<P>Tachycardia</P>
<P>Other haemodynamic parameters</P>
<P>Use of vasoactive drugs</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-15 20:31:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Stenseth-1996">
<CHAR_METHODS>
<P>Randomized controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-05-07 05:04:04 +0100" MODIFIED_BY="[Empty name]">
<P>52 male patients age &lt; 65 years and with an ejection fraction of &gt; 50%. They were all in NYHA class III and presented with double- or triple-vessel disease</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-05-15 20:31:19 +0100" MODIFIED_BY="[Empty name]">
<P>High dose fentanyl general anaesthesia and an epidural group receiving low dose fentanyl general anaesthesia + thoracic epidural analgesia with bupivacaine 0.5% (26 patients in each group)</P>
<P>Patients allocated to the epidural group had an epidural catheter inserted at level T4- T5 or T5-T6. Epidural group patients received an epidural injection of 10 mL of bupivacaine 5 mg/mL. Top up bolus doses of 4 mL bupivacaine 5 mg/mL were given hourly during the operation. General anaesthesia consisted of thiopentone, diazepam, nitrous oxide and pancuronium (with no difference between the groups) in addition to fentanyl. The control group patients received a total of 55 ug/kg of fentanyl, the epidural group a total of 15 ug/kg. Control group patients received morphine IV on demand for pain relief during the first 20 hr after surgery. During the next 2 days daily paracetamol 3.2 g and codeine 240 mg (Paralgin forte) were given rectally as basal analgesia, which was supplemented with morphine IV as needed. Epidural group patients received a continuous epiduraI infusion of bupivacaine 5 mg/ml, 3 ml/h with additional top up doses of 4 mL bupivacaine every 4 hr and supplementation with IV morphine when needed. They received morphine epidurally 4-6 mg 3-4 times a day for the next 2 days, supplemented with bupivacaine 5 mg/mL and morphine IV when needed. For both groups, supplementation was most often needed in association with physiotherapy and mobilization.<BR/>From the 3rd postoperative day all patients received only Paralgin forte on request</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-02-18 19:12:40 +0000" MODIFIED_BY="[Empty name]">
<P>(Mortality)<BR/>(Myocardial infarction)</P>
<P>Extubation time</P>
<P>Spirometry results after surgery</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-07 05:07:42 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Svircevic-2011">
<CHAR_METHODS MODIFIED="2013-05-07 05:07:37 +0100" MODIFIED_BY="[Empty name]">
<P>Two centre, randomized controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-05-07 05:07:42 +0100" MODIFIED_BY="[Empty name]">
<P>656 patients scheduled for elective cardiac surgery, including off-pump procedures</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-02-08 11:13:52 +0000" MODIFIED_BY="[Empty name]">
<P>Not known</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-02-08 11:41:38 +0000" MODIFIED_BY="[Empty name]">
<P>Mortality<BR/>Myocardial infarction</P>
<P>Pulmonary complications</P>
<P>Length of hospital stay</P>
<P>Arrhythmias</P>
<P>Stroke</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-02-08 11:13:52 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-07 05:09:11 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tenling-1999">
<CHAR_METHODS>
<P>Randomized controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-05-07 05:08:22 +0100" MODIFIED_BY="[Empty name]">
<P>28 patients scheduled for coronary artery bypass grafting. Inclusion criteria were stable angina pectoris with a left ventricular ejection fraction of more than 40%</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-05-07 05:08:39 +0100" MODIFIED_BY="[Empty name]">
<P>Perioperative and postoperative TEA ( bupivacaine) was added to general anaesthesia (GA) in 14 patients, and 14 patients receiving GA alone served as controls</P>
<P>Epidural at T3-4 or T4-5. Epidural analgesia was induced with 8 to 12 mL of bupivacaine, 5 mg/mL. The block was maintained with an infusion of bupivacaine, 5 mg/mL, 4 to 8 mL/hr, until the patient arrived at the intensive care unit. Anaesthesia was induced with fentanyl, 5 to 10 ug/kg; thiopental, 1.5 to 2.5 mg/kg; and pancuronium, 0.1 mg/kg. In the TEA group, fentanyl was restricted to the dose administered at induction. From then on, analgesia was achieved with TEA. The GA group was administered small doses of fentanyl as needed (1 to 2 mg total). In both groups, anaesthesia was maintained with inhaled isoflurane, 0.5 to 1.0 minimal alveolar concentration.<BR/>In the GA group, postoperative analgesia was achieved with titrated doses of ketobemidone, 1 to 3 mg<BR/>intravenously, according to standard procedures. The TEA group<BR/>received a continuous infusion of bupivacaine, 2 mg/mL, and sufentanil, 1 ug/mL epidurally (3 to 7 mL/hr), from arrival at the ICU until the end of the study on the day after surgery.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-05-07 05:09:11 +0100" MODIFIED_BY="[Empty name]">
<P>Mortality<BR/>Respiratory: ventilation/perfusion mismatch, atelectasis, time to extubation</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2013-05-07 05:09:34 +0100" MODIFIED_BY="Jane Cracknell" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2010-09-26 16:22:09 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chae-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-09-26 16:22:09 +0100" MODIFIED_BY="[Empty name]">
<P>No adequate sequence generation</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-09-26 16:22:59 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dohle-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-09-26 16:22:59 +0100" MODIFIED_BY="[Empty name]">
<P>No adequate sequence generation and no allocation concealment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-09-26 16:22:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fawcett-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-09-26 16:22:14 +0100" MODIFIED_BY="[Empty name]">
<P>No adequate sequence generation</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-02-08 13:42:29 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Greisen-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-02-08 13:42:29 +0000" MODIFIED_BY="[Empty name]">
<P>Not randomized</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-02-08 18:35:06 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jakobsen-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-02-08 18:35:06 +0000" MODIFIED_BY="[Empty name]">
<P>No relevant outcomes reported</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-06 13:37:54 +0000" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Jideus-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-06 13:37:54 +0000" MODIFIED_BY="Jane Cracknell">
<P>Not randomized</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-09-26 16:22:21 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kessler-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-09-26 16:22:21 +0100" MODIFIED_BY="[Empty name]">
<P>No adequate sequence generation</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-05-07 05:09:34 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liang-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-05-07 05:09:34 +0100" MODIFIED_BY="[Empty name]">
<P>Comparison between epidural anesthesia perioperatively and postoperatively</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-09-26 16:24:02 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liem-1992a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-09-26 16:24:02 +0100" MODIFIED_BY="[Empty name]">
<P>No relevant outcomes reported</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-09-26 16:24:08 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liem-1992b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-09-26 16:24:08 +0100" MODIFIED_BY="[Empty name]">
<P>No relevant outcomes reported</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-09-26 16:23:11 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mehta-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-09-26 16:23:11 +0100" MODIFIED_BY="[Empty name]">
<P>No adequate sequence generation and no allocation concealment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-09-26 14:38:47 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Olivier-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-09-26 14:38:47 +0100" MODIFIED_BY="[Empty name]">
<P>No comparison to general anaesthesia</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-09-26 16:24:11 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Stenseth-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-09-26 16:24:11 +0100" MODIFIED_BY="[Empty name]">
<P>No relevant outcomes reported</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-09-26 16:22:28 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Thorelius-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-09-26 16:22:28 +0100" MODIFIED_BY="[Empty name]">
<P>No adequate sequence generation</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2013-02-08 18:46:18 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2010-02-04 09:31:16 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2013-05-15 20:20:57 +0100" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2013-05-07 05:07:54 +0100" MODIFIED_BY="Jane Cracknell" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-02 10:48:58 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bach-2002">
<DESCRIPTION>
<P>One day before surgery and after written informed consent was obtained, patients were randomly assigned to the study groups by drawing lots</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-06 13:39:29 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Bakhtiary-2007">
<DESCRIPTION>
<P>Patients were randomized to receive either GA or combined GATEA</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-07 04:03:57 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Barrington-2005">
<DESCRIPTION>
<P>Patients were randomized the day before surgery to two groups. The random allocation sequence was computer-generated in permuted blocks of four and enclosed in sequentially numbered opaque sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-11-05 14:22:33 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Berendes-2003">
<DESCRIPTION>
<P>Computer-generated block randomization</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-02 16:59:36 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Brix_x002d_Christensen-1998">
<DESCRIPTION>
<P>Patients were randomly allocated into two groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-07 04:09:27 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Caputo-2009">
<DESCRIPTION>
<P>Patients were randomly assigned to receive either general anaesthesia only or general anaesthesia plus epidural. Random treatment allocations were generated by computer in advance of starting the study, using block randomization with varying block sizes. Allocation details were concealed in sequentially numbered opaque sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-08 11:52:52 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Caputo-2011">
<DESCRIPTION>
<P>Randomized treatment allocations were generated using Stata version 8. They were stratified by consultant team with a 1:1 allocation using blocks of varying sizes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-07 04:15:48 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-El_x002d_Baz-1987">
<DESCRIPTION>
<P>"Patients were randomly divided into two equal groups of 30 patients"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-11-05 14:27:46 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fillinger-2002">
<DESCRIPTION>
<P>Computerized randomization</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-02 13:09:56 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hansdottir-2006">
<DESCRIPTION>
<P>Patients were randomly assigned the day before surgery to one of two regimens</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-06 13:39:43 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Heijmans-2007">
<DESCRIPTION>
<P>"60 patients scheduled to undergo coronary artery bypass surgery were randomized"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-02 13:04:34 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kendall-2004">
<DESCRIPTION>
<P>Patients were randomly allocated to one of three groups using a shuffled, sealed envelope technique</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-06 13:39:50 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Kilickan-2006">
<DESCRIPTION>
<P>80 patients scheduled for elective CABG were randomized in two groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-06 13:39:55 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Kirno-1994">
<DESCRIPTION>
<P>The patients were randomized into two groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-02 10:45:05 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lagunilla-2006">
<DESCRIPTION>
<P>Patients enrolled in the study were randomly assigned, randomization was performed using a computer-generated random sequence</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-02 10:37:20 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liem-1992">
<DESCRIPTION>
<P>On the day before surgery, the patients were assigned randomly to either a TEA or a GA group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-11-05 14:34:06 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Loick-1999">
<DESCRIPTION>
<P>"The patients were randomly allocated to one of the following three study groups"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-02 17:01:48 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lundstrom-2005">
<DESCRIPTION>
<P>"Patients were randomly assigned to receive either conventional IV anaesthesia (CON) or general anaesthesia combined with TEA. The randomization list was generated from a table of random numbers."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-02 10:03:25 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Moore-1995">
<DESCRIPTION>
<P>Patients were allocated by selection of a sealed envelope</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-07 04:46:49 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nygard-2004">
<DESCRIPTION>
<P>Patients were randomly assigned to four groups; randomization was 1:1:1:1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-09 18:47:24 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Onan-2011">
<DESCRIPTION>
<P>"The patients were assigned randomly into 2 groups"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-06 13:40:02 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Priestley-2002">
<DESCRIPTION>
<P>Block randomization using sealed envelopes was used; patients at high risk were randomized separately</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-02 09:59:56 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Rein-1989">
<DESCRIPTION>
<P>"16 male patients were allocated at random to two groups"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-06 13:40:06 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Royse-2003">
<DESCRIPTION>
<P>Eighty patients undergoing elective CABG were randomized</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-06 13:40:11 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Scott-2001">
<DESCRIPTION>
<P>"Patients were randomized to one of two regimens...by using cards drawn from a sealed envelope"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-08 18:52:54 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sharma-2010">
<DESCRIPTION>
<P>"Patients were randomized into two groups of 30 each."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-06 13:40:15 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Stenseth-1994">
<DESCRIPTION>
<P>30 male patients gave informed consent and were randomized into one of three groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-06 13:38:05 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Stenseth-1996">
<DESCRIPTION>
<P>54 male patients were randomized into two groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-07 05:07:54 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Svircevic-2011">
<DESCRIPTION>
<P>The random allocation sequence was concealed and computer-generated in permuted unequal blocks, accessible through an Internet site</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-06 13:38:17 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Tenling-1999">
<DESCRIPTION>
<P>"After giving their informed consent, 30 patients scheduled for CABG were randomized to receive either general anaesthesia (GA group) or GA with TEA (TEA group). Randomization was achieved with sealed envelopes"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-02 13:21:01 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-de-Vries-2002">
<DESCRIPTION>
<P>"90 patients were randomly divided into 3 groups"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2013-05-07 05:09:18 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-07 03:54:02 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bach-2002">
<DESCRIPTION>
<P>Drawing lots</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-02-04 13:00:25 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bakhtiary-2007">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-07 04:04:16 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barrington-2005">
<DESCRIPTION>
<P>Opaque sealed envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-07 04:06:27 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Berendes-2003">
<DESCRIPTION>
<P>Administered through a sequential opaque envelope technique</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-02 10:27:24 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Brix_x002d_Christensen-1998">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-07 04:09:29 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Caputo-2009">
<DESCRIPTION>
<P>Opaque sealed envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-07 04:11:36 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Caputo-2011">
<DESCRIPTION>
<P>Allocation details were concealed in sequentially numbered, opaque sealed envelopes. These were prepared by the clinical trials and evaluation unit</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-02 10:32:51 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-El_x002d_Baz-1987">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-11-05 14:27:52 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fillinger-2002">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-07 04:21:44 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hansdottir-2006">
<DESCRIPTION>
<P>Sealed envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-02 13:18:24 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Heijmans-2007">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-07 04:31:09 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kendall-2004">
<DESCRIPTION>
<P>Sealed envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-07 04:32:35 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kilickan-2006">
<DESCRIPTION>
<P>Sealed envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-02-04 13:12:06 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kirno-1994">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-07 04:34:55 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lagunilla-2006">
<DESCRIPTION>
<P>Computer-generated random sequence</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-02 10:37:29 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liem-1992">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-02 10:23:29 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Loick-1999">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-02 13:34:38 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lundstrom-2005">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-07 04:45:33 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Moore-1995">
<DESCRIPTION>
<P>Sealed envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-02 10:54:24 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Nygard-2004">
<DESCRIPTION>
<P>The randomization list was generated from a computerized table of random numbers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-07 04:48:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Onan-2011">
<DESCRIPTION>
<P>Not clear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-07 04:50:41 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Priestley-2002">
<DESCRIPTION>
<P>Sealed envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-02 10:00:06 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Rein-1989">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-07 04:52:42 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Royse-2003">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-07 04:54:58 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Scott-2001">
<DESCRIPTION>
<P>Sealed envelope</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-07 05:01:26 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sharma-2010">
<DESCRIPTION>
<P>Not clear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-02 10:17:52 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stenseth-1994">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-02 10:10:56 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Stenseth-1996">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-07 05:08:03 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Svircevic-2011">
<DESCRIPTION>
<P>The random allocation sequence was concealed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-07 05:09:18 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tenling-1999">
<DESCRIPTION>
<P>Sealed envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-02 13:21:44 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-de-Vries-2002">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2013-05-07 05:08:07 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1" REF_IDS="CMP-001.01 CMP-001.02 CMP-003.01 CMP-002.01 CMP-002.02 CMP-005.01 CMP-004.01 CMP-004.02">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-02 09:55:48 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bach-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-02 09:55:56 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bakhtiary-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-02 11:02:21 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Barrington-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-05-07 04:06:39 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Berendes-2003">
<DESCRIPTION>
<P>Participants, staff and research personnel unblinded to the intervention. The investigator collected data, but was not involved in patient care or management</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-02 10:27:29 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Brix_x002d_Christensen-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-02 13:26:22 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Caputo-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-05-07 04:11:39 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Caputo-2011">
<DESCRIPTION>
<P>Not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-02 10:32:58 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-El_x002d_Baz-1987">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-05-07 04:18:23 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fillinger-2002">
<DESCRIPTION>
<P>Participants, staff and research personnel unblinded to the intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-02 13:10:00 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hansdottir-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-02 13:15:53 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Heijmans-2007">
<DESCRIPTION>
<P>The study was blinded for the opioid infusion, except in the thoracic epidural group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-02 13:04:50 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kendall-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-02 13:00:19 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kilickan-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-02 12:55:07 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kirno-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-02 10:44:36 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lagunilla-2006">
<DESCRIPTION>
<P>Patients enrolled in the study were randomly assigned to receive either epidural saline or epidural 0.3% ropivacaine</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-02 10:37:31 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Liem-1992">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-02 10:23:35 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Loick-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-02 13:34:44 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lundstrom-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-02-04 13:21:48 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Moore-1995">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-02 10:55:21 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Nygard-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-05-07 04:48:14 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Onan-2011">
<DESCRIPTION>
<P>Not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-02 09:41:59 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Priestley-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-02 10:00:09 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Rein-1989">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-02 09:51:16 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Royse-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-02 09:45:52 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Scott-2001">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-02-08 18:46:49 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Sharma-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-02 10:17:56 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Stenseth-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-02 10:11:48 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Stenseth-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-05-07 05:08:07 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Svircevic-2011">
<DESCRIPTION>
<P>Not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-02 10:06:45 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Tenling-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-02 13:21:47 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-de-Vries-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2013-05-07 05:08:13 +0100" MODIFIED_BY="Jane Cracknell" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-05-07 03:54:11 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bach-2002">
<DESCRIPTION>
<P>One patient of the control group was excluded during the study. He died 8h after surgery as a result of a non-occlusive ischaemia of the small intestine. All other patients who were initially included terminated the study.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-05-07 04:03:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bakhtiary-2007">
<DESCRIPTION>
<P>All pre-specified outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-01-02 13:32:00 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barrington-2005">
<DESCRIPTION>
<P>All patients were included in the intention to treat analysis; all pre-specified outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-05-07 04:06:44 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Berendes-2003">
<DESCRIPTION>
<P>All pre-specified outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-05-07 04:08:06 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Brix_x002d_Christensen-1998">
<DESCRIPTION>
<P>The peri- and postoperative courses were uneventful for all patients. All data addressed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-01-02 13:28:28 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Caputo-2009">
<DESCRIPTION>
<P>All patients received the treatment allocated, all pre-specified outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-05-07 04:11:47 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Caputo-2011">
<DESCRIPTION>
<P>There were 18 protocol violations in patients allocated to GAE who received GA because the epidural could not be inserted</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-01-02 10:34:44 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-El_x002d_Baz-1987">
<DESCRIPTION>
<P>Appears have no incomplete outcome data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-05-07 04:18:26 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fillinger-2002">
<DESCRIPTION>
<P>All pre-specified outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-01-06 13:39:39 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Hansdottir-2006">
<DESCRIPTION>
<P>113 patients were randomized, 110 patients received allocated treatment, and 97 patients were eventually analysed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-01-02 13:19:36 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Heijmans-2007">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-01-06 13:39:47 +0000" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Kendall-2004">
<DESCRIPTION>
<P>"Three patients were excluded from the study and further analysis. Their treatment was re-randomized and reallocated,<BR/>providing 30 complete data sets for analysis"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-05-07 04:32:44 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kilickan-2006">
<DESCRIPTION>
<P>All pre-specified outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-05-07 04:33:44 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kirno-1994">
<DESCRIPTION>
<P>All pre-specified outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-01-02 17:01:35 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lagunilla-2006">
<DESCRIPTION>
<P>One patient was excluded in the ropivacaine group due to a wet tap (no catheter placement). One patient in the saline group became unstable after anaesthesia induction and required inotropic support; this patient was subsequently withdrawn from the study.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-05-07 04:38:01 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liem-1992">
<DESCRIPTION>
<P>Re-sternotomy was necessary in two patients (1 in each group). In one TEA group patient, the epidural catheter was dislocated. These patients were excluded from the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-02-04 13:19:19 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Loick-1999">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-01-02 13:37:00 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lundstrom-2005">
<DESCRIPTION>
<P>All pre-specified outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-01-02 10:04:38 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Moore-1995">
<DESCRIPTION>
<P>One patient had a severe haemorrhage and data from this patient were not presented</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-01-02 17:01:57 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nygard-2004">
<DESCRIPTION>
<P>Of the 196 patients included, 163 were evaluated: 18 patients had surgery cancelled, and 4 patients had a change in surgical procedure. One withdrew consent preoperatively, and 6 withdrew consent postoperatively. One patient had a stroke before surgery, and in 1 patient placement of the epidural catheter was unsuccessful. Two patients were excluded because of protocol violations.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-02-08 18:41:47 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Onan-2011">
<DESCRIPTION>
<P>Data appear to be completed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-02-04 13:22:22 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Priestley-2002">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-05-07 04:51:43 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Rein-1989">
<DESCRIPTION>
<P>One patient died 9 hr postoperatively and was excluded from the final analyses</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-02-08 18:39:34 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Royse-2003">
<DESCRIPTION>
<P>4 patients were withdrawn: 1 patient withdrew itself from the study after randomization, deciding not to participate in research, and 2 patients failed epidurals and 1 patient from the control group requested the epidural</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-01-02 09:47:26 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Scott-2001">
<DESCRIPTION>
<P>12 subjects had insufficient data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-02-08 18:54:58 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sharma-2010">
<DESCRIPTION>
<P>Data appear to be completed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-01-02 10:19:47 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stenseth-1994">
<DESCRIPTION>
<P>Two patients were excluded from the final analysis due to surgical problems</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-01-02 10:12:52 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stenseth-1996">
<DESCRIPTION>
<P>Two patients were excluded from the analysis because of the suffered complications</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-05-07 05:08:13 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Svircevic-2011">
<DESCRIPTION>
<P>One patient was excluded because his surgery was cancelled, and one patient withdrew his consent after randomization</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-01-02 10:07:40 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tenling-1999">
<DESCRIPTION>
<P>Two patients were excluded from the analyses</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-01-02 13:24:22 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-de-Vries-2002">
<DESCRIPTION>
<P>Five patients were excluded from analysis: three because of surgical reasons and in two patients the epidural technique failed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2013-05-15 20:20:57 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-02 10:51:29 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bach-2002">
<DESCRIPTION>
<P>Appears to be free of other sources of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-02 13:30:55 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bakhtiary-2007">
<DESCRIPTION>
<P>Appears to be free of other sources of bias. Sample size calculation not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-15 20:20:57 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barrington-2005">
<DESCRIPTION>
<P>Appears to be free of other sources of bias. A formal sample size determination was not possible because primary endpoint data were not available at the time of study inception. The confidence intervals between groups were calculated post hoc to assess the precision of the data and the adequacy of sample size</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-11-05 14:25:42 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Berendes-2003">
<DESCRIPTION>
<P>Appears to be free of other sources of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-02 10:30:27 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Brix_x002d_Christensen-1998">
<DESCRIPTION>
<P>Appears to be free of other sources of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-07 04:09:45 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Caputo-2009">
<DESCRIPTION>
<P>Appears to be free of other sources of bias. Sample size calculation stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-08 11:52:06 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Caputo-2011">
<DESCRIPTION>
<P>Appears to be free of other sources of bias. Sample size calculation stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-02 10:34:08 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-El_x002d_Baz-1987">
<DESCRIPTION>
<P>Appears to be free of other sources of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-11-05 14:30:39 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fillinger-2002">
<DESCRIPTION>
<P>Appears to be free of other sources of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-07 04:21:55 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hansdottir-2006">
<DESCRIPTION>
<P>Appears to be free of other sources of bias. Sample size calculation stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-02 13:19:29 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Heijmans-2007">
<DESCRIPTION>
<P>Appears to be free of other sources of bias. Sample size calculation not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-07 04:31:18 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kendall-2004">
<DESCRIPTION>
<P>Appears to be free of other sources of bias. Sample size calculation not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-07 04:32:48 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kilickan-2006">
<DESCRIPTION>
<P>Appears to be free of other sources of bias. Sample size calculation not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-02 12:54:29 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kirno-1994">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-07 04:35:16 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lagunilla-2006">
<DESCRIPTION>
<P>Appears to be free of other sources of bias. Sample size calculation stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-02 10:40:20 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liem-1992">
<DESCRIPTION>
<P>Appears to be free of other sources of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-11-05 14:31:45 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Loick-1999">
<DESCRIPTION>
<P>Appears to be free of other sources of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-02 13:37:14 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lundstrom-2005">
<DESCRIPTION>
<P>Appears to be free of other sources of bias. Sample size calculation stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-02 10:05:38 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Moore-1995">
<DESCRIPTION>
<P>Appears to be free of other sources of bias. Sample size calculation not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-07 04:47:09 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nygard-2004">
<DESCRIPTION>
<P>Appears to be free of other sources of bias. Sample size calculation stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-08 18:41:33 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Onan-2011">
<DESCRIPTION>
<P>Appears to be free of other sources of bias. Sample size calculation stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-07 04:50:44 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Priestley-2002">
<DESCRIPTION>
<P>Appears to be free of other sources of bias. Sample size calculation stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-02-04 13:22:42 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Rein-1989">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-02 09:54:54 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Royse-2003">
<DESCRIPTION>
<P>Appears to be free of other sources of bias. Sample size calculation not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-02 17:02:21 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Scott-2001">
<DESCRIPTION>
<P>Appears to be free of other sources of bias. Sample size calculation stated. Interim analysis performed and presented after 120 patients</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-08 18:55:49 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sharma-2010">
<DESCRIPTION>
<P>Appears to be free of other sources of bias. Sample size calculation not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-02 10:20:16 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stenseth-1994">
<DESCRIPTION>
<P>Appears to be free of other sources of bias. Sample size calculation not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-02 10:14:01 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stenseth-1996">
<DESCRIPTION>
<P>Appears to be free of other sources of bias. Sample size calculation not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-08 11:49:32 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Svircevic-2011">
<DESCRIPTION>
<P>Appears to be free of other sources of bias. Sample size calculation stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-02 10:09:24 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tenling-1999">
<DESCRIPTION>
<P>Appears to be free of other sources of bias. Sample size calculation stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-07 04:14:43 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-de-Vries-2002">
<DESCRIPTION>
<P>Appears to be free of other sources of bias. Sample size calculation stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2013-05-07 05:10:44 +0100" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2013-05-07 05:10:44 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2010-09-26 16:03:44 +0100" MODIFIED_BY="[Empty name]">Epidural analgesia for cardiac surgery</TITLE>
<TABLE COLS="6" ROWS="11">
<TR>
<TD COLSPAN="6">
<P>Studies: randomized clinical trials</P>
<P>Patient or population: adult patients undergoing cardiac surgery<BR/>Intervention: thoracic epidural anaesthesia<BR/>Comparison: general anaesthesia</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TD>
<TD ALIGN="CENTER" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks*</P>
</TD>
<TD ALIGN="CENTER" ROWSPAN="3" VALIGN="TOP">
<P>Relative<BR/>effect<BR/>(95% CI)</P>
</TD>
<TD ALIGN="CENTER" ROWSPAN="3" VALIGN="TOP">
<P>Number of<BR/>participants<BR/>(studies)</P>
</TD>
<TD ALIGN="CENTER" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the<BR/>evidence</P>
<P>(GRADE)</P>
</TD>
</TR>
<TR>
<TD ALIGN="CENTER">
<P>Assumed risk</P>
</TD>
<TD ALIGN="CENTER">
<P>Corresponding risk</P>
</TD>
</TR>
<TR>
<TD ALIGN="CENTER" VALIGN="TOP">
<P>GA</P>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<P>TEA</P>
</TD>
</TR>
<TR>
<TD>
<P>respiratory complications</P>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE">
<P>144 per 1000</P>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE">
<P>100 per 1000</P>
<P>(79 to 141)</P>
</TD>
<TD ALIGN="CENTER">
<P>0.66 (0.45, 0.98)</P>
</TD>
<TD ALIGN="CENTER">
<P>2011 (14)</P>
</TD>
<TD ALIGN="CENTER">
<P>++OO<SUP>1</SUP>
</P>
</TD>
</TR>
<TR>
<TD>
<P>supraventricular arrhythmias</P>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE">
<P>372 per 1000</P>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE">
<P>242 per 1000</P>
<P>(186 to 208)</P>
</TD>
<TD ALIGN="CENTER">
<P>0.65 (0.50, 0.86)</P>
</TD>
<TD ALIGN="CENTER">
<P>2250 (15)</P>
</TD>
<TD ALIGN="CENTER">
<P>++OO<SUP>2</SUP>
</P>
</TD>
</TR>
<TR>
<TD>
<P>mortality</P>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE">
<P>7 per 1000</P>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE">
<P>6 per 1000</P>
<P>(2 to 16)</P>
</TD>
<TD ALIGN="CENTER">
<P>0.84 (0.33, 2.13)</P>
</TD>
<TD ALIGN="CENTER">
<P>2877 (31)</P>
</TD>
<TD ALIGN="CENTER">
<P>+++O<SUP>3</SUP>
</P>
</TD>
</TR>
<TR>
<TD>
<P>myocardial infarction</P>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE">
<P>44 per 1000</P>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE">
<P>33 per 1000</P>
<P>(22 to 52)</P>
</TD>
<TD ALIGN="CENTER">
<P>0.76 (0.49, 1.19)</P>
</TD>
<TD ALIGN="CENTER">
<P>2127 (17)</P>
</TD>
<TD ALIGN="CENTER">
<P>+OOO<SUP>4</SUP>
</P>
</TD>
</TR>
<TR>
<TD>
<P>stroke</P>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE">
<P>15 per 1000</P>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE">
<P>8 per 1000</P>
<P>(3 to 18)</P>
</TD>
<TD ALIGN="CENTER">
<P>0.50 (0.21, 1.18)</P>
</TD>
<TD ALIGN="CENTER">
<P>1791 (10)</P>
</TD>
<TD ALIGN="CENTER">
<P>+OOO<SUP>5</SUP>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="6">
<P>*The basis for the assumed risk (e.g. the mean control group risk) is provided in footnotes. The corresponding risk is based on the assumed risk in the comparison group and the effect estimate of the intervention.<BR/>CI: Confidence interval;</P>
</TD>
</TR>
<TR>
<TD COLSPAN="6">
<P>GRADE Working Group grades of evidence<BR/>High quality (++++): Further research is very unlikely to change our confidence in the estimate of effect.<BR/>Moderate quality (+++O): Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>Low quality (++OO): Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>Very low quality (+OOO): We are very uncertain about the estimate.</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1 </SUP>Narrow confidence intervals, however high variability in effect estimates (I<SUP>2</SUP> = 42%) and the definition of this endpoint was variable among the studies, for this reason the quality of evidence was down graded</P>
<P>
<SUP>2 </SUP>There was substantial variability in effect estimates (I<SUP>2</SUP> = 67%)</P>
<P>
<SUP>3 </SUP>Large number of participants with narrow confidence intervals and small variability in effect estimates (I<SUP>2</SUP> = 0%)</P>
<P>
<SUP>4 </SUP>Large number of participants and small variability in effect estimates, but with wide confidence intervals indicating imprecision in results</P>
<P>
<SUP>5 </SUP>The wide confidence intervals indicate imprecision in results</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2013-05-07 05:27:09 +0100" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2013-04-30 12:02:40 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Thoracic epidural analgesia versus general anaesthesia for mortality</NAME>
<DICH_OUTCOME CHI2="11.844332689389512" CI_END="2.1298454007559915" CI_START="0.3324732588765139" CI_STUDY="95" CI_TOTAL="95" DF="11" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.8414966674280412" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="10" I2="7.128579646752824" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.3283480804174577" LOG_CI_START="-0.4782432796523064" LOG_EFFECT_SIZE="-0.07494759961742432" METHOD="PETO" MODIFIED="2013-04-30 12:02:35 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.3754574942288573" P_Q="1.0" P_Z="0.7156821748190287" Q="0.0" RANDOM="NO" SCALE="534.59" SORT_BY="EFFECT_SIZE" STUDIES="29" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1394" TOTAL_2="1483" WEIGHT="99.99999999999999" Z="0.36423548093838837">
<NAME>Mortality two weeks</NAME>
<GROUP_LABEL_1>Epidural</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="11.844332689389512" CI_END="2.1298454007559915" CI_START="0.3324732588765139" DF="11" EFFECT_SIZE="0.8414966674280412" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="10" I2="7.128579646752824" ID="CMP-001.01.01" LOG_CI_END="0.3283480804174577" LOG_CI_START="-0.4782432796523064" LOG_EFFECT_SIZE="-0.07494759961742432" MODIFIED="2013-02-09 19:10:32 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.3754574942288573" P_Z="0.7156821748190287" STUDIES="29" TAU2="0.0" TOTAL_1="1394" TOTAL_2="1483" WEIGHT="99.99999999999999" Z="0.36423548093838837">
<NAME>All studies</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-06-04 12:53:47 +0100" MODIFIED_BY="[Empty name]" ORDER="30" O_E="0.0" SE="0.0" STUDY_ID="STD-Lundstrom-2005" TOTAL_1="26" TOTAL_2="24" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-06-04 12:54:21 +0100" MODIFIED_BY="[Empty name]" ORDER="2" O_E="0.0" SE="0.0" STUDY_ID="STD-Bakhtiary-2007" TOTAL_1="66" TOTAL_2="66" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-06-04 12:53:01 +0100" MODIFIED_BY="[Empty name]" ORDER="60" O_E="0.0" SE="0.0" STUDY_ID="STD-Brix_x002d_Christensen-1998" TOTAL_1="8" TOTAL_2="8" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-06-04 12:54:20 +0100" MODIFIED_BY="[Empty name]" ORDER="30" O_E="0.0" SE="0.0" STUDY_ID="STD-Heijmans-2007" TOTAL_1="15" TOTAL_2="45" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-09 19:10:32 +0000" MODIFIED_BY="[Empty name]" ORDER="107" O_E="0.0" SE="0.0" STUDY_ID="STD-Sharma-2010" TOTAL_1="30" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-06-02 10:59:05 +0100" MODIFIED_BY="[Empty name]" ORDER="15" O_E="0.0" SE="0.0" STUDY_ID="STD-Moore-1995" TOTAL_1="9" TOTAL_2="9" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-06-02 10:59:04 +0100" MODIFIED_BY="[Empty name]" ORDER="66" O_E="0.0" SE="0.0" STUDY_ID="STD-Kilickan-2006" TOTAL_1="40" TOTAL_2="40" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-06-04 12:52:46 +0100" MODIFIED_BY="[Empty name]" ORDER="26" O_E="0.0" SE="0.0" STUDY_ID="STD-Stenseth-1994" TOTAL_1="18" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-09 19:09:16 +0000" MODIFIED_BY="[Empty name]" ORDER="106" O_E="0.0" SE="0.0" STUDY_ID="STD-Onan-2011" TOTAL_1="15" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-06-04 12:52:15 +0100" MODIFIED_BY="[Empty name]" ORDER="27" O_E="0.0" SE="0.0" STUDY_ID="STD-Liem-1992" TOTAL_1="27" TOTAL_2="27" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-06-04 12:53:39 +0100" MODIFIED_BY="[Empty name]" ORDER="13" O_E="0.0" SE="0.0" STUDY_ID="STD-Kendall-2004" TOTAL_1="8" TOTAL_2="18" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-06-02 10:59:00 +0100" MODIFIED_BY="[Empty name]" ORDER="79" O_E="0.0" SE="0.0" STUDY_ID="STD-Tenling-1999" TOTAL_1="14" TOTAL_2="14" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-06-04 12:52:03 +0100" MODIFIED_BY="[Empty name]" ORDER="36" O_E="0.0" SE="0.0" STUDY_ID="STD-El_x002d_Baz-1987" TOTAL_1="30" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-06-04 12:53:31 +0100" MODIFIED_BY="[Empty name]" ORDER="50" O_E="0.0" SE="0.0" STUDY_ID="STD-de-Vries-2002" TOTAL_1="30" TOTAL_2="60" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-06-04 12:54:18 +0100" MODIFIED_BY="[Empty name]" ORDER="36" O_E="0.0" SE="0.0" STUDY_ID="STD-Lagunilla-2006" TOTAL_1="25" TOTAL_2="25" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-06-04 12:52:51 +0100" MODIFIED_BY="[Empty name]" ORDER="60" O_E="0.0" SE="0.0" STUDY_ID="STD-Kirno-1994" TOTAL_1="10" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-06-02 10:59:06 +0100" MODIFIED_BY="[Empty name]" ORDER="4" O_E="0.0" SE="0.0" STUDY_ID="STD-Berendes-2003" TOTAL_1="36" TOTAL_2="37" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.152389596845182" CI_START="0.008225822639062" EFFECT_SIZE="0.13306079465346146" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.33292088430195566" LOG_CI_START="-2.084820658759141" LOG_EFFECT_SIZE="-0.8759498872285927" MODIFIED="2012-06-02 10:59:07 +0100" MODIFIED_BY="[Empty name]" ORDER="13" O_E="-1.0" SE="1.420193350407744" STUDY_ID="STD-Barrington-2005" TOTAL_1="60" TOTAL_2="60" VAR="0.49579831932773105" WEIGHT="11.129800651324294"/>
<DICH_DATA CI_END="2.2914449761804145" CI_START="0.008789123500531355" EFFECT_SIZE="0.1419147381011634" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.3601094331155524" LOG_CI_START="-2.056054432987967" LOG_EFFECT_SIZE="-0.8479724999362073" MODIFIED="2009-06-04 12:53:41 +0100" MODIFIED_BY="[Empty name]" ORDER="8" O_E="-0.9693251533742331" SE="1.4192666151532363" STUDY_ID="STD-Nygard-2004" TOTAL_1="79" TOTAL_2="84" VAR="0.49644601129414256" WEIGHT="11.14434019732235"/>
<DICH_DATA CI_END="7.189114748306881" CI_START="0.0028228622148494197" EFFECT_SIZE="0.14245659121715704" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8566754156130331" LOG_CI_START="-2.549310319441091" LOG_EFFECT_SIZE="-0.8463174519140291" MODIFIED="2009-06-04 12:53:34 +0100" MODIFIED_BY="[Empty name]" ORDER="25" O_E="-0.4868421052631579" SE="2.0006928806720943" STUDY_ID="STD-Royse-2003" TOTAL_1="37" TOTAL_2="39" VAR="0.24982686980609423" WEIGHT="5.608174029424663"/>
<DICH_DATA CI_END="7.321112159116381" CI_START="0.002868373559124908" EFFECT_SIZE="0.14491267901946084" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8645770602767631" LOG_CI_START="-2.5423642895098384" LOG_EFFECT_SIZE="-0.8388936146165378" MODIFIED="2013-02-09 19:08:33 +0000" MODIFIED_BY="[Empty name]" ORDER="105" O_E="-0.4823008849557522" SE="2.0012542134963205" STUDY_ID="STD-Caputo-2011" TOTAL_1="109" TOTAL_2="117" VAR="0.24968674132665047" WEIGHT="5.605028391408187"/>
<DICH_DATA CI_END="14.926289339246635" CI_START="0.0034613831813535157" EFFECT_SIZE="0.22730069704883135" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.1739518559645512" LOG_CI_START="-2.460750320863075" LOG_EFFECT_SIZE="-0.6433992324492619" MODIFIED="2009-06-04 12:53:23 +0100" MODIFIED_BY="[Empty name]" ORDER="1" O_E="-0.325" SE="2.135042050734495" STUDY_ID="STD-Bach-2002" TOTAL_1="13" TOTAL_2="27" VAR="0.21937500000000001" WEIGHT="4.924583086919116"/>
<DICH_DATA CI_END="4.850743005075677" CI_START="0.051891954559432185" EFFECT_SIZE="0.5017116060037585" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6858082660847162" LOG_CI_START="-1.2848999708855449" LOG_EFFECT_SIZE="-0.29954585240041426" MODIFIED="2012-06-02 10:59:03 +0100" MODIFIED_BY="[Empty name]" ORDER="27" O_E="-0.5147058823529411" SE="1.1576037735594338" STUDY_ID="STD-Scott-2001" TOTAL_1="206" TOTAL_2="202" VAR="0.7462427628950121" WEIGHT="16.751838125987774"/>
<DICH_DATA CI_END="19.06202091676682" CI_START="0.20480901191765327" EFFECT_SIZE="1.975872887894525" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.2801689417626443" LOG_CI_START="-0.6886509376376146" LOG_EFFECT_SIZE="0.2957590020625147" MODIFIED="2013-02-09 19:07:40 +0000" MODIFIED_BY="[Empty name]" ORDER="104" O_E="0.5091743119266054" SE="1.1564945429752935" STUDY_ID="STD-Svircevic-2011" TOTAL_1="325" TOTAL_2="329" VAR="0.747674939577559" WEIGHT="16.783987974732394"/>
<DICH_DATA CI_END="354.1023540965725" CI_START="0.1390343459692309" EFFECT_SIZE="7.016579594644527" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.5491288139870094" LOG_CI_START="-0.856877901743304" LOG_EFFECT_SIZE="0.8461254561218526" MODIFIED="2012-06-02 10:59:08 +0100" MODIFIED_BY="[Empty name]" ORDER="71" O_E="0.48672566371681414" SE="2.0007052048251435" STUDY_ID="STD-Hansdottir-2006" TOTAL_1="58" TOTAL_2="55" VAR="0.2498237919962409" WEIGHT="5.608104938004272"/>
<DICH_DATA CI_END="372.3848896839504" CI_START="0.1466175227450357" EFFECT_SIZE="7.38905609893065" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.570992050236215" LOG_CI_START="-0.8338141226232083" LOG_EFFECT_SIZE="0.8685889638065036" MODIFIED="2009-06-04 12:52:18 +0100" MODIFIED_BY="[Empty name]" ORDER="25" O_E="0.5" SE="2.0" STUDY_ID="STD-Stenseth-1996" TOTAL_1="26" TOTAL_2="26" VAR="0.25" WEIGHT="5.612060497913522"/>
<DICH_DATA CI_END="372.3848896839504" CI_START="0.1466175227450357" EFFECT_SIZE="7.38905609893065" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.570992050236215" LOG_CI_START="-0.8338141226232083" LOG_EFFECT_SIZE="0.8685889638065036" MODIFIED="2009-06-04 12:53:24 +0100" MODIFIED_BY="[Empty name]" ORDER="8" O_E="0.5" SE="2.0" STUDY_ID="STD-Fillinger-2002" TOTAL_1="30" TOTAL_2="30" VAR="0.25" WEIGHT="5.612060497913522"/>
<DICH_DATA CI_END="372.3848896839504" CI_START="0.1466175227450357" EFFECT_SIZE="7.38905609893065" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.570992050236215" LOG_CI_START="-0.8338141226232083" LOG_EFFECT_SIZE="0.8685889638065036" MODIFIED="2009-06-04 12:52:07 +0100" MODIFIED_BY="[Empty name]" ORDER="10" O_E="0.5" SE="2.0" STUDY_ID="STD-Rein-1989" TOTAL_1="8" TOTAL_2="8" VAR="0.25" WEIGHT="5.612060497913522"/>
<DICH_DATA CI_END="394.2227027877215" CI_START="0.15477158811151107" EFFECT_SIZE="7.811176209769427" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.5957416311345005" LOG_CI_START="-0.8103087610877985" LOG_EFFECT_SIZE="0.8927164350233509" MODIFIED="2012-06-02 10:59:06 +0100" MODIFIED_BY="[Empty name]" ORDER="71" O_E="0.5135135135135135" SE="2.000730860612738" STUDY_ID="STD-Caputo-2009" TOTAL_1="36" TOTAL_2="38" VAR="0.2498173849525201" WEIGHT="5.607961111136375"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.513002364066194" CI_END="22.82919579689418" CI_START="0.07947636847841427" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="1.3469898207558322" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="33.90625000000001" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="1.3584906128865202" LOG_CI_START="-1.0997619853696894" LOG_EFFECT_SIZE="0.12936431375841545" METHOD="PETO" MODIFIED="2013-04-30 12:02:40 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.21868192178590218" P_Q="1.0" P_Z="0.8365688813563009" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="EFFECT_SIZE" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="75" TOTAL_2="95" WEIGHT="100.00000000000001" Z="0.20628424925175867">
<NAME>Mortality six months</NAME>
<GROUP_LABEL_1>Epidural</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="12.614954397388997" CI_START="0.003531635933120045" EFFECT_SIZE="0.2110720877910902" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.1008856848973416" LOG_CI_START="-2.4520240730407914" LOG_EFFECT_SIZE="-0.675569194071725" MODIFIED="2009-06-04 15:43:54 +0100" MODIFIED_BY="[Empty name]" ORDER="5" O_E="-0.35714285714285715" SE="2.086996778999804" STUDY_ID="STD-Loick-1999" TOTAL_1="25" TOTAL_2="45" VAR="0.22959183673469388" WEIGHT="47.872340425531924"/>
<DICH_DATA CI_END="372.3848896839504" CI_START="0.1466175227450357" EFFECT_SIZE="7.38905609893065" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.570992050236215" LOG_CI_START="-0.8338141226232083" LOG_EFFECT_SIZE="0.8685889638065036" ORDER="50" O_E="0.5" SE="2.0" STUDY_ID="STD-Priestley-2002" TOTAL_1="50" TOTAL_2="50" VAR="0.25" WEIGHT="52.12765957446809"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2013-04-30 12:02:54 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Thoracic epidural analgesia versus general anaesthesia for myocardial infarction</NAME>
<DICH_OUTCOME CHI2="7.036443889621192" CI_END="1.1859520460819049" CI_START="0.493160740470724" CI_STUDY="95" CI_TOTAL="95" DF="11" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.7647646626306176" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="48" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="0.0740671287052587" LOG_CI_START="-0.3070115040056947" LOG_EFFECT_SIZE="-0.11647218765021802" METHOD="PETO" MODIFIED="2013-04-30 12:02:50 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7961246532263524" P_Q="1.0" P_Z="0.23088600033303663" Q="0.0" RANDOM="NO" SCALE="62.31" SORT_BY="EFFECT_SIZE" STUDIES="15" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1029" TOTAL_2="1098" WEIGHT="99.99999999999999" Z="1.1980797315821623">
<NAME>Myocardial infarction two weeks</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="42" O_E="0.0" SE="0.0" STUDY_ID="STD-Heijmans-2007" TOTAL_1="15" TOTAL_2="45" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="39" O_E="0.0" SE="0.0" STUDY_ID="STD-Bakhtiary-2007" TOTAL_1="66" TOTAL_2="66" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-09 19:11:03 +0000" MODIFIED_BY="[Empty name]" ORDER="108" O_E="0.0" SE="0.0" STUDY_ID="STD-Onan-2011" TOTAL_1="15" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.138000806260133" CI_START="0.007932442631348553" EFFECT_SIZE="0.1302289090080826" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.3300078646493077" LOG_CI_START="-2.1005930601010268" LOG_EFFECT_SIZE="-0.8852925977258594" ORDER="44" O_E="-1.0" SE="1.427747014866968" STUDY_ID="STD-Liem-1992" TOTAL_1="27" TOTAL_2="27" VAR="0.49056603773584906" WEIGHT="2.4581132005074413"/>
<DICH_DATA CI_END="4.218828881404321" CI_START="0.011405626617911141" EFFECT_SIZE="0.21935903670958584" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6251919104567838" LOG_CI_START="-1.9428808498677865" LOG_EFFECT_SIZE="-0.6588444697055013" ORDER="48" O_E="-0.6666666666666666" SE="1.5084986515798353" STUDY_ID="STD-de-Vries-2002" TOTAL_1="30" TOTAL_2="60" VAR="0.4394506866416979" WEIGHT="2.201985972758419"/>
<DICH_DATA CI_END="4.759210216118142" CI_START="0.010364787937812113" EFFECT_SIZE="0.22209953768869828" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6775348881742154" LOG_CI_START="-1.9844395790867788" LOG_EFFECT_SIZE="-0.6534523454562817" ORDER="43" O_E="-0.6153846153846154" SE="1.5636569790552364" STUDY_ID="STD-Kendall-2004" TOTAL_1="8" TOTAL_2="18" VAR="0.40899408284023675" WEIGHT="2.049374959993387"/>
<DICH_DATA CI_END="5.027984319194635" CI_START="0.049649136813624074" EFFECT_SIZE="0.49963494809755943" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7013939145791824" LOG_CI_START="-1.304088297628593" LOG_EFFECT_SIZE="-0.30134719152470535" ORDER="46" O_E="-0.5" SE="1.178030178747903" STUDY_ID="STD-Stenseth-1996" TOTAL_1="26" TOTAL_2="26" VAR="0.7205882352941176" WEIGHT="3.6107013471254668"/>
<DICH_DATA CI_END="1.7053096382865334" CI_START="0.16724143067276515" EFFECT_SIZE="0.5340397210387028" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" LOG_CI_END="0.23180324666578492" LOG_CI_START="-0.7766561259181447" LOG_EFFECT_SIZE="-0.27242643962617985" MODIFIED="2013-02-09 19:12:53 +0000" MODIFIED_BY="[Empty name]" ORDER="110" O_E="-1.7876106194690262" SE="0.5923740274102037" STUDY_ID="STD-Caputo-2011" TOTAL_1="109" TOTAL_2="117" VAR="2.8497580076748377" WEIGHT="14.27947969910066"/>
<DICH_DATA CI_END="2.4529882217254184" CI_START="0.14088561433608837" EFFECT_SIZE="0.5878696731223465" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.389695462901886" LOG_CI_START="-0.8511333499240911" LOG_EFFECT_SIZE="-0.23071894351110253" ORDER="40" O_E="-1.0" SE="0.7288689868556626" STUDY_ID="STD-Barrington-2005" TOTAL_1="60" TOTAL_2="60" VAR="1.8823529411764706" WEIGHT="9.432036172082851"/>
<DICH_DATA CI_END="2.115757034086752" CI_START="0.25151170788246613" EFFECT_SIZE="0.7294776659415284" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="8" LOG_CI_END="0.3254657934132998" LOG_CI_START="-0.5994417937078463" LOG_EFFECT_SIZE="-0.13698800014727325" ORDER="45" O_E="-1.068627450980392" SE="0.5432952950413564" STUDY_ID="STD-Scott-2001" TOTAL_1="206" TOTAL_2="202" VAR="3.387880724385915" WEIGHT="16.975888442652295"/>
<DICH_DATA CI_END="6.909216202088806" CI_START="0.1297623412980708" EFFECT_SIZE="0.9468664483007136" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8394287827700203" LOG_CI_START="-0.8868513270997855" LOG_EFFECT_SIZE="-0.023711272164882655" MODIFIED="2009-06-04 13:10:59 +0100" MODIFIED_BY="[Empty name]" ORDER="73" O_E="-0.053097345132743445" SE="1.0140254817618835" STUDY_ID="STD-Hansdottir-2006" TOTAL_1="58" TOTAL_2="55" VAR="0.9725283331282235" WEIGHT="4.873115033734199"/>
<DICH_DATA CI_END="2.0603294154892127" CI_START="0.4979872625572851" EFFECT_SIZE="1.0129253701955165" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="16" LOG_CI_END="0.3139366630350653" LOG_CI_START="-0.3027817654166476" LOG_EFFECT_SIZE="0.0055774488092088376" MODIFIED="2013-02-09 19:12:05 +0000" MODIFIED_BY="[Empty name]" ORDER="109" O_E="0.09785932721712598" SE="0.36226345767799195" STUDY_ID="STD-Svircevic-2011" TOTAL_1="325" TOTAL_2="329" VAR="7.619929338121729" WEIGHT="38.181707358748476"/>
<DICH_DATA CI_END="17.233492289011526" CI_START="0.06475366465962244" EFFECT_SIZE="1.0563767228582996" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2363732941724737" LOG_CI_START="-1.1887356481514906" LOG_EFFECT_SIZE="0.02381882301049137" MODIFIED="2009-12-18 13:16:02 +0000" MODIFIED_BY="[Empty name]" ORDER="72" O_E="0.027027027027026973" SE="1.4245209972039667" STUDY_ID="STD-Caputo-2009" TOTAL_1="36" TOTAL_2="38" VAR="0.4927904579885328" WEIGHT="2.469259257033968"/>
<DICH_DATA CI_END="95.85717041423214" CI_START="0.26392506927463905" EFFECT_SIZE="5.029822098449118" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9816246050060478" LOG_CI_START="-0.5785193557801576" LOG_EFFECT_SIZE="0.701552624612945" ORDER="47" O_E="0.7142857142857142" SE="1.503841235482809" STUDY_ID="STD-Stenseth-1994" TOTAL_1="18" TOTAL_2="10" VAR="0.44217687074829937" WEIGHT="2.215646252158068"/>
<DICH_DATA CI_END="372.3848896839504" CI_START="0.1466175227450357" EFFECT_SIZE="7.38905609893065" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.570992050236215" LOG_CI_START="-0.8338141226232083" LOG_EFFECT_SIZE="0.8685889638065036" ORDER="41" O_E="0.5" SE="2.0" STUDY_ID="STD-Fillinger-2002" TOTAL_1="30" TOTAL_2="30" VAR="0.25" WEIGHT="1.2526923041047537"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.13397911848710573" CI_END="3.0253392843869236" CI_START="0.05588182803919856" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.4111708764617724" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="0.48077408678164285" LOG_CI_START="-1.2527293954291672" LOG_EFFECT_SIZE="-0.38597765432376213" METHOD="PETO" MODIFIED="2013-04-30 12:02:54 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.7143416042208586" P_Q="1.0" P_Z="0.38277123980912287" Q="0.0" RANDOM="NO" SCALE="64.38" SORT_BY="USER" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="75" TOTAL_2="95" WEIGHT="100.0" Z="0.8728015940839361">
<NAME>Myocardial infarction six months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="12.614954397388997" CI_START="0.003531635933120045" EFFECT_SIZE="0.2110720877910902" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.1008856848973416" LOG_CI_START="-2.4520240730407914" LOG_EFFECT_SIZE="-0.675569194071725" ORDER="5" O_E="-0.35714285714285715" SE="2.086996778999804" STUDY_ID="STD-Loick-1999" TOTAL_1="25" TOTAL_2="45" VAR="0.22959183673469388" WEIGHT="23.805706957358126"/>
<DICH_DATA CI_END="4.982699036562526" CI_START="0.05146792598685368" EFFECT_SIZE="0.506408121211111" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6974646558430367" LOG_CI_START="-1.288463332247462" LOG_EFFECT_SIZE="-0.2954993382022126" ORDER="51" O_E="-0.5" SE="1.1665439307064442" STUDY_ID="STD-Priestley-2002" TOTAL_1="50" TOTAL_2="50" VAR="0.7348484848484849" WEIGHT="76.19429304264187"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2013-04-30 12:03:01 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Thoracic epidural analgesia versus general anaesthesia for respiratory complications</NAME>
<DICH_OUTCOME CHI2="18.81731367612975" CI_END="0.9825780212750793" CI_START="0.4487360563318617" CI_STUDY="95" CI_TOTAL="95" DF="11" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6640167063450612" ESTIMABLE="YES" EVENTS_1="99" EVENTS_2="147" I2="41.54319692319427" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="-0.0076329545770442795" LOG_CI_START="-0.34800903312607756" LOG_EFFECT_SIZE="-0.17782099385156092" METHOD="MH" MODIFIED="2013-04-30 12:03:01 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.06445269173221002" P_Q="1.0" P_Z="0.04057287522330242" Q="0.0" RANDOM="YES" SCALE="146.5253845360764" SORT_BY="EFFECT_SIZE" STUDIES="13" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.15056122629944438" TOTALS="YES" TOTAL_1="988" TOTAL_2="1023" WEIGHT="99.99999999999997" Z="2.047868611271817">
<NAME>Respiratory complications two weeks</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="35" O_E="0.0" SE="0.0" STUDY_ID="STD-Tenling-1999" TOTAL_1="14" TOTAL_2="14" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.9774190029426781" CI_START="0.006243329812231785" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.29609870339830113" LOG_CI_START="-2.204583722276951" LOG_EFFECT_SIZE="-0.9542425094393249" ORDER="29" O_E="0.0" SE="1.4689132354192893" STUDY_ID="STD-El_x002d_Baz-1987" TOTAL_1="30" TOTAL_2="30" VAR="2.1577060931899643" WEIGHT="1.7318375911068848"/>
<DICH_DATA CI_END="4.025049578857407" CI_START="0.009937765788056413" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6047712341924788" LOG_CI_START="-2.002711242864516" LOG_EFFECT_SIZE="-0.6989700043360187" ORDER="28" O_E="0.0" SE="1.5316481142697058" STUDY_ID="STD-Berendes-2003" TOTAL_1="36" TOTAL_2="36" VAR="2.3459459459459455" WEIGHT="1.6012548085811595"/>
<DICH_DATA CI_END="1.1608047914885673" CI_START="0.05982002513548424" EFFECT_SIZE="0.2635135135135135" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="8" LOG_CI_END="0.0647591920836682" LOG_CI_START="-1.2231534088205847" LOG_EFFECT_SIZE="-0.5791971083684583" ORDER="33" O_E="0.0" SE="0.7565262370413517" STUDY_ID="STD-Royse-2003" TOTAL_1="37" TOTAL_2="39" VAR="0.5723319473319474" WEIGHT="5.529923728749525"/>
<DICH_DATA CI_END="7.947668126079229" CI_START="0.01948751892121073" EFFECT_SIZE="0.3935483870967742" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.9002397238099838" LOG_CI_START="-1.7102434501290327" LOG_EFFECT_SIZE="-0.40500186315952447" ORDER="36" O_E="0.0" SE="1.5334107384718942" STUDY_ID="STD-de-Vries-2002" TOTAL_1="30" TOTAL_2="60" VAR="2.3513484928609203" WEIGHT="1.5977971081853626"/>
<DICH_DATA CI_END="0.960016530277381" CI_START="0.22684794574824094" EFFECT_SIZE="0.4666666666666667" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="15" LOG_CI_END="-0.017721288891219305" LOG_CI_START="-0.6442651491916295" LOG_EFFECT_SIZE="-0.3309932190414244" ORDER="31" O_E="0.0" SE="0.36803496498258886" STUDY_ID="STD-Liem-1992" TOTAL_1="27" TOTAL_2="27" VAR="0.13544973544973543" WEIGHT="13.976891269366694"/>
<DICH_DATA CI_END="5.368170063591449" CI_START="0.046570804769315244" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7298262658251348" LOG_CI_START="-1.3318862571530974" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="27" O_E="0.0" SE="1.2110601416389968" STUDY_ID="STD-Barrington-2005" TOTAL_1="60" TOTAL_2="60" VAR="1.4666666666666668" WEIGHT="2.4718495962146076"/>
<DICH_DATA CI_END="5.224499169520386" CI_START="0.047851476646507" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7180446644790353" LOG_CI_START="-1.3201046558069978" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="30" O_E="0.0" SE="1.1972189997378646" STUDY_ID="STD-Fillinger-2002" TOTAL_1="30" TOTAL_2="30" VAR="1.4333333333333331" WEIGHT="2.523870095962767"/>
<DICH_DATA CI_END="0.7602519777405121" CI_START="0.3491645176326466" EFFECT_SIZE="0.5152213263123252" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="59" LOG_CI_END="-0.11904244139668937" LOG_CI_START="-0.4569698960641128" LOG_EFFECT_SIZE="-0.2880061687304011" ORDER="2" O_E="0.0" SE="0.19850025963952322" STUDY_ID="STD-Scott-2001" TOTAL_1="206" TOTAL_2="202" VAR="0.03940235307695813" WEIGHT="21.043739685986683"/>
<DICH_DATA CI_END="1.2541057982998431" CI_START="0.33074025171085575" EFFECT_SIZE="0.6440366972477064" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="20" LOG_CI_END="0.09833417579266905" LOG_CI_START="-0.48051294741430584" LOG_EFFECT_SIZE="-0.19108938581081839" MODIFIED="2013-02-09 19:14:42 +0000" MODIFIED_BY="[Empty name]" ORDER="112" O_E="0.0" SE="0.3400176655112485" STUDY_ID="STD-Caputo-2011" TOTAL_1="109" TOTAL_2="117" VAR="0.11561201285971928" WEIGHT="15.018580105360897"/>
<DICH_DATA CI_END="1.6372674048350349" CI_START="0.3932316283790749" EFFECT_SIZE="0.8023872679045093" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="13" LOG_CI_END="0.21411961585676362" LOG_CI_START="-0.4053515582913739" LOG_EFFECT_SIZE="-0.09561597121730515" MODIFIED="2009-06-04 13:15:44 +0100" MODIFIED_BY="[Empty name]" ORDER="74" O_E="0.0" SE="0.3638804341263828" STUDY_ID="STD-Hansdottir-2006" TOTAL_1="58" TOTAL_2="55" VAR="0.13240897034000482" WEIGHT="14.127085331565201"/>
<DICH_DATA CI_END="2.7810463894711503" CI_START="0.9186543762813307" EFFECT_SIZE="1.5983805668016193" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="19" LOG_CI_END="0.44420823320911057" LOG_CI_START="-0.036847851733243724" LOG_EFFECT_SIZE="0.20368019073793336" MODIFIED="2013-02-09 19:13:55 +0000" MODIFIED_BY="[Empty name]" ORDER="111" O_E="0.0" SE="0.2825747255611639" STUDY_ID="STD-Svircevic-2011" TOTAL_1="325" TOTAL_2="329" VAR="0.07984847552596712" WEIGHT="17.34972131184105"/>
<DICH_DATA CI_END="30.75832503713365" CI_START="0.4432340213004337" EFFECT_SIZE="3.6923076923076925" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.4879626820092333" LOG_CI_START="-0.35336691187173225" LOG_EFFECT_SIZE="0.5672978850687505" ORDER="32" O_E="0.0" SE="1.0816061181741692" STUDY_ID="STD-Lundstrom-2005" TOTAL_1="26" TOTAL_2="24" VAR="1.1698717948717947" WEIGHT="3.027449367079154"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2013-05-07 05:27:09 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Thoracic epidural analgesia versus general anaesthesia for supraventricular tachycardias (SVTs)</NAME>
<DICH_OUTCOME CHI2="38.333714983958615" CI_END="0.8617296090759863" CI_START="0.49686059408440864" CI_STUDY="95" CI_TOTAL="95" DF="12" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6543389683532685" ESTIMABLE="YES" EVENTS_1="305" EVENTS_2="427" I2="68.69596384012976" I2_Q="0.0" ID="CMP-004.01" LOG_CI_END="-0.0646289844161611" LOG_CI_START="-0.3037654456982641" LOG_EFFECT_SIZE="-0.18419721505721257" METHOD="MH" MODIFIED="2013-05-07 05:26:10 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.3541075159906324E-4" P_Q="1.0" P_Z="0.0025330671573740816" Q="0.0" RANDOM="YES" SCALE="42.12" SORT_BY="EFFECT_SIZE" STUDIES="13" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.1410984434925967" TOTALS="YES" TOTAL_1="1103" TOTAL_2="1147" WEIGHT="99.99999999999997" Z="3.019363133745046">
<NAME>SVTs two weeks</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.45989629911230956" CI_START="0.02684448436783524" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="18" LOG_CI_END="-0.3373400852760801" LOG_CI_START="-1.5711449336025698" LOG_EFFECT_SIZE="-0.9542425094393249" ORDER="59" O_E="0.0" SE="0.7247430753394787" STUDY_ID="STD-Bakhtiary-2007" TOTAL_1="66" TOTAL_2="66" VAR="0.5252525252525253" WEIGHT="2.9611729071646833"/>
<DICH_DATA CI_END="0.5276598339496482" CI_START="0.03369173970417127" EFFECT_SIZE="0.13333333333333333" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="15" LOG_CI_END="-0.2776459635411538" LOG_CI_START="-1.4724765632422463" LOG_EFFECT_SIZE="-0.8750612633917001" ORDER="63" O_E="0.0" SE="0.7018494087712781" STUDY_ID="STD-Liem-1992" TOTAL_1="27" TOTAL_2="27" VAR="0.49259259259259264" WEIGHT="3.113789406744479"/>
<DICH_DATA CI_END="0.8643161564454347" CI_START="0.1949578066778939" EFFECT_SIZE="0.4104938271604938" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="18" LOG_CI_END="-0.06332736876607205" LOG_CI_START="-0.7100593697129807" LOG_EFFECT_SIZE="-0.38669336923952635" MODIFIED="2009-12-18 13:18:20 +0000" MODIFIED_BY="[Empty name]" ORDER="74" O_E="0.0" SE="0.37989357873124996" STUDY_ID="STD-Caputo-2009" TOTAL_1="36" TOTAL_2="38" VAR="0.14431913116123643" WEIGHT="6.913310918937474"/>
<DICH_DATA CI_END="0.7683744199426776" CI_START="0.25196049604884424" EFFECT_SIZE="0.44" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="25" LOG_CI_END="-0.11442710172635133" LOG_CI_START="-0.5986675453012738" LOG_EFFECT_SIZE="-0.3565473235138126" ORDER="62" O_E="0.0" SE="0.284445233584764" STUDY_ID="STD-Kilickan-2006" TOTAL_1="40" TOTAL_2="40" VAR="0.08090909090909093" WEIGHT="8.887898514925341"/>
<DICH_DATA CI_END="0.7396991520075478" CI_START="0.28309144110570955" EFFECT_SIZE="0.4576051779935275" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="45" LOG_CI_END="-0.13094487917379005" LOG_CI_START="-0.548073260754118" LOG_EFFECT_SIZE="-0.339509069963954" ORDER="66" O_E="0.0" SE="0.24502327615907446" STUDY_ID="STD-Scott-2001" TOTAL_1="206" TOTAL_2="202" VAR="0.06003640585972606" WEIGHT="9.810236474011653"/>
<DICH_DATA CI_END="0.8860633202481565" CI_START="0.3720255177313522" EFFECT_SIZE="0.5741412417324515" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="43" LOG_CI_END="-0.052535241259960314" LOG_CI_START="-0.4294272702529509" LOG_EFFECT_SIZE="-0.2409812557564556" MODIFIED="2013-02-09 19:16:16 +0000" MODIFIED_BY="[Empty name]" ORDER="113" O_E="0.0" SE="0.2213882434761149" STUDY_ID="STD-Caputo-2011" TOTAL_1="109" TOTAL_2="117" VAR="0.04901275434943954" WEIGHT="10.379085807194354"/>
<DICH_DATA CI_END="1.3886375968911264" CI_START="0.46088338774121357" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="20" LOG_CI_END="0.14258891945525418" LOG_CI_START="-0.33640894547136696" LOG_EFFECT_SIZE="-0.09691001300805639" ORDER="60" O_E="0.0" SE="0.2813657169355689" STUDY_ID="STD-Barrington-2005" TOTAL_1="60" TOTAL_2="60" VAR="0.07916666666666668" WEIGHT="8.95820692566463"/>
<DICH_DATA CI_END="1.6372674048350349" CI_START="0.3932316283790749" EFFECT_SIZE="0.8023872679045093" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="13" LOG_CI_END="0.21411961585676362" LOG_CI_START="-0.4053515582913739" LOG_EFFECT_SIZE="-0.09561597121730515" MODIFIED="2009-06-04 13:24:37 +0100" MODIFIED_BY="[Empty name]" ORDER="75" O_E="0.0" SE="0.3638804341263828" STUDY_ID="STD-Hansdottir-2006" TOTAL_1="58" TOTAL_2="55" VAR="0.13240897034000482" WEIGHT="7.214358132605021"/>
<DICH_DATA CI_END="1.6900249061018646" CI_START="0.4829910483933344" EFFECT_SIZE="0.9034749034749034" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="14" LOG_CI_END="0.22789310491124898" LOG_CI_START="-0.316060918253467" LOG_EFFECT_SIZE="-0.044083906671109" ORDER="65" O_E="0.0" SE="0.31952128582279476" STUDY_ID="STD-Royse-2003" TOTAL_1="37" TOTAL_2="39" VAR="0.1020938520938521" WEIGHT="8.113663430631087"/>
<DICH_DATA CI_END="1.0634842807685603" CI_START="0.7835216285586313" EFFECT_SIZE="0.9128323699421965" ESTIMABLE="YES" EVENTS_1="156" EVENTS_2="173" LOG_CI_END="0.026731075032422773" LOG_CI_START="-0.10594901063889064" LOG_EFFECT_SIZE="-0.039608967803233905" MODIFIED="2013-02-09 19:16:51 +0000" MODIFIED_BY="[Empty name]" ORDER="114" O_E="0.0" SE="0.07793693910034592" STUDY_ID="STD-Svircevic-2011" TOTAL_1="325" TOTAL_2="329" VAR="0.006074166476331029" WEIGHT="13.407253127654593"/>
<DICH_DATA CI_END="3.723945821594102" CI_START="0.26853237074537567" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.5710033539543428" LOG_CI_START="-0.5710033539543428" LOG_EFFECT_SIZE="0.0" ORDER="67" O_E="0.0" SE="0.6708203932499369" STUDY_ID="STD-de-Vries-2002" TOTAL_1="30" TOTAL_2="60" VAR="0.45" WEIGHT="3.338158739942121"/>
<DICH_DATA CI_END="1.678666844520456" CI_START="0.766297350576034" EFFECT_SIZE="1.1341772151898735" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="30" LOG_CI_END="0.22496451272941625" LOG_CI_START="-0.11560267598604865" LOG_EFFECT_SIZE="0.05468091837168379" ORDER="64" O_E="0.0" SE="0.200050852486237" STUDY_ID="STD-Nygard-2004" TOTAL_1="79" TOTAL_2="84" VAR="0.04002034358047016" WEIGHT="10.894399566153103"/>
<DICH_DATA CI_END="3.0028281703186757" CI_START="0.550501437554572" EFFECT_SIZE="1.2857142857142858" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.47753048144390436" LOG_CI_START="-0.2592415425937682" LOG_EFFECT_SIZE="0.10914446942506807" ORDER="61" O_E="0.0" SE="0.4327835340000672" STUDY_ID="STD-Fillinger-2002" TOTAL_1="30" TOTAL_2="30" VAR="0.1873015873015873" WEIGHT="6.008466048371458"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.029318676886499487" CI_END="1.5134440209276758" CI_START="0.3850969819698686" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.7634282709197967" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="29" I2="0.0" I2_Q="0.0" ID="CMP-004.02" LOG_CI_END="0.17996636196135923" LOG_CI_START="-0.4144298849580748" LOG_EFFECT_SIZE="-0.1172317614983578" METHOD="PETO" MODIFIED="2013-05-07 05:26:20 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.8640453303261821" P_Q="1.0" P_Z="0.43945093988415296" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="75" TOTAL_2="95" WEIGHT="100.0" Z="0.773120730730705">
<NAME>SVTs six months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.005398001372402" CI_START="0.25384794055882287" EFFECT_SIZE="0.7134887193566299" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="16" LOG_CI_END="0.30220057777733283" LOG_CI_START="-0.595426355629741" LOG_EFFECT_SIZE="-0.14661288892620405" ORDER="69" O_E="-1.2142857142857135" SE="0.5272705040082966" STUDY_ID="STD-Loick-1999" TOTAL_1="25" TOTAL_2="45" VAR="3.5969387755102042" WEIGHT="43.849067983489455"/>
<DICH_DATA CI_END="2.005977051549332" CI_START="0.3229228703100529" EFFECT_SIZE="0.8048452442938376" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="13" LOG_CI_END="0.3023259603680977" LOG_CI_START="-0.4909011959313518" LOG_EFFECT_SIZE="-0.09428761778162704" MODIFIED="2010-02-05 12:26:06 +0000" MODIFIED_BY="[Empty name]" ORDER="70" O_E="-1.0" SE="0.46594555814804667" STUDY_ID="STD-Priestley-2002" TOTAL_1="50" TOTAL_2="50" VAR="4.606060606060606" WEIGHT="56.150932016510545"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2013-04-30 12:03:30 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Thoracic epidural analgesia versus general anaesthesia for stroke</NAME>
<DICH_OUTCOME CHI2="3.2402581231806042" CI_END="1.1778565451844212" CI_START="0.21057466875201075" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.49802284268856306" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="14" I2="0.0" I2_Q="0.0" ID="CMP-005.01" LOG_CI_END="0.07109239959487795" LOG_CI_START="-0.676593873810054" LOG_EFFECT_SIZE="-0.30275073710758804" METHOD="PETO" MODIFIED="2013-04-30 12:03:30 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7781439030863129" P_Q="1.0" P_Z="0.112457232244693" Q="0.0" RANDOM="NO" SCALE="88.49" SORT_BY="EFFECT_SIZE" STUDIES="9" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="884" TOTAL_2="907" WEIGHT="100.0" Z="1.5872447097941136">
<NAME>Stroke two weeks</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="53" O_E="0.0" SE="0.0" STUDY_ID="STD-Fillinger-2002" TOTAL_1="30" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="54" O_E="0.0" SE="0.0" STUDY_ID="STD-Heijmans-2007" TOTAL_1="15" TOTAL_2="45" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="6.820467167072353" CI_START="0.0026853936013588454" EFFECT_SIZE="0.1353352832366127" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8338141226232082" LOG_CI_START="-2.570992050236215" LOG_EFFECT_SIZE="-0.8685889638065036" ORDER="52" O_E="-0.5" SE="2.0" STUDY_ID="STD-Barrington-2005" TOTAL_1="60" TOTAL_2="60" VAR="0.25" WEIGHT="4.822297814305551"/>
<DICH_DATA CI_END="7.189114748306881" CI_START="0.0028228622148494197" EFFECT_SIZE="0.14245659121715704" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8566754156130331" LOG_CI_START="-2.549310319441091" LOG_EFFECT_SIZE="-0.8463174519140291" MODIFIED="2009-12-18 13:16:47 +0000" MODIFIED_BY="[Empty name]" ORDER="55" O_E="-0.4868421052631579" SE="2.0006928806720943" STUDY_ID="STD-Royse-2003" TOTAL_1="37" TOTAL_2="39" VAR="0.24982686980609423" WEIGHT="4.818958272882902"/>
<DICH_DATA CI_END="7.1993591024118775" CI_START="0.002826463909323219" EFFECT_SIZE="0.14264897010923275" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8572938366153432" LOG_CI_START="-2.5487565556069556" LOG_EFFECT_SIZE="-0.8457313594958062" MODIFIED="2009-12-18 13:17:11 +0000" MODIFIED_BY="[Empty name]" ORDER="73" O_E="-0.4864864864864865" SE="2.000730860612738" STUDY_ID="STD-Caputo-2009" TOTAL_1="36" TOTAL_2="38" VAR="0.2498173849525201" WEIGHT="4.818775317728265"/>
<DICH_DATA CI_END="1.4340381860124047" CI_START="0.08754557326480181" EFFECT_SIZE="0.3543214572645474" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.15656071601355936" LOG_CI_START="-1.0577658090925202" LOG_EFFECT_SIZE="-0.4506025465394804" ORDER="56" O_E="-2.0392156862745097" SE="0.7133014118605548" STUDY_ID="STD-Scott-2001" TOTAL_1="206" TOTAL_2="202" VAR="1.965413038077398" WEIGHT="37.911227990913076"/>
<DICH_DATA CI_END="4.716612097195363" CI_START="0.04890743602672625" EFFECT_SIZE="0.4802888759970039" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6736301605419125" LOG_CI_START="-1.3106251044784962" LOG_EFFECT_SIZE="-0.3184974719682918" MODIFIED="2009-06-04 13:28:41 +0100" MODIFIED_BY="[Empty name]" ORDER="76" O_E="-0.5398230088495575" SE="1.1655613648949605" STUDY_ID="STD-Hansdottir-2006" TOTAL_1="58" TOTAL_2="55" VAR="0.7360879585603527" WEIGHT="14.198541414808895"/>
<DICH_DATA CI_END="6.703010385635575" CI_START="0.129219454932828" EFFECT_SIZE="0.9306768227698132" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.826269892289553" LOG_CI_START="-0.8886720952116859" LOG_EFFECT_SIZE="-0.031201101461066402" MODIFIED="2013-02-09 19:17:44 +0000" MODIFIED_BY="[Empty name]" ORDER="115" O_E="-0.07079646017699126" SE="1.0073654125579763" STUDY_ID="STD-Caputo-2011" TOTAL_1="117" TOTAL_2="109" VAR="0.985430339102514" WEIGHT="19.008154281617724"/>
<DICH_DATA CI_END="19.06202091676682" CI_START="0.20480901191765327" EFFECT_SIZE="1.975872887894525" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.2801689417626443" LOG_CI_START="-0.6886509376376146" LOG_EFFECT_SIZE="0.2957590020625147" MODIFIED="2013-02-09 19:18:29 +0000" MODIFIED_BY="[Empty name]" ORDER="116" O_E="0.5091743119266054" SE="1.1564945429752935" STUDY_ID="STD-Svircevic-2011" TOTAL_1="325" TOTAL_2="329" VAR="0.747674939577559" WEIGHT="14.42204490774359"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" MODIFIED="2013-04-16 08:45:45 +0100" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Thoracic epidural analgesia versus general anaesthesia for mortality - sensitivity analysis</NAME>
<DICH_OUTCOME CHI2="5.696076289341546" CI_END="2.700197009774456" CI_START="0.2527881200652513" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.8261826226123966" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" I2="12.220276800787213" I2_Q="0.0" ID="CMP-006.01" LOG_CI_END="0.4313954519873426" LOG_CI_START="-0.597243339849064" LOG_EFFECT_SIZE="-0.0829239439308607" METHOD="PETO" MODIFIED="2013-02-09 19:25:09 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.33692406655799045" P_Q="1.0" P_Z="0.751998059932356" Q="0.0" RANDOM="NO" SCALE="437.9518760783689" SORT_BY="EFFECT_SIZE" STUDIES="10" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="901" TOTAL_2="893" WEIGHT="99.99999999999999" Z="0.31600586104739087">
<NAME>Low risk of bias studies</NAME>
<GROUP_LABEL_1>Epidural</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-11-06 14:58:27 +0000" MODIFIED_BY="[Empty name]" ORDER="97" O_E="0.0" SE="0.0" STUDY_ID="STD-Berendes-2003" TOTAL_1="36" TOTAL_2="37" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-11-06 14:58:17 +0000" MODIFIED_BY="[Empty name]" ORDER="96" O_E="0.0" SE="0.0" STUDY_ID="STD-Moore-1995" TOTAL_1="9" TOTAL_2="9" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-11-06 15:01:06 +0000" MODIFIED_BY="[Empty name]" ORDER="99" O_E="0.0" SE="0.0" STUDY_ID="STD-Tenling-1999" TOTAL_1="14" TOTAL_2="14" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-11-06 14:59:24 +0000" MODIFIED_BY="[Empty name]" ORDER="98" O_E="0.0" SE="0.0" STUDY_ID="STD-Kilickan-2006" TOTAL_1="40" TOTAL_2="40" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="6.353410065487704" CI_START="0.0024892329260971942" EFFECT_SIZE="0.12575817082006766" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8030068867269252" LOG_CI_START="-2.6039344630596752" LOG_EFFECT_SIZE="-0.9004637881663752" MODIFIED="2013-02-09 19:25:06 +0000" MODIFIED_BY="[Empty name]" ORDER="122" O_E="-0.5176991150442478" SE="2.00125421349632" STUDY_ID="STD-Caputo-2011" TOTAL_1="117" TOTAL_2="109" VAR="0.24968674132665053" WEIGHT="9.115835553910413"/>
<DICH_DATA CI_END="2.152389596845182" CI_START="0.008225822639062" EFFECT_SIZE="0.13306079465346146" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.33292088430195566" LOG_CI_START="-2.084820658759141" LOG_EFFECT_SIZE="-0.8759498872285927" MODIFIED="2012-11-06 14:58:04 +0000" MODIFIED_BY="[Empty name]" ORDER="102" O_E="-1.0" SE="1.420193350407744" STUDY_ID="STD-Barrington-2005" TOTAL_1="60" TOTAL_2="60" VAR="0.49579831932773105" WEIGHT="18.10114515045078"/>
<DICH_DATA CI_END="4.850743005075677" CI_START="0.051891954559432185" EFFECT_SIZE="0.5017116060037585" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6858082660847162" LOG_CI_START="-1.2848999708855449" LOG_EFFECT_SIZE="-0.29954585240041426" MODIFIED="2012-11-06 15:01:05 +0000" MODIFIED_BY="[Empty name]" ORDER="103" O_E="-0.5147058823529411" SE="1.1576037735594338" STUDY_ID="STD-Scott-2001" TOTAL_1="206" TOTAL_2="202" VAR="0.7462427628950121" WEIGHT="27.24464372318117"/>
<DICH_DATA CI_END="19.06202091676682" CI_START="0.20480901191765327" EFFECT_SIZE="1.975872887894525" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.2801689417626443" LOG_CI_START="-0.6886509376376146" LOG_EFFECT_SIZE="0.2957590020625147" MODIFIED="2013-02-09 19:24:33 +0000" MODIFIED_BY="[Empty name]" ORDER="121" O_E="0.5091743119266054" SE="1.1564945429752935" STUDY_ID="STD-Svircevic-2011" TOTAL_1="325" TOTAL_2="329" VAR="0.747674939577559" WEIGHT="27.29693118967969"/>
<DICH_DATA CI_END="354.1023540965725" CI_START="0.1390343459692309" EFFECT_SIZE="7.016579594644527" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.5491288139870094" LOG_CI_START="-0.856877901743304" LOG_EFFECT_SIZE="0.8461254561218526" MODIFIED="2012-11-06 14:58:56 +0000" MODIFIED_BY="[Empty name]" ORDER="101" O_E="0.48672566371681414" SE="2.0007052048251435" STUDY_ID="STD-Hansdottir-2006" TOTAL_1="58" TOTAL_2="55" VAR="0.2498237919962409" WEIGHT="9.120839149054877"/>
<DICH_DATA CI_END="394.2227027877215" CI_START="0.15477158811151107" EFFECT_SIZE="7.811176209769427" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.5957416311345005" LOG_CI_START="-0.8103087610877985" LOG_EFFECT_SIZE="0.8927164350233509" MODIFIED="2012-11-06 14:58:42 +0000" MODIFIED_BY="[Empty name]" ORDER="100" O_E="0.5135135135135135" SE="2.000730860612738" STUDY_ID="STD-Caputo-2009" TOTAL_1="36" TOTAL_2="38" VAR="0.2498173849525201" WEIGHT="9.120605233723069"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2013-05-16 15:20:46 +0100" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2013-05-16 15:20:46 +0100" MODIFIED_BY="Jane Cracknell" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P> Study flow diagram.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAZEAAAQKCAYAAACBuEdwAAB1zUlEQVR42uydD2RW7///v0ySJDGT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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2013-05-16 15:20:46 +0100" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAiMAAADOCAMAAADbsfL2AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA
AMAAwMD/gADAwMD/gICA/4CAgP/g4OBAAAAAQAAAAECAgID///8AAAALCwsWFhYhISEsLCw3NzdC
QkJNTU1YWFhjY2Nubm55eXmEhISPj4+ampqlpaWwsLC7u7vGxsbR0dHc3Nzn5+cAAAAAADMAAGYA
AJkAAMwAAP8AMwAAMzMAM2YAM5kAM8wAM/8AZgAAZjMAZmYAZpkAZswAZv8AmQAAmTMAmWYAmZkA
mcwAmf8AzAAAzDMAzGYAzJkAzMwAzP8A/wAA/zMA/2YA/5kA/8wA//8zAAAzADMzAGYzAJkzAMwz
AP8zMwAzMzMzM2YzM5kzM8wzM/8zZgAzZjMzZmYzZpkzZswzZv8zmQAzmTMzmWYzmZkzmcwzmf8z
zAAzzDMzzGYzzJkzzMwzzP8z/wAz/zMz/2Yz/5kz/8wz//9mAABmADNmAGZmAJlmAMxmAP9mMwBm
MzNmM2ZmM5lmM8xmM/9mZgBmZjNmZmZmZplmZsxmZv9mmQBmmTNmmWZmmZlmmcxmmf9mzABmzDNm
zGZmzJlmzMxmzP9m/wBm/zNm/2Zm/5lm/8xm//+ZAACZADOZAGaZAJmZAMyZAP+ZMwCZMzOZM2aZ
M5mZM8yZM/+ZZgCZZjOZZmaZZpmZZsyZZv+ZmQCZmTOZmWaZmZmZmcyZmf+ZzACZzDOZzGaZzJmZ
zMyZzP+Z/wCZ/zOZ/2aZ/5mZ/8yZ///MAADMADPMAGbMAJnMAMzMAP/MMwDMMzPMM2bMM5nMM8zM
M//MZgDMZjPMZmbMZpnMZszMZv/MmQDMmTPMmWbMmZnMmczMmf/MzADMzDPMzGbMzJnMzMzMzP/M
/wDM/zPM/2bM/5nM/8zM////AAD/ADP/AGb/AJn/AMz/AP//MwD/MzP/M2b/M5n/M8z/M///ZgD/
ZjP/Zmb/Zpn/Zsz/Zv//mQD/mTP/mWb/mZn/mcz/mf//zAD/zDP/zGb/zJn/zMz/zP///wD//zP/
/2b//5n//8z///9BjlLGAAAVl0lEQVR42u1da2wc13U+lHZmdrh8zawYi3YgSCLhP4qBQIYsUTUd
YyUXJuKWadCgAtoiln5QECIXKPLHKVC06Y9KEOAfTpygEoqqaJOiRg0VUmtLtaQ1IpItTBUCitho
IYiSINdcuiRnSIrk7swsub2P2XntLPfB4XIpnU+Pnb1z7z1n735z75nHtwcAgVgbLaDgICDWgr4N
xwBRAcgRBHIEgRxBIEcQyBEEcgSBHEE86YjhEIRAxyHwXFtFjuD0GvqJ87jWIPCAQSBHEMgRBHIE
gRyJDFrDGyLW4kiKQJTHw+qlNsvB58rYVhMVPHw2vGEqvHZbFrlQ3TySTqenxG81lYP9xKuwWeJ3
v6jQ8HB4w+InDbx/pOC8U/Vaoz5YAdghi3GFHGxdcXEEwEqI9KKb1Sq1koFMnRePqCOSxA88VRLj
ZEtrlRIaq3IxxQ9S8s9qExMW2eocFEkVa1C86JSx7oYVUmk8IbaOc1Oq00+qSyI+CMSHFPsD47bt
rqLdvR0qtS27tsHpq5vasxsS3z0+UHTLzB75kCcliXyurCgMjoB6ei+Soep4pI8ULWlm6zLZLkze
PAKQFKfod6BIRnwXeR2e+lfjjcxcJ6u91Gq2ku9217xxjYx3Mp55y+0pqZtSkm788mYHaf7DzlOs
TEzyvcJZ2uuBL8zZo+R1dbJtyekHPsgQHyziQ5of8Snb9mrRbn6I2ZZd27SvT8zZA+Rb/4+lrmLD
pGBejjk+UBhfth5gG4t/YMwRk50fWZdeAxiykAxVcYTGI8YtMsoyaL9B3j9QB14mozqh3qZfywTc
o1dob6vywQeq/DJrEbPUe+QAzQswIJOa91TPrQ5DAM3gvQwAmPunc6xMN/jeB6xuXAXZJK8PVWrR
7gf2q44PnBLEtsVq2XbNfUHbtK+XQCZb1n3BcHy4D/vjjg8Us+pMnG3kBoB2FjuSzRLH9iFHysH3
XHwqDSPv/wWd8ves5A+n6Xv6TzLYC30nmsVC9o/U/Hr+zX+eZqvLqEl3F2vSF1IoXnPepYux4ijl
hFOXbI5Y3iaj3IbrQ6ltgNevUdsr33dt+/sCT0Piv9uQ/j98gb5Y3T9+uz9Neyl0TnN/itDxfk1e
KTsYAy/uYicT4i3faSRdFcbIy0BJ+LI89U8LZB+JdskYt2gw7p55jpLCa07NURYzjPKK4NRtIQXu
ITzm7Pb7UGI7PU5tZzy23b5GPeEn2dYKPo+7Qfs7ttFR6FhgnyBznryO43xRdTxyHMg8svo/9466
RdJeNtkIMvR9GqwuZ9UWus+Ci2SWl3qBthsd0XbTqd+CG61OTfGOFWdlCi+T9sDRUYAb46DKTiW7
HwriwwGHWueCtsUXiG21aDvLVw+7L3GvJRHqMOYZfXDH8Hmched59LoyM0QjI9LLMcKiF0QkQ9Ux
q3xQg9YTPZ4dsxYLPdNJMVtyNvmxKizNkX2d4qkFWlOk7eZTPdtpuy7hHfcqhvxOm87KDvGy2bxE
6+qvStkFd3rg/VAkTvRQZoo72RlwUsz5bAvPENtZYYn0le4Slcd8VuR96bm2GyTOaGNTpiEM5f2f
bzDLY6bz7T2UYh8fFDtJ1WfwKYmq4pFIkEpXXfXW68t1X0XtyaiRXs719YfxiDceiZ4j3thvLRSO
jghzQt1mLr61GKXXifeOA3KkURx5EoDPKnqeVdRxFV5zfBCAzwYgkCMI5AgCOYLYfGDMiuc1leJ2
5MimTa/NPYWjBguB8QgCOYJAjiCQIwjkyAYKEbTNd+Epw3aQ6zp5PjyXA0g9oH/D8G6+3J6qsFbb
n/CzMiVmrt3mJ+Eu2GXBXQU153mXa2nA0Lc0NTFWHV7k6pxHrE//cM39awug1oV+Pksc0ivXq0GD
lT+E8060a41mfvFXzphaCbHNIi9xSQXYEReHHeWU1SZwAVRcGOFVWR2tVZQ1R3ZllyVEKrLKyGL8
Bj/QFVFSdzDJlb2P109xGWbvmABZUYzvcGRWzBNmz5IlxwW/Le4D88mxNSLQXoSxXiRDpBzpM1TB
GdOkaMaSAF1y+zLA4nWz31FOJWOWSC/kFibTR1hVXkeRTJkJqpjsyi6bM/9NATihmfK3bR5OzeVM
Jrmi+3YX69tdmyJAZ5vZtkiszJnSj7gnc+zJW0VqP1Ss57fFSiavcREYtfUGYUu7ef0xgGggGSLl
iKnCZUfwYEzAfYPKpGZyTNh03FFOHbsPEyeBKqcGuHKK14k7giomu2JlMhdSXZVBt5vrqnyIS67o
PlemZa8NdwGEPxu5y2Vd2k+5PbJ1jGqwZq4W6/ltUTxSB46xDWrrMH22cmQfcf/uCpKhbOBUxzNX
2k7yzY1OqSX6KPL9dOcHjPRaAigICKpcbdaIBdruNy84wiuvMMsj02L1BbqmdFkD/zUT0GCNGSUa
LJ94y/XJtkV6aWmf2QQNVpPfr1HWNxh9QjqdFvvsd6OORIugs3D1b5x6Y1rgDJTXocUtwTIun3pu
2y8el5gb88m07AEmrYSlqR8temVdtKJR7NF1wX8CYRV9sm2RXmTSi9aCE0aUZJ6leiXhhP3uj/pg
bxwg1tdN/s/P7HvH+eJzfdDrPaW061AxlxAoy3Hx1apwr/ROdM4VZtEZhSnqYp+TdSSrSqteqZeU
YQKvWO+OwWI9vy2KDvhc4md33FZ8RM2QdeZzvAMeKUdOTpD/Jt6zj8czhmDNAswtPybfz3x7z1+T
snM9bL4yRNM3kfA6j5Ji7lGgTO+UqPgqsfh2qWxGd4VZlAgstBE/A2hXxCM3mazrt7is60GfmCOu
zX3v8aVivUdJyWOLYuH067Nsw7bV9r5INZ2foU4v0nikCaD9/hUhyv6s3/5lozVYWyYe2bL6GiXa
AKKQ9E54yBEvR7bsKqxHG2O2+IPr1QZ8gtWtMtQYqYVOUjgEW2bCQyBHEMgRBHIE8TQAY9bQkyYc
AtRg1T69lptwn9TbxQVcaxAYjyCQIwjkCAI5gkCONB5ahfeIKDhCs07Eu9mzpf40UakyuagutoUU
ZsVCPY6UyU+1ZmXf1nOBOs/VlAcrcRG5UNU8kk5Pyfxx0hL1UmguqlNhpZ1t67lrX79yq7/0fQ0a
rC9O4bxT5Vqj6qvOzKHwzFRU0MQLuJTKSkhd/CjsFV+CVJYJoIrZrJR46uVv0sxUdtYqKqWK21mz
umWRqq3sfrn0ym5H0d3K2jj17CxXBCMsI5Zr31FT8S3eB1Vc2RmxSAcX3TxYARlYGTuqiHmwqo1H
PDkguGzpfTlTvJRYmFygWbGEzBn+3vyK/Hdhiua1OjDHs1nBJNU+7ZKM+N+TN1cyAH85peeMzFwX
wO8lzMSS0+/P5YfLnnYA//e/rbvYhl1vsdXU+PXg32QZsYr2Y+IUfx4VklenqPaX90Htvj9vzNDs
Z//SecqRgV22eN4t1nYNO19hjqOqOEICkm+ec949YLKlD+6p9ldiJ6Ey7qsv2sfxr+mUrk5QWZUA
MhW6TbBD/OAE3LtCXr9B3r2oyof2qzLp6b2ZYnIt+nJlosfTjiCvzhxkG3Y9wWL5qcDNysXtx3lW
LgLjG+pD8Pbxx2TraDHjFkduP1D/wEncVc7Or5Ej5eB9npXKk7oXDI96ifxzU1v5s2IBOFtU0gRB
mVQgYxbLO2Wt9qdDpVfgFWbZ9cZfXYFF9lyztmdOPlzevmvbk0VrzTxYoXYkj5hTx/s1hfIarOng
Scm2oI4KnIKC5rzzy6RKhU8smC3MeM6DfNIrih3FNna9l5YzrT/gZygtyVth9oFn0nL7sDNijQY0
WP6PVMaOVsAJo8p4RNkePJXthd2+ApoVa5RtCVSptxt6JSaT8kQy50qET2ySn8l6DtVYb2bQ1y4L
z+e89WiGrb/lgdF/+7Jy3Sk6RLZoud0HYcM5viXeoaouWwb2GfTG/R8o3I6M+poq4xEx96tAhdum
dMlXMGuJF/gWU+ptF81ZJqHKupNESdYqhvn273msfZLd/amvXevg8m1vvcR3haV5fu3ixE5vVq4h
6V176zsSZTTpY3mBkG4n9HeJy7+iGbcWdPaeEmGQ+edBGTt/ik9JVBOPVA3FZL/ToD07qabST8Y4
WO2TKsYj4fFI7RxpswqxxDQ/UTaWqs161exom/b+5hdyZH0ceRqAzypiHqyqxwcB+GwAAjmCQI4g
kCOIzQfGrHheUyluR448HdNr1R/IeRAE1xoExiMI5AgCOYJAjiCQIwFode2qtYnm3YVaiKhQz33f
qp8ZcSvaKogwsEfea+st7vuBccVadMttQ6Qu6TfMUbssuKtNbPjvszb5ua/S6MHoL7/rUO29HfZN
Hm5GrMOOoTTrtwYNlp7FeSfitSbVNSySI9Y6Ld0CR3KlDEvqCCtPZSWZj7n2rpjQuEAqwWqBW5/2
w/5kZKrRmk0MM7nUDWk4OxIfZiVigj9oaCWGKa93yJKdZav7NBNQAc+I5ZSz/rqG7X55HiwuB2N+
sa7itM8U7WyYysuyonh6BIRlzIMVdTyyenaeZqj6RfsZgF1xQ6KyJu3sXO7brBzimZ/zuUrpN2cU
JohS5oyf7WZlxfr2AZ2GM1JHF4AqXGBZs76b6VffmOwn3ZyZMyWu94qJZ+kkuPix0c9TYT3+RzPB
lxjzQ085U161nLX7pbZ+ZjJb3F/W1eS1PWzjgHYhQda5zoT54msA3SaSIWKOcD0Uzzhl3YMJKl5w
M1dBXh3iz/7FXwKZb8kCHOffQ7G+g/P3pw2Ak/dhgmYNmVWP9z9Qj5NufupkuDo5weRWNMsWl1Ll
ZkCzc2vt85ZTTHieTLWGuK2HjgbrtjrAH8+/yqVd4p+PDJH45m4eyRBtzOoXUpVIruiLEJBFhcmt
PEIpCMql3MbgyK2s7nyeq7GsbusVw82I5ZT7fCuXB4sXjL+2krfzYD3s4f1gzBp9zBqW18o+8dR4
z2O+JFUW+OvbceKo0833fb30OY1t4VVHYdrOy9tZmLlif3rNWx7iYcC3btDeZBvfavnIzoP1IVl8
NLxStDHXR3jGKeEy9AYkV7uhjyebyo0zWdSo5clmZdcfVbXdnCBib7fEs2ad9/XSYYEyyLakvUx4
tTKTZVm2LMhfzyZtH2Rv+eh4sTEnXqlvSyB38CNGiNMu7Gxal/EO+MZwZC5LM049+oFo+HNNwSXJ
eMgnqldFKpAS2oqZrsCp37bUQ78X8RnQc79zg2XNsvxBwZkuIfefbGs2L9G6N3mWLdLb/Cs9tjSM
KsLcctEJS0i/3FYgD9Z8fMefsI3E4gCVcNnZtN5EnV6U8UiEV9kiQDQZsSpqsJ7ieGRjOCI1MqGy
OhtBuqOC6n32DDni5cjGrMINzbkdSdK0Fv/jiatPGkfW84EwUgsDarCii1kRyBEEAjmCQI4g1g+M
WcOAGizUYOH0WvGT5nGtQeABg0COIJAjCOQIAjlSDloDWqyvHSKIyJ8NsDpXCvFZ54mO4JMkcrbW
h0viufAWSoX7vWXaldNgVfp91qfu3HcDNVgdUmYKkmV399ec6upwmSRcuXxd7WwEdz1ScN5p2Fqz
OqGqCzlvhis7O5U16GSnGrTIu2I5Pai74k4mrYtiK33Q3cmkZWupSBWelStuJ+G6LAh1tQNLZvUB
dsQlrsESBkdAPY15sBrGEWGPYoEJcOATc/YAK9k1b1wj30Xsh052qrGvwdf+vVhOkZl06r81dYXM
QopkxKl06oOMraWys2cp0qT9tMxpsb52kPyylfu1eN2YI7u6PrIuvQYwhPqahnHk0YqZkHd4xVd5
AQbIluRmp/rQBEsollNkVae+ru43SJsJuEeFFvudh0wfsuxZ8v1iVi7rbn3tYFad4clKcgNAdVnb
j7A8WPtQp9ewmJUuLnvM7JrZqbQeg0aUUFRYMYWUUx9evxYu03KzcgGXTNXTzpWHWd0/frs/DdrX
X0l3TlfMg4Uxa3SQNFDnVwj51shOpQpdMa88i5HVrj8O2idcOjUQRmkNbDndNq2+dlSDxfM4dax2
UC2HuvwP58nrOObBathak9traZ0kVrjhZLgSuPjKm51K3D/tlNso1j8KdySyT4a+T/mOUa80ONcL
SZ6DNfZ5fe1gGZ7nUpqV2SF6/iWr6jHCjxdQX9Mwjuh62868zjNccclVulM8xbNTXSdfIstO9dVY
1ikvtrPrbxe+85DsS4pZ+/RU8CYjv21Il7jL4mB97aB1MPuQbdxs76FFHx8UO0nVZ/ApiUbGI+tB
5Qtsao798JH27JfJetqVi6HePvtEa7DWE480G0cq5NUqSC3b5/lFXNVcrKtdOBLvHQfkyNbgSHMA
n1XEPFhVjw8C8NkABHIEgRxBIEcQyBEEcgSBHEEgRxAI5EgY9E1u31wdIEcQOI8gkCOIjQbe992Q
1fwJAN73rXaA6uTYeg+8JugA1xoExiMI5AgCY1ZE8wTwGLOWDdkU9qJUH/85bdhrTU3dOFGpz7Yb
ZypVe8B3uV6XM4ocKTt85B/7WzVFiqOr2O+qb+o7narHtttch2o90AOftKxRjEeiPl+u/6xTVyIj
d6TWcB6J/JvT66aLHrwwU7ttpWoPlKo/MHJkzalBp3/1quP64lJDXmttCk7LOm2X9FOXB2FtkCOV
V3ilpuNZqbupsm7b6/UgvA3GIxEuNfo6V4r1L3PK+iOc0jbIkajpVP/9wKjuJEZ9RxKvoa0dPurF
6ww1XZ2otWnJBZZ6O1BqcT7s+khIG9SEIyoSD9caRCUgRxDIEQRyBIEcQSBHEM2OWOD8HoGwoYRw
BK+UICBsysC1BoHxCAI5gkCOIJAjiC107rvGWXCznvGgo5vGkeDssrpV3G/enHiBPLNbKqESrjUI
5AiicRzRq9xbUk/X3dJGXO/XQy3pzee842g5+00yqFFpJyqpSps6VNts55XmHtTa1xpdt5nvMFln
f+w93iOE19QDzLerubU3bkIpWvK6XnzRm8d53jH4nG2iQa15HgkTlOqKf4/3fVFh7Ah7/CLkjSWJ
4v4ttew61gTO0059lppoUOtcaxTd/hOY7JSSibBkQlQaN0kqoYYU/+smOq8HxrTUm6YY1Ai1nIrn
9zcqj4yiNz46WSPG2xTnq9BsNcOgxqI9bCnbKyhMdc+PqDSYJIrPga3hfBP4ta3uSUOBwI+ZVHty
7Il2N2ZU9ZKpWa9wYtwUzuvrueKwkYMaq/EzKOWnM3cPJ4+/pqI7O/mejVtrAl17LdMt24Hmcj7U
qSYZVI+W0z30guq91aa9VRa8X9O0jgbv1yiVLnpsvstKmUFGbNY3As17Lxg50hxo5mcFwjmyulWG
Nr9VHC1sYf7Gthqp0dGGA58NQCBHEMgRBHIEgRxBIEcQWx3ec1/8cQlEBY7gT0sgcK1BIEcQyBEE
cgSBHEEgRxDIEQQCgQjB/wO7ff2nYYn69gAAAABJRU5ErkJggg==
</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2013-05-16 15:20:46 +0100" MODIFIED_BY="[Empty name]" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAASoAAAS8CAIAAAC0X1CBAAA8E0lEQVR42u3dvW4lxdbG8S0hIQIH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==
</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2013-05-16 15:01:44 +0100" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2013-05-07 05:29:42 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2011-01-06 13:42:33 +0000" MODIFIED_BY="Jane Cracknell">Search strategies</TITLE>
<APPENDIX_BODY MODIFIED="2013-05-07 05:29:42 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>1 CENTRAL</B>
<BR/>#1. ANALGESIA EPIDURAL explode all trees (MeSH)<BR/>#2. ANESTHESIA EPIDURAL explode all trees (MeSH)<BR/>#3. ANESTHESIA SPINAL explode all trees (MeSH)<BR/>#4. INJECTIONS SPINAL explode all trees (MeSH)<BR/>#5. (epidural* or peridural* or spinal* or intraspinal* or intrathecal* or neuraxial*)<BR/>#6. (#1 or #2 or #3 or #4 or #5)<BR/>#7. CARDIAC SURGICAL PROCEDURES explode all trees (MeSH)<BR/>#8. CARDIOPULMONARY BYPASS explode all trees (MeSH)<BR/>#9. (#6 and (#7 or #8))<BR/>#10. ((coronary next artery next bypass next surgery) or (coronary next artery next surgery) or (coronary next<BR/>bypass next graft next surgery) or (coronary next artery next bypass next graft) or (coronary next bypass next<BR/>graft) or (coronary next artery next bypass next graft*) or (coronary next bypass next graft*) or cabg or (((off<BR/>next pump) or offpump or off-pump) and (coronary next surgery)) or (open next heart next surgery) or (heart<BR/>next surgery) or (heart next valve next surgery) or (cardiopulmonary next bypass))<BR/>#11. (#7 or #8 or #10)<BR/>#12. (#11 and #6)</P>
<P>
<BR/>
<B>2 MEDLINE (PubMed)</B>
<BR/>(("Cardiac Surgical Procedures"[MeSH] OR cardiac surgery[tiab] OR heart surgery[tiab] OR cardiac surgical<BR/>procedures[tiab] OR cardiopulmonary bypass[tiab]) NOT Pulmonary Surgical Procedures[MeSH]) AND ("Analgesia, Epidural"[MeSH] OR "Anesthesia, Epidural"[MeSH] OR "Anesthesia, Spinal"[MeSH] OR epidural*[tiab] OR peridural*[tiab] OR extradural*[tiab] OR spinal*[tiab] OR subarachnoid*[tiab] OR intrathecal*[tiab] OR neuraxial*[tiab]) AND ((randomized controlled trial [pt] OR controlled clinical trial [pt] OR randomized controlled trials [mh] OR random alocation [mh] OR double-blind method [mh] OR single-blind method [mh] OR clinical trial [pt] OR clinical trials [mh] OR ("clinical trial" [tw]) OR ((singl* [tw] OR doubl* [tw] OR trebl* [tw] OR tripl* [tw]) AND (mask* [tw] OR blind* [tw])) OR (placebos [mh] OR placebo* [tw] OR random* [tw] OR research design [mh:noexp] OR comparative study [mh] OR evaluation studies [mh] OR follow-up studies [mh] OR prospective studies [mh] OR control* [tw] OR prospective* [tw] OR volunteer* [tw] NOT (animals [mh] NOT human [mh]))</P>
<P>
<BR/>
<B>3 Ovid EMBASE</B>
<BR/>((heart-surgery/) or (cardiopulmonary bypass/)) or ((coronary artery bypass surgery or coronary artery surgery or coronary bypass graft surgery or coronary artery bypass graft or coronary bypass graft or coronary artery bypass graft* or coronary bypass graft* or CABG or ((off pump or offpump or off-pump) and (coronary surgery)) or open heart surgery or heart surgery or heart valve surgery or cardiopulmonary bypass).mp.)) and ((( epidural or peridural or extradural or spinal or subarachnoid or intraspinal or intrathecal or neuraxial).mp.)) or ((spinal anesthesia/ or intraspinal drug administration/ or epidural anesthesia/))) and (((randomized-controlled-trial/ or randomization/ or controlled-study/ or multicenter-study/ or phase-3-clinical-trial/ or phase-4-clinical-trial/ or double-blind-procedure/ or single-blind-procedure/) or (random* or cross?over* or multicenter* or factorial* or placebo* or volunteer*) or ((singl* or doubl* or trebl* or tripl*) adj3 (blind* or mask*)).ti,ab or (latin adj square).mp.) not (animals.sh not (humans.sh and animals.sh)))</P>
<P>
<BR/>
<B>4 CINAHL, EBSCOhost </B>
<BR/>S1 (MM "Heart Surgery+") OR (MM "Cardiopulmonary Bypass+") or (coronary and (surg* or bypass or graft)) or CABG or off?pump or open heart surgery or heart surgery or heart valve surgery or cardiopulmonary bypass<BR/>S2 (epidural or peridural or extradural or spinal or subarachnoid or intrathecal or neuraxial) or (TI an?esth*) or (AB an?esth*) or (MM "Anesthesia, Spinal+") OR (MM "Injections, Intraspinal+") OR (MM "Infusions, Intraspinal+") OR (MM "Analgesia, Epidural+") OR (MM "Anesthesia, Epidural+") OR (MM "Epidural Analgesia Administration (Iowa NIC)")<BR/>S3 S1 and S2<BR/>S4 (MH "Placebos") OR ( (MM "Randomized Controlled Trials") OR (MM "Random Assignment") OR (MH "Prospective Studies") OR (MH "Multicenter Studies") OR (MH "Clinical Trials") OR (MH "Single-Blind Studies") OR (MH "Triple-Blind Studies") OR (MH "Double-Blind Studies") ) OR ( placebo* or multicenter or prospective or ((random* or control*) and trial*) )<BR/>S5 S3 and S4</P>
<P>
<BR/>
<B>5 Web of Science (SCI/SSCI)</B>
<BR/>TI=((epidural* OR peridural* OR extradural* OR spinal* OR subarachnoid* OR intrathecal* OR neuraxial*) AND<BR/>(anesthes* OR anaesthes* OR analges*) AND (card* surg* OR heart surg* OR CABG OR coronar* arter* bypass* OR coronar* bypass* OR heart* valv* surg*) AND (metaanalysis OR meta-analysis OR review OR consensus OR guideline OR random* OR trial* OR control* OR ((singl* OR doubl* OR trebl* OR tripl*) AND (blind* OR mask*))))</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2013-05-16 15:01:44 +0100" MODIFIED_BY="Jane Cracknell" NO="2">
<TITLE MODIFIED="2013-04-30 12:02:07 +0100" MODIFIED_BY="Jane Cracknell">Processing-form: Epidural versus non-epidural anaesthesia in cardiac surgery</TITLE>
<APPENDIX_BODY MODIFIED="2013-05-16 15:01:44 +0100" MODIFIED_BY="[Empty name]">
<P>Article nr:</P>
<P>Date:                            //.</P>
<P>Name reviewer:  Svircevic           Passier             van Dijk</P>
<P>First authors name        ..................................................................</P>
<P>Year of publication         ..................................................................</P>
<SUBSECTION>
<HEADING LEVEL="3">Study Quality</HEADING>
<P>1 Group size</P>
<P>·         Neuraxial                N=</P>
<P>·         Control                   N=</P>
<P>2 Randomized allocation                                    Yes      No        Method unclear</P>
<P>3 Concealed allocation                                       Yes      No       Method unclear</P>
<P>4 Number Crossovers</P>
<P>·         Neuraxial                N=</P>
<P>·         Control                   N= </P>
<P>5 Maximum number dropouts</P>
<P>·         Neuraxial                N=</P>
<P>·         Control                   N= </P>
<P>6 Maximum number Loss-to-follow-up</P>
<P>·         Neuraxial                N=</P>
<P>·         Control                   N= </P>
<P>7 Intention to treat analyses                              Yes      No        unclear</P>
<P>8 Blinded analyses                                           Yes      No        unclear</P>
<P>9 Blinding pre- and post surgery care               Yes      No        unclear</P>
<P>10 Standardized pre- and post surgery care     Yes      No        unclear</P>
<P>11 Blinding end points                                       Yes      No        unclear</P>
<P>12 Standardization endpoints                            Yes      No        unclear</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Preoperative data</HEADING>
<P> 13 Age</P>
<P>·         Neuraxial                  Mean=                                               Sd=</P>
<P>·         Control                      Mean=                                               Sd=</P>
<P> 14 Males</P>
<P>·         Neuraxial                  N=</P>
<P>·         Control                      N= </P>
<P>15 Prior vascular surgery:</P>
<P>·         Neuraxial                  N=                                                    </P>
<P>·         Control                      N=</P>
<P> 16 Diabetic status:        Type                 1                                  2                                  dialysis</P>
<P>·         Neuraxial                              N=                                  N=                                  N=           </P>
<P>·         Control                                 N=                                  N=                                  N=           </P>
<P> 17 Preoperative risk score:         French score                Parsonnet score            Euro score</P>
<P>·         Neuraxial                  Mean=                                               SD=</P>
<P>·         Control                      Mean=                                               SD=</P>
<P> 18 Type(s) of surgery                            ..............................</P>
<P>19 Type of neuraxial anaesthesia:         Intrathecal                       epidural</P>
<P>20 Outcome measures</P>
<P>·         Primary endpoint                           ................................</P>
<P>·         Secondary endpoints                    ................................</P>
<P> 21 Time to follow-up                                ...............................</P>
<P> 22 Main outcomes of this study (give absolute numbers, no percentages)</P>
<TABLE COLS="4" ROWS="5">
<TR>
<TD VALIGN="TOP">
<P>Outcome</P>
</TD>
<TD VALIGN="TOP">
<P>Neuraxial group</P>
</TD>
<TD VALIGN="TOP">
<P>Control group</P>
</TD>
<TD VALIGN="TOP">
<P>P</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Mortality</P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>MI</P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>SVT</P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Respiratory complications</P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
</TR>
</TABLE>
<P> </P>
<P>Other important outcomes:</P>
<P>...............................................................................................................................................................</P>
<P> ...............................................................................................................................................................</P>
<P> main conclusion(s) (see last paragraph discussion):</P>
<P> ...............................................................................................................................................................</P>
<P> ...............................................................................................................................................................</P>
<P> Remarks:</P>
<P> ...............................................................................................................................................................</P>
<P> ...............................................................................................................................................................</P>
<P> ...............................................................................................................................................................</P>
<P> </P>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;# of studies included in quantitative synthesis (meta-analysis) = 31&lt;/p&gt;&lt;p&gt;Mortality 31&lt;/p&gt;&lt;p&gt;Myocardial Infarction 17&lt;/p&gt;&lt;p&gt;Respiratory Complications 14&lt;/p&gt;&lt;p&gt;Supraventricular Tachyarrhythmias 15&lt;/p&gt;&lt;p&gt;Stroke 10&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;Full paper review = 45&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;Excluded records identified through database = 4997&lt;/p&gt;&lt;p&gt;Search overlap 3145&lt;/p&gt;&lt;p&gt;Not RCT/irrelevant 1804&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;Exluded records identified through other sources = 2&lt;/p&gt;&lt;p&gt;Not RCT 2&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;# of records identified through database searching = 5035&lt;/p&gt;&lt;p&gt;MEDLINE 1890&lt;/p&gt;&lt;p&gt;EMBASE 2422&lt;/p&gt;&lt;p&gt;CINHAL 452&lt;/p&gt;&lt;p&gt;Web of Science 271&lt;/p&gt;" WIDTH="120"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;# of additional records identified through other sources =2&lt;/p&gt;&lt;p&gt;Conference proceedings 2&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;# of records excluded = 14&lt;/p&gt;&lt;p&gt;Not RCT/Irrelevant 14&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>